Processing 00000000.tx.1: Association between Parkinson's disease and polymorphisms in the nNOS and iNOS genes in a community-based casecontrol study Clotilde Levecque1,, Alexis Elbaz2,, Jacqueline Clavel3, Florence Richard1, Jean-Sbastien Vidal4, Philippe Amouyel1, Christophe Tzourio2, Annick Alprovitch2 and Marie-Christine Chartier-Harlin1,* 1INSERM Unit 508 Institut Pasteur de Lille, Lille, France, 2INSERM Unit 360 Hpital de la Salptrire, Paris, France, 3INSERM Unit 170, Villejuif, France and 4Service de Neurologie, Hpital Saint-Antoine, Paris, France Received September 16, 2002; 

Phrase: "Association between Parkinson's disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C1511978:Disease Association [Temporal Concept]
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "polymorphisms in the nNOS"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0032529:polymorphisms [Genetic Function]
   726 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "iNOS genes in a community-based casecontrol study Clotilde Levecque1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0017337:Genes [Gene or Genome]

Phrase: ", Alexis Elbaz2,"

Phrase: ", Jacqueline Clavel3,"

Phrase: "Florence Richard1,"

Phrase: "Jean-Sbastien Vidal4,"

Phrase: "Philippe Amouyel1,"

Phrase: "Christophe Tzourio2,"

Phrase: "Annick Alprovitch2"

Phrase: "and"

Phrase: "Marie-Christine Chartier-Harlin1,"

Phrase: "* 1INSERM Unit 508 Institut Pasteur de Lille,"

Phrase: "Lille,"

Phrase: "France,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: "2INSERM Unit 360 Hpital de la Salptrire,"

Phrase: "Paris,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030561:Paris [Geographic Area]
  1000   C0331677:Paris [Plant]
  1000   C1824032:PARIS [Gene or Genome]
   966 E C1824369:PARI [Gene or Genome]

Phrase: "France,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: "3INSERM Unit 170,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439148:Unit [Quantitative Concept]
   827   C1519795:Unit [Quantitative Concept]
   827   C1704753:Unit [Manufactured Object]
   827   C1880519:Unit [Quantitative Concept]

Phrase: "Villejuif,"

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: "and"

Phrase: "4Service de Neurologie,"

Phrase: "Hpital Saint-Antoine,"

Phrase: "Paris,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030561:Paris [Geographic Area]
  1000   C0331677:Paris [Plant]
  1000   C1824032:PARIS [Gene or Genome]
   966 E C1824369:PARI [Gene or Genome]

Phrase: "France Received September 16,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0016674:France [Geographic Area]
   812   C1514756:Received [Qualitative Concept]

Phrase: "2002"

Phrase: ";"
Processing 00000000.tx.2: Accepted November 11, 2002  ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Excess of nitric oxide (NO) has been shown to exert neurotoxic impacts in the brain. 

Phrase: "Accepted November 11,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "2002  ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Excess of nitric oxide (NO)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1979886:Excess [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "neurotoxic impacts in the brain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1825598:IMPACT [Gene or Genome]
Processing 00000000.tx.3: Moreover, inhibition of two NO-synthesizing enzymes, neuronal NOS (nNOS) and inducible NOS (iNOS), displays neuroprotective effects in the MPTP model of Parkinson's disease (PD). 

Phrase: "Moreover,"

Phrase: "inhibition of two NO-synthesizing enzymes,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   757   C0877008:enzyme inhibition [Disease or Syndrome]
   757   C1524081:Enzyme Inhibition [Physiologic Function]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "neuronal NOS (NOS)"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0669368:Neuronal Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0907533:Neuronal Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0030015:oxide [Inorganic Chemical]
   812   C0521390:Neuronal [Immunologic Factor]
   812   C2986642:oxide [Chemical Viewed Functionally]
   741 E C0027882:Neuron [Cell]

Phrase: "and"

Phrase: "inducible NOS (iNOS),"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0669372:Nitric Oxide Synthase, Inducible [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417760:NITRIC OXIDE SYNTHASE, INDUCIBLE [Gene or Genome]
  1000   C1533698:Inducible Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "neuroprotective effects in the MPTP"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0815279:Neuroprotective Effects [Functional Concept]
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "MPTP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "MPTP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "MPTP model of Parkinson's disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0683033:disease model [Intellectual Product]
   783   C0684309:Disease model [Experimental Model of Disease]
   753   C3161035:Model [Intellectual Product]

Phrase: "(PD"

Phrase: ")."
Processing 00000000.tx.4: These data suggest a possible involvement of NOS as factors controlling the resistance of the nigral dopaminergic neurons to environmental insults. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a possible involvement of NOS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1314939:Involvement [Functional Concept]

Phrase: "as factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "controlling"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0332298:controlling [Functional Concept]
  1000   C2587213:Controlling [Functional Concept]
   966 E C0243148:control [Qualitative Concept]
   966 E C1550141:Control [Substance]
   966 E C1882979:Control [Conceptual Entity]
   966 E C3274648:Control [Qualitative Concept]

Phrase: "the resistance of the nigral dopaminergic neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0237834:Resistance [Mental Process]
   748   C1514892:Resistance [Physiologic Function]

Phrase: "to environmental insults."
Processing 00000000.tx.5: Therefore, we investigated whether polymorphisms present in these genes could contribute to the risk of developing PD. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "whether"

Phrase: "polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032529:polymorphisms [Genetic Function]
   966 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "present in these genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0017337:Genes [Gene or Genome]
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "could"

Phrase: "contribute to the risk of developing PD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035647:Risk [Qualitative Concept]
   748   C1880177:Contribute [Activity]
Processing 00000000.tx.6: We carried out a community-based casecontrol study among subjects enrolled in the Mutualit Sociale Agricole, the French health insurance organization for workers connected to agriculture. 

Phrase: "We"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "a community-based casecontrol study among subjects"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0007328:Case-Control Study [Research Activity]
   757   C0681850:Study Subject [Group]
   748   C0557651:Study [Manufactured Object]
   748   C2603343:Study [Research Activity]

Phrase: "enrolled in the Mutualit Sociale Agricole,"

Phrase: "the French health insurance organization for workers"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0920545:health organization [Health Care Related Organization]
   748   C0029237:Organisation [Physiologic Function]
   748   C0029246:Organization [Organization]
   748   C0220885:organization [Qualitative Concept]
   748   C1300196:Organization [Functional Concept]
   748   C1522486:Organization [Professional or Occupational Group]

Phrase: "connected to agriculture."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0001829:Agriculture [Occupation or Discipline]
   756   C2986575:Connect [Activity]
Processing 00000000.tx.7: Two-hundred and nine PD patients and 488 controls of European (mostly French) ancestry and matched for age, sex and region of residency were included in this study. 

Phrase: "Two-hundred"

Phrase: "and"

Phrase: "nine PD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "488 controls of European"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   737   C0243148:control [Qualitative Concept]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]

Phrase: "(mostly French"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1556084:French [Population Group]

Phrase: ")"

Phrase: "ancestry"

Phrase: "and"

Phrase: "matched for age,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0001779:Age [Organism Attribute]
   790   C0150103:matched [Research Activity]
   790   C1708943:Matched [Qualitative Concept]

Phrase: "sex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0009253:Sex [Organism Function]
  1000   C0036864:Sex [Behavior]
  1000   C0079399:sex [Organism Attribute]
  1000   C1314687:Sex [Finding]
  1000   C1522384:sex [Organism Attribute]

Phrase: "and"

Phrase: "region of residency"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0017446:Region [Geographic Area]
   790   C0205147:Region [Spatial Concept]
   718 E C0205276:Regional [Spatial Concept]
   718 E C1947913:Regional [Spatial Concept]

Phrase: "were"

Phrase: "included in this study."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0332257:included [Functional Concept]
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]
Processing 00000000.tx.8: Associations were observed with polymorphisms present in exon 22 of iNOS (OR for AA carriers=0.50, 95% CI=0.290.86, P=0.01) and in exon 29 of nNOS (OR for carriers of the T allele=1.53, 95% CI=1.082.16, P=0.02); 

Phrase: "Associations"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0004083:Associations [Mental Process]
   966 E C0439849:Association [Qualitative Concept]
   966 E C0596306:Association [Phenomenon or Process]
   966 E C0699792:association [Social Behavior]

Phrase: "were"

Phrase: "observed with polymorphisms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0032529:polymorphisms [Genetic Function]
   790   C1441672:Observed [Functional Concept]
   756 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "present in exon 22 of iNOS (OR"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C0028873:Odds Ratio [Quantitative Concept]
   742   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0150312:Present [Quantitative Concept]
   742   C0205263:Inducible [Functional Concept]
   742   C0449450:Present [Idea or Concept]
   742   C0456603:Ratio [Quantitative Concept]
   742   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]
   742   C1518425:{NOS} [Qualitative Concept]
   742   C1547037:Ratio [Intellectual Product]

Phrase: "for AA carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0007294:carriers [Finding]
   827 E C0560175:Carrier [Finding]
   827 E C1706209:Carrier [Medical Device]
   827 E C3273162:Carrier [Intellectual Product]

Phrase: "=0.50,"

Phrase: "95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: "=0.290.86,"

Phrase: "P=0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and in exon 29 of nNOS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0521390:Neuronal [Immunologic Factor]
   748   C1515981:And [Idea or Concept]
   748   C1518425:{NOS} [Qualitative Concept]

Phrase: "(OR for carriers of the T allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0028873:Odds Ratio [Quantitative Concept]
   744   C0456603:Ratio [Quantitative Concept]
   744   C1547037:Ratio [Intellectual Product]

Phrase: "=1.53,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: "=1.082.16,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]

Phrase: "P=0.02"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.9: no association was observed with a polymorphism in exon 18 of nNOS (OR for carriers of the T allele=1.20, 95% CI=0.851.69, P=0.30). 

Phrase: "no association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "was"

Phrase: "observed with a polymorphism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0032529:Polymorphism [Genetic Function]
   770   C1441672:Observed [Functional Concept]
   770   C1882417:Polymorphism [Qualitative Concept]

Phrase: "in exon 18"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "of nNOS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0521390:Neuronal [Immunologic Factor]
   861   C1518425:{NOS} [Qualitative Concept]
   789 E C0027882:Neuron [Cell]

Phrase: "(OR for carriers of the T allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0028873:Odds Ratio [Quantitative Concept]
   744   C0456603:Ratio [Quantitative Concept]
   744   C1547037:Ratio [Intellectual Product]

Phrase: "=1.20,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: "=0.851.69,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450388:69 [Intellectual Product]

Phrase: "P=0.30"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0069900:P-30 [Biomedical or Dental Material]
   913   C0069919:P-30 [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.10: Moreover, a significant interaction of the nNOS polymorphisms with current and ever cigarette smoking was found (nNOS 18, P=0.05; nNOS 29, P=0.04). 

Phrase: "Moreover,"

Phrase: "a significant interaction of the nNOS polymorphisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1704675:Interaction [Functional Concept]

Phrase: "with current"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0521116:Current [Temporal Concept]
  1000   C1705970:Current [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "ever cigarette smoking"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0239059:cigarette smoking [Hazardous or Poisonous Substance]
   901   C0700219:Cigarette Smoking [Individual Behavior]
   827   C0037369:Smoking [Individual Behavior]
   827   C0453996:Smoking [Individual Behavior]
   827   C1881674:SMOKING [Phenomenon or Process]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "(nNOS 18,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0521390:Neuronal [Immunologic Factor]
   827   C1518425:{NOS} [Qualitative Concept]
   755 E C0027882:Neuron [Cell]

Phrase: "P=0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; nNOS 29,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0521390:Neuronal [Immunologic Factor]
   827   C1518425:{NOS} [Qualitative Concept]
   755 E C0027882:Neuron [Cell]

Phrase: "P=0.04"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.11: All together, these data favour an involvement of these two genes as new modifier genes in PD.  

Phrase: "All together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "favour"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "an involvement of these two genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1314939:Involvement [Functional Concept]

Phrase: "as new modifier genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C3178895:Genes, Modifier [Gene or Genome]
   827   C0017337:Genes [Gene or Genome]

Phrase: "in PD."
Processing 00000000.tx.12: INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Parkinson's disease (PD) is the most common neurodegenerative disorder after Alzheimer's disease. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "(PD)"

Phrase: "is"

Phrase: "the most common neurodegenerative disorder after Alzheimer's disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0524851:Neurodegenerative Disorder [Disease or Syndrome]
   767   C0012634:disease/disorder [Disease or Syndrome]
           Disorder
Processing 00000000.tx.13: In the last 10 years, the identification of mutations in three different genes (-synuclein, Parkin and Ubiquitin C-terminal Hydrolase) and the localization of at least five other loci have underscored the importance of genetic factors in the development of PD (19) Moreover, the observation that dopaminergic neurotoxin MPTP effects are similar to those observed in PD has led investigators to undertake association studies for polymorphisms in candidate genes involved in the dopamine pathway, mitochondrial function, lipoprotein metabolism or xenobiotic detoxification (10). 

Phrase: "In the last 10 years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439234:years [Temporal Concept]
   793 E C0439508:/year [Temporal Concept]

Phrase: "the identification of mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020792:Identification [Mental Process]
   770   C0205396:Identification [Qualitative Concept]

Phrase: "in three different genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "(-synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "Ubiquitin C-terminal Hydrolase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0164005:ubiquitin C-terminal hydrolase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0020289:Hydrolase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "and"

Phrase: "the localization of"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0475264:Localisation [Functional Concept]
   790   C1744691:localisation [Biologic Function]

Phrase: "at least five"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205451:Five [Quantitative Concept]
   827   C0439092:less [Intellectual Product]
   827   C0547044:Less [Qualitative Concept]

Phrase: "other loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708726:Locus [Gene or Genome]

Phrase: "have"

Phrase: "underscored"

Phrase: "the importance of genetic factors"

Phrase: "in the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of PD (19"

Phrase: ")"

Phrase: "Moreover,"

Phrase: "the observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that dopaminergic neurotoxin MPTP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0027934:Neurotoxin [Hazardous or Poisonous Substance]
   799   C0282151:Dopaminergic [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   799   C2945751:phenyl [Chemical Viewed Structurally]

Phrase: "MPTP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "MPTP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "MPTP effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "are"

Phrase: "similar to those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "observed in PD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "has"

Phrase: "led investigators to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035173:Investigators [Professional or Occupational Group]

Phrase: "undertake"

Phrase: "association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "studies for polymorphisms"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0032529:polymorphisms [Genetic Function]
   790   C0557651:Study [Manufactured Object]
   790   C0947630:studies [Laboratory Procedure]
   790   C2603343:Study [Research Activity]
   756 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "in candidate genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1332838:Candidate Genes [Gene or Genome]
   861   C0017337:Genes [Gene or Genome]

Phrase: "involved in the dopamine pathway,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C1314939:Involved [Functional Concept]
   760   C1704259:Pathway [Molecular Function]
   760   C1705987:Pathway [Conceptual Entity]

Phrase: "mitochondrial function,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "lipoprotein metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1158917:lipoprotein metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "or"

Phrase: "xenobiotic detoxification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025516:Detoxification [Organism Function]
   861   C0150543:Detoxification [Therapeutic or Preventive Procedure]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.14: Nitric oxide (NO) is a biological messenger molecule with diverse physiologic roles. 

Phrase: "Nitric oxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "(NO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: ")"

Phrase: "is"

Phrase: "a biological messenger molecule with diverse physiologic roles."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0567416:Molecule [Substance]
Processing 00000000.tx.15: However, NO is also a free radical and can combine with superoxide anions to form peroxynitrite. 

Phrase: "However,"

Phrase: "NO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "is"

Phrase: "also"

Phrase: "a free radical"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0016693:Free radical [Biologically Active Substance,Chemical Viewed Structurally]
   861   C0302912:Radical [Chemical Viewed Structurally]
   861   C0332296:free [Functional Concept]
   861   C0439807:Radical [Qualitative Concept]
   861   C1880497:Free [Qualitative Concept]
   861   C1996904:Free [Qualitative Concept]

Phrase: "and"

Phrase: "can"

Phrase: "combine with superoxide anions to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   773   C0038836:Superoxide Anion [Element, Ion, or Isotope]
           Superoxide
   760   C0003075:Anions [Element, Ion, or Isotope]
   760   C0336789:Combine [Manufactured Object]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "peroxynitrite."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0136157:Peroxynitrite [Biologically Active Substance,Inorganic Chemical]
Processing 00000000.tx.16: Therefore, NO contributes to oxidative stress and induces numerous changes in the cells, including (1) lipid peroxidation, (2) functional alterations in proteins (e.g. nitrosylation), (3) DNA damage and (4) mitochondrial energy dysfunction (11). 

Phrase: "Therefore,"

Phrase: "NO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "contributes to oxidative stress"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   770   C0038435:Stress [Finding]
   770   C0311404:Oxidative [Functional Concept]
   770   C1880177:Contribute [Activity]

Phrase: "and"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "numerous changes in the cells,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "lipid peroxidation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023775:Lipid Peroxidation [Molecular Function]
   861   C0023779:Lipid [Lipid]
   861   C0178796:peroxidation [Phenomenon or Process]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "functional alterations in proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1515926:Alteration [Idea or Concept]

Phrase: "("

Phrase: "e.g. nitrosylation"

Phrase: ")"

Phrase: ","

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "DNA damage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   861   C0010957:Damage [Injury or Poisoning]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1883709:Damage [Functional Concept]

Phrase: "and ("

Phrase: "4"

Phrase: ")"

Phrase: "mitochondrial energy dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0031847:dysfunction [Functional Concept]
   827   C0277785:Dysfunction, NOS [Qualitative Concept]
   771 E C0231174:Malfunction [Functional Concept]
   771 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.17: The formation of NO is catalysed from arginin and oxygen by the nitric oxide synthase (NOS). 

Phrase: "The formation of NO"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   844   C1157570:nitric oxide formation [Molecular Function]
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "is"

Phrase: "catalysed from arginin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756   C0007382:catalyse [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "oxygen by the nitric oxide synthase (NOS)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.18: Three isoforms of NOS have been identified: neuronal NOS (nNOS); 

Phrase: "Three isoforms of NOS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "have"

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ":"

Phrase: "neuronal NOS"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0669368:Neuronal Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0907533:Neuronal Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0030015:oxide [Inorganic Chemical]
   812   C0521390:Neuronal [Immunologic Factor]
   812   C2986642:oxide [Chemical Viewed Functionally]
   741 E C0027882:Neuron [Cell]

Phrase: "(nNOS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0521390:Neuronal [Immunologic Factor]
   861   C1518425:{NOS} [Qualitative Concept]
   789 E C0027882:Neuron [Cell]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.19: endothelial NOS (eNOS); 

Phrase: "endothelial NOS (NOS)"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0014257:Endothelial [Tissue]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: ";"
Processing 00000000.tx.20: and the inducible NOS (iNOS). 

Phrase: "and"

Phrase: "the inducible NOS"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0669372:Nitric Oxide Synthase, Inducible [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417760:NITRIC OXIDE SYNTHASE, INDUCIBLE [Gene or Genome]
  1000   C1533698:Inducible Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "(iNOS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518425:{NOS} [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.21: Of the three isoforms, nNOS and iNOS are particularly relevant with respect to their potential implications in neurodegeneration and glial response occurring in PD. 

Phrase: "Of the three isoforms,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "nNOS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0521390:Neuronal [Immunologic Factor]
   861   C1518425:{NOS} [Qualitative Concept]
   789 E C0027882:Neuron [Cell]

Phrase: "and"

Phrase: "iNOS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518425:{NOS} [Qualitative Concept]

Phrase: "are"

Phrase: "particularly relevant with respect to their potential implications"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2347946:Relevant [Qualitative Concept]

Phrase: "in neurodegeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "glial response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "occurring in PD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C1709305:Occur [Activity]
   756   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.22: Indeed, nNOS is the main isoform constitutively expressed in neurons and glia. 

Phrase: "Indeed,"

Phrase: "nNOS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0521390:Neuronal [Immunologic Factor]
   861   C1518425:{NOS} [Qualitative Concept]
   789 E C0027882:Neuron [Cell]

Phrase: "is"

Phrase: "the main isoform constitutively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "expressed in neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0027882:Neurons [Cell]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and"

Phrase: "glia."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027836:Glia [Cell]
  1000   C1087003:Glia [Plant]
Processing 00000000.tx.23: Moreover, iNOS can be induced in brain glial cells and invading macrophages in responses to a variety of injuries (12,13). 

Phrase: "Moreover,"

Phrase: "iNOS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518425:{NOS} [Qualitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "induced in brain glial cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   806   C0027836:Glial Cells [Cell]
           Glial
   797   C0596208:brain cells [Cell]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0007634:Cells [Cell]
   760   C0205263:Induced [Functional Concept]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "invading macrophages in responses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0024432:Macrophages [Cell]
   770   C1546706:Macrophages [Intellectual Product]
   770   C1550652:Macrophages [Body Substance]

Phrase: "to a variety"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1883525:Variety [Conceptual Entity]
  1000   C2346866:Variety [Conceptual Entity]

Phrase: "of injuries"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1510467:injuries [Injury or Poisoning]
  1000   C3263723:Injuries [Injury or Poisoning]
   966 E C3263722:Injury [Injury or Poisoning]

Phrase: "(12,"

Phrase: "13"

Phrase: ")."
Processing 00000000.tx.24: There are several lines of evidence in humans as well as in animal models favouring an implication of NO and NOS in the aetiology of PD. 

Phrase: "There"

Phrase: "are"

Phrase: "several lines of evidence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205132:lines [Spatial Concept]
   737 E C1550648:Line [Substance]
   737 E C1552960:Line [Quantitative Concept]

Phrase: "in humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]

Phrase: "as well as in animal models"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0599779:Models, Animal [Animal]
   753   C0003062:Animal [Animal]
   753   C0205170:Well [Qualitative Concept]
   753   C3146287:Well [Manufactured Object]
   753   C3161035:Models [Intellectual Product]

Phrase: "favouring"

Phrase: "an implication of NO"

Phrase: "and"

Phrase: "NOS in the aetiology of PD."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   800   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   770   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   744   C0030015:oxide [Inorganic Chemical]
   744   C2986642:oxide [Chemical Viewed Functionally]
Processing 00000000.tx.25: In particular, the inhibition of nNOS or iNOS, either using pharmacological substances or gene-deficient mice, prevents the destruction of dopaminergic neurons in MPTP models of PD (1419). 

Phrase: "In particular,"

Phrase: "the inhibition of nNOS"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0234074:Neuronal inhibition [Organ or Tissue Function]
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "or"

Phrase: "iNOS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518425:{NOS} [Qualitative Concept]

Phrase: "either"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "pharmacological substances"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1254351:Pharmacological Substance [Pharmacologic Substance]
   861   C0439861:Substances [Substance]

Phrase: "or"

Phrase: "gene-deficient mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "the destruction of dopaminergic neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1261381:Destruction [Therapeutic or Preventive Procedure]
   760   C1948029:Destruction [Activity]

Phrase: "in MPTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2945751:phenyl [Chemical Viewed Structurally]

Phrase: "MPTP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "MPTP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "MPTP models of PD (1419"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Models [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.26: We therefore explored the relation between polymorphisms in the nNOS and iNOS genes and PD in a community-based casecontrol study. 

Phrase: "We therefore"

Phrase: "explored"

Phrase: "the relation between polymorphisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0080103:Relation [Family Group]
   770   C0869014:relation [Social Behavior]

Phrase: "in the nNOS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0521390:Neuronal [Immunologic Factor]
   861   C1518425:{NOS} [Qualitative Concept]
   789 E C0027882:Neuron [Cell]

Phrase: "and"

Phrase: "iNOS genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "and"

Phrase: "PD in a community-based casecontrol study."
Processing 00000000.tx.27: Moreover, we investigated if exposure to pesticides or cigarette smoking modified the relation between these polymorphisms and PD. 

Phrase: "Moreover,"

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "if"

Phrase: "exposure to pesticides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332157:Exposure to [Clinical Attribute]
           Exposure
   790   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "or"

Phrase: "cigarette smoking"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0239059:cigarette smoking [Hazardous or Poisonous Substance]
  1000   C0700219:Cigarette Smoking [Individual Behavior]
   861   C0037369:Smoking [Individual Behavior]
   861   C0453996:Smoking [Individual Behavior]
   861   C1881674:SMOKING [Phenomenon or Process]

Phrase: "modified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]

Phrase: "the relation between these polymorphisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0080103:Relation [Family Group]
   760   C0869014:relation [Social Behavior]

Phrase: "and"

Phrase: "PD."
Processing 00000000.tx.28: MPTP is an analog of the pesticide Paraquat, and exposure to pesticides is associated with PD (20). 

Phrase: "MPTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2945751:phenyl [Chemical Viewed Structurally]

Phrase: "MPTP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "MPTP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "MPTP"

Phrase: "is"

Phrase: "an analog of the pesticide Paraquat,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0243071:Analog [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "exposure to pesticides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332157:Exposure to [Clinical Attribute]
           Exposure
   790   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "is"

Phrase: "associated with PD (20"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C0429911:PD 20 [Laboratory or Test Result]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: ")."
Processing 00000000.tx.29: In addition, MPTP modulates nNOS and iNOS expression (18,21). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "MPTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2945751:phenyl [Chemical Viewed Structurally]

Phrase: "MPTP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "MPTP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "MPTP"

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "nNOS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0521390:Neuronal [Immunologic Factor]
   861   C1518425:{NOS} [Qualitative Concept]
   789 E C0027882:Neuron [Cell]

Phrase: "and"

Phrase: "iNOS expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(18,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.30: Conversely, cigarette smoking is inversely associated with PD and may affect NO production (22). 

Phrase: "Conversely,"

Phrase: "cigarette smoking"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0239059:cigarette smoking [Hazardous or Poisonous Substance]
  1000   C0700219:Cigarette Smoking [Individual Behavior]
   861   C0037369:Smoking [Individual Behavior]
   861   C0453996:Smoking [Individual Behavior]
   861   C1881674:SMOKING [Phenomenon or Process]

Phrase: "is"

Phrase: "inversely"

Phrase: "associated with PD"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "may"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "NO production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033268:production [Occupational Activity]
   734   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.31: Our data tend to implicate both nNOS and iNOS genes in the development of PD.  

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "tend"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "implicate"

Phrase: "both nNOS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0521390:Neuronal [Immunologic Factor]
   861   C1518425:{NOS} [Qualitative Concept]
   789 E C0027882:Neuron [Cell]

Phrase: "and"

Phrase: "iNOS genes in the development of PD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0017337:Genes [Gene or Genome]
   731   C0017340:Genes, Developmental [Gene or Genome]
Processing 00000000.tx.32: RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Two-hundred and ninety-two subjects requested free health coverage for PD to the Mutualit Sociale Agricole (MSA). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Two-hundred"

Phrase: "and"

Phrase: "ninety-two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205448:Two [Quantitative Concept]

Phrase: "subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "requested free health coverage for PD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1551362:coverage [Idea or Concept]
   753   C1999244:Coverage [Functional Concept]

Phrase: "to the Mutualit Sociale Agricole (MSA)."
Processing 00000000.tx.33: Of these, 184 were directly examined by the neurologist: 153 were found to have PD, 29 had another cause of parkinsonism, and two did not fulfill the criteria for parkinsonism. 

Phrase: "Of these,"

Phrase: "184"

Phrase: "were"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "examined by the neurologist"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237426:Neurologist [Professional or Occupational Group]
   770   C0332128:Examined [Finding]

Phrase: ":"

Phrase: "153"

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "PD,"

Phrase: "29"

Phrase: "had"

Phrase: "another cause of parkinsonism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015127:cause [Functional Concept]
   770   C1524003:Cause [Conceptual Entity]

Phrase: "and"

Phrase: "two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "fulfill"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550543:Fulfill [Idea or Concept]

Phrase: "the criteria for parkinsonism."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0243161:criteria [Intellectual Product]
Processing 00000000.tx.34: Of the remaining 108 patients, the neurologist who had requested free health coverage provided clinical information for 86 patients: he confirmed the PD diagnosis for 72 and diagnosed another cause of parkinsonism for 14. 

Phrase: "Of the remaining 108 patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "the neurologist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237426:Neurologist [Professional or Occupational Group]

Phrase: "who"

Phrase: "had"

Phrase: "requested free health coverage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1551362:coverage [Idea or Concept]
   812   C1999244:Coverage [Functional Concept]

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "clinical information for 86 patients"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C2708732:Clinical information [Clinical Attribute]
   806   C2708733:Clinical information [Intellectual Product]
   781   C1955348:Patient Information [Intellectual Product]
   781   C2598117:Patient Information [Clinical Attribute]
   760   C1533716:Information [Idea or Concept]

Phrase: ":"

Phrase: "he"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the PD diagnosis for 72"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0011900:Diagnosis [Finding]
   760   C1704338:diagnosis [Qualitative Concept]
   760   C1704656:DIAGNOSIS [Research Activity]

Phrase: "and"

Phrase: "diagnosed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011900:Diagnosed [Finding]

Phrase: "another cause of parkinsonism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015127:cause [Functional Concept]
   770   C1524003:Cause [Conceptual Entity]

Phrase: "for 14."
Processing 00000000.tx.35: No detailed clinical information was obtained for 22 patients. 

Phrase: "No detailed clinical information"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C2708732:Clinical information [Clinical Attribute]
   901   C2708733:Clinical information [Intellectual Product]
   827   C1533716:Information [Idea or Concept]
   755 E C3242430:informational [Idea or Concept]

Phrase: "was"

Phrase: "obtained for 22 patients."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]
Processing 00000000.tx.36: However, based on the clinical examination by the MSA physician, all fulfilled the criteria for parkinsonism, and none had used neuroleptics prior to PD onset; 

Phrase: "However,"

Phrase: "based on the clinical examination"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   806   C0031809:Clinical examination [Health Care Activity]
   760   C0205210:Clinical [Qualitative Concept]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "by the MSA physician,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0031831:Physician [Professional or Occupational Group]
   812   C0804815:Physician [Clinical Attribute]

Phrase: "all"

Phrase: "fulfilled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550543:Fulfill [Idea or Concept]

Phrase: "the criteria for parkinsonism,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0243161:criteria [Intellectual Product]

Phrase: "and"

Phrase: "none"

Phrase: "had"

Phrase: "used neuroleptics prior to PD onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0040615:Neuroleptics [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.37: they were therefore retained for our analyses. 

Phrase: "they"

Phrase: "were"

Phrase: "therefore"

Phrase: "retained for our analyses."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0333118:Retained [Functional Concept]
   737   C0002778:Analysis [Laboratory Procedure]
   737   C0936012:Analysis [Research Activity]
   737   C1524024:analysis [Functional Concept]
Processing 00000000.tx.38: The 247 (153+72+22) patients were matched to 676 controls (194 quadruplets, 41 triplets, 12 pairs); 

Phrase: "The 247"

Phrase: "(153+72+22"

Phrase: ")"

Phrase: "patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "matched to 676 controls"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0150103:matched [Research Activity]
   770   C1708943:Matched [Qualitative Concept]
   737   C0243148:control [Qualitative Concept]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]

Phrase: "(194 quadruplets,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0034373:Quadruplets [Family Group]
   827 E C0205175:Quadruplet [Quantitative Concept]

Phrase: "41 triplets,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0041095:Triplets [Family Group]
   827 E C0205174:Triplet [Quantitative Concept]

Phrase: "12 pairs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709450:Pair [Qualitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.39: 89% of the PD patients and 84% of the matched controls accepted blood sampling for DNA extraction. 

Phrase: "89% of the PD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "84% of the matched controls"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0150103:matched [Research Activity]
   760   C1708943:Matched [Qualitative Concept]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]

Phrase: "accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: "blood sampling for DNA extraction."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0005834:Blood sampling [Diagnostic Procedure]
   806   C0190979:blood sampling [Diagnostic Procedure]
   790 E C0178913:Blood sample [Body Substance]
   760   C0005767:Blood [Tissue]
   760   C0005768:blood [Body Substance]
   760   C0229664:Blood [Body Substance]
   760   C0441621:Sampling [Diagnostic Procedure]
   760   C0870078:Sampling [Idea or Concept]
   726 E C0370003:Sample [Substance]
   726 E C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.40: In addition, five patients and seven controls with at least one parent born outside Europe were excluded. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "five patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "seven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205453:Seven [Quantitative Concept]

Phrase: "controls with"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0243148:control [Qualitative Concept]
   833   C1550141:Control [Substance]
   833   C1882979:Control [Conceptual Entity]
   833   C2587213:Control [Functional Concept]
   833   C3274648:Control [Qualitative Concept]

Phrase: "at least one parent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030551:parent [Family Group]
   827   C2699423:Parent [Conceptual Entity]

Phrase: "born"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0004897:Bear [Mammal]

Phrase: "outside Europe"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015176:Europe [Geographic Area]

Phrase: "were"

Phrase: "excluded."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]
Processing 00000000.tx.41: The final sample includes 209 patients and 488 matched controls (108 quadruplets, 63 triplets, 38 pairs). 

Phrase: "The final sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "209 patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "488 matched controls"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0150103:matched [Research Activity]
   827   C1708943:Matched [Qualitative Concept]
   793   C0243148:control [Qualitative Concept]
   793   C1550141:Control [Substance]
   793   C1882979:Control [Conceptual Entity]
   793   C2587213:Control [Functional Concept]
   793   C3274648:Control [Qualitative Concept]

Phrase: "(108 quadruplets,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0034373:Quadruplets [Family Group]
   827 E C0205175:Quadruplet [Quantitative Concept]

Phrase: "63 triplets,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0041095:Triplets [Family Group]
   827 E C0205174:Triplet [Quantitative Concept]

Phrase: "38 pairs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709450:Pair [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.42: Their general characteristics are shown in Table 1. 

Phrase: "Their general characteristics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1521970:Characteristics [Qualitative Concept]

Phrase: "are"

Phrase: "shown in Table 1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.43: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.44: General characteristics of Parkinson's disease patients and controls  The results concerning the three biallelic polymorphisms in the two candidate genes are presented in Table 2. 

Phrase: "General characteristics of Parkinson's disease patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   847   C1285579:General characteristic of patient [Clinical Attribute]
   783   C0599878:characteristics disease [Pathologic Function]
   767   C0815172:patient characteristics [Clinical Attribute]
   753   C1521970:Characteristics [Qualitative Concept]

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "concerning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2699424:Concern [Idea or Concept]

Phrase: "the three biallelic polymorphisms in the two candidate genes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   745   C0678951:gene polymorphisms [Genetic Function]
   742   C0032529:polymorphisms [Genetic Function]
   708 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "are"

Phrase: "presented in Table 2."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C0449450:Presented [Idea or Concept]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.45: The control population was in HardyWeinberg equilibrium for all three polymorphisms (iNOS22, P=0.45; nNOS18, P=0.47; nNOS29, P=0.56). 

Phrase: "The control population"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0032662:control population [Occupation or Discipline]
   861   C0032659:Population [Quantitative Concept]
   861   C0243148:control [Qualitative Concept]
   861   C1257890:Population [Population Group]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "was in HardyWeinberg equilibrium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0014653:Equilibrium [Organism Function]
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1421478:WAS [Gene or Genome]
   770   C1547026:Equilibrium [Quantitative Concept]

Phrase: "for all three polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032529:polymorphisms [Genetic Function]
   827 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "(iNOS22,"

Phrase: "P=0.45"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; nNOS18,"

Phrase: "P=0.47"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; nNOS29,"

Phrase: "P=0.56"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.46: View this table: [in this window] [in a new window]  Table 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.47: The association between Parkinson's disease and nNOS and iNOS polymorphisms  AA homozygotes for the iNOS 22 polymorphism were more frequent among controls than among patients (OR=0.56, 95% CI=0.321.01; P=0.05), whereas there was no significant difference in the frequency of heterozygotes between the two groups. 

Phrase: "The association between Parkinson's disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C1511978:Disease Association [Temporal Concept]
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "nNOS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0521390:Neuronal [Immunologic Factor]
   861   C1518425:{NOS} [Qualitative Concept]
   789 E C0027882:Neuron [Cell]

Phrase: "and"

Phrase: "iNOS polymorphisms  AA homozygotes for the iNOS 22 polymorphism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0019904:Homozygotes [Organism Attribute]

Phrase: "were"

Phrase: "more frequent among controls"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332183:Frequent [Temporal Concept]

Phrase: "than"

Phrase: "among patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "(OR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "=0.56,"

Phrase: "95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: "=0.321.01"

Phrase: "; P=0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "there"

Phrase: "was"

Phrase: "no significant difference in the frequency of heterozygotes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1705241:*Difference [Quantitative Concept]
   744   C1705242:Difference [Qualitative Concept]

Phrase: "between the two groups."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
Processing 00000000.tx.48: Assuming a recessive effect of the A allele, the OR for AA carriers was 0.50 (95% CI=0.290.86; P=0.01) compared with the two other genotypes. 

Phrase: "Assuming"

Phrase: "a recessive effect of the"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "A allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Allele [Gene or Genome]

Phrase: "the OR for AA carriers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0028873:Odds Ratio [Quantitative Concept]
   753   C0456603:Ratio [Quantitative Concept]
   753   C1547037:Ratio [Intellectual Product]

Phrase: "was"

Phrase: "0.50"

Phrase: "(95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: "=0.290.86"

Phrase: "; P=0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "compared with the two"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205448:Two [Quantitative Concept]
   770   C1707455:Compared [Activity]

Phrase: "other genotypes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotypes [Organism Attribute]
Processing 00000000.tx.49: This inverse association was stronger in men (OR=0.40, 95% CI=0.170.92; P=0.03), than in women (OR=0.61, 95% CI=0.301.23; P=0.16); 

Phrase: "This inverse association"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1708567:Inverse Association [Conceptual Entity]
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "was"

Phrase: "stronger in men (OR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0442821:Strong [Qualitative Concept]

Phrase: "=0.40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: "95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: "=0.170.92"

Phrase: "; P=0.03"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "than"

Phrase: "in women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "(OR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "=0.61,"

Phrase: "95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: "=0.301.23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450348:23 [Quantitative Concept]

Phrase: "; P=0.16"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.50: however, the interaction between sex and iNOS 22 was not significant (P=0.49). 

Phrase: "however,"

Phrase: "the interaction between sex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "iNOS 22"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205263:Inducible [Functional Concept]
   827   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1518425:{NOS} [Qualitative Concept]

Phrase: "was"

Phrase: "not significant"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1273937:Not significant [Finding]
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]

Phrase: "(P=0.49"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.51: Similar results were obtained when considering only cases and matched controls without family history of PD (OR for AA carriers=0.48, 95% CI=0.270.86; P=0.01) or with both parents born in France (OR for AA carriers=0.53, 95% CI=0.300.93; P=0.03), and when cases with young onset PD (45 years, n=4 and 10 matched controls) were excluded from the analyses (OR for AA carriers=0.47, 95% CI=0.270.82; P=0.01). 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "when"

Phrase: "considering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considering [Idea or Concept]

Phrase: "only cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "matched controls without family history of PD (OR"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0150103:matched [Research Activity]
   742   C1708943:Matched [Qualitative Concept]
   708   C0243148:control [Qualitative Concept]
   708   C1550141:Control [Substance]
   708   C1882979:Control [Conceptual Entity]
   708   C2587213:Control [Functional Concept]
   708   C3274648:Control [Qualitative Concept]

Phrase: "for AA carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0007294:carriers [Finding]
   827 E C0560175:Carrier [Finding]
   827 E C1706209:Carrier [Medical Device]
   827 E C3273162:Carrier [Intellectual Product]

Phrase: "=0.48,"

Phrase: "95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: "=0.270.86"

Phrase: "; P=0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "or with both parents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0030551:Parents [Family Group]
   737 E C2699423:Parent [Conceptual Entity]

Phrase: "born in France"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1277359:Born in France [Finding]
   790   C0016674:France [Geographic Area]
   756   C0004897:Bear [Mammal]

Phrase: "(OR for AA carriers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0028873:Odds Ratio [Quantitative Concept]
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: "=0.53,"

Phrase: "95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: "=0.300.93"

Phrase: "; P=0.03"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "when"

Phrase: "cases with young onset PD (45 years,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   748   C0868928:Cases [Functional Concept]
   748   C1533148:Cases [Quantitative Concept]
   714 E C1706255:CASE [Medical Device]
   714 E C1706256:Case [Conceptual Entity]

Phrase: "n=4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "10 matched controls"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0150103:matched [Research Activity]
   827   C1708943:Matched [Qualitative Concept]
   793   C0243148:control [Qualitative Concept]
   793   C1550141:Control [Substance]
   793   C1882979:Control [Conceptual Entity]
   793   C2587213:Control [Functional Concept]
   793   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "excluded from the analyses"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C1554077:Excluded [Idea or Concept]
   770   C2828389:Excluded [Activity]
   737   C0002778:Analysis [Laboratory Procedure]
   737 E C0332196:Exclude [Functional Concept]
   737   C0936012:Analysis [Research Activity]
   737   C1524024:analysis [Functional Concept]

Phrase: "(OR for AA carriers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0028873:Odds Ratio [Quantitative Concept]
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: "=0.47,"

Phrase: "95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: "=0.270.82"

Phrase: "; P=0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.52: This association was not modified by age at onset of PD. 

Phrase: "This association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "modified by age at onset of PD."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   800   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   778   C0205349:Modified By [Qualitative Concept]
   748   C0001779:Age [Organism Attribute]
   748   C0332162:Onset [Qualitative Concept]
   748   C0392747:Modified [Functional Concept]
Processing 00000000.tx.53: (Data not shown.) 

Phrase: "(Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"
Processing 00000000.tx.54: There were no statistically significant differences in the genotypic distributions of the nNOS 18 polymorphism between patients and controls (Table 2). 

Phrase: "There"

Phrase: "were"

Phrase: "no statistically significant differences in the genotypic distributions of the nNOS 18 polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   701   C1705241:*Difference [Quantitative Concept]
   701   C1705242:Difference [Qualitative Concept]

Phrase: "between patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.55: Conversely, genotypic distributions of the nNOS 29 polymorphism were different between patients and controls (P=0.01). 

Phrase: "Conversely,"

Phrase: "genotypic distributions of the nNOS 29 polymorphism"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C0037775:Distributions [Spatial Concept]
   711 E C0520511:distribution [Idea or Concept]
   711 E C1704711:Distribution [Functional Concept]

Phrase: "were"

Phrase: "different between patients"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1705242:Different [Qualitative Concept]
   718 E C1705241:*Difference [Quantitative Concept]

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "(P=0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.56: Both heterozygotes and TT homozygotes were at increased risk of PD. 

Phrase: "Both heterozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygotes [Organism Attribute]

Phrase: "and"

Phrase: "TT homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]

Phrase: "were at increased risk of PD."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0035647:Risk [Qualitative Concept]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
Processing 00000000.tx.57: The OR increased with the number of T alleles (P for trend=0.004). 

Phrase: "The OR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "increased with the number of T alleles"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0002085:Alleles [Gene or Genome]
   748   C0205217:Increased [Quantitative Concept]
   748   C0237753:*Number [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "(P for trend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C2603361:P' [Clinical Attribute]

Phrase: "=0.004"

Phrase: ")."
Processing 00000000.tx.58: The OR for carriers of at least one T allele was 1.53 (95% CI=1.082.16; P=0.02). 

Phrase: "The OR for carriers of"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0028873:Odds Ratio [Quantitative Concept]
   753   C0456603:Ratio [Quantitative Concept]
   753   C1547037:Ratio [Intellectual Product]

Phrase: "at least one T allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Allele [Gene or Genome]

Phrase: "was"

Phrase: "1.53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "(95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: "=1.082.16"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]

Phrase: "; P=0.02"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.59: According to the Akaike Information Criterion of the codominant (484.281) and dominant (486.868) models, the codominant model was the best fitting model. 

Phrase: "According to the Akaike Information Criterion"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0243161:Criterion [Intellectual Product]
   827   C1533716:Information [Idea or Concept]
   755 E C3242430:informational [Idea or Concept]

Phrase: "of the codominant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3275072:CO-DOMINANT [Finding]

Phrase: "(484.281"

Phrase: ")"

Phrase: "and"

Phrase: "dominant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1527180:Dominant [Functional Concept]

Phrase: "(486.868"

Phrase: ")"

Phrase: "models,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Models [Intellectual Product]

Phrase: "the codominant model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "was"

Phrase: "the best fitting model."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3161035:Model [Intellectual Product]
Processing 00000000.tx.60: Again, we noted that the association between the polymorphism and PD was stronger in men (OR=1.84, 95% CI=1.152.94; P=0.01), than in women (OR=1.21, 95% CI=0.722.04; P=0.47), although the interaction between sex and nNOS 29 was not statistically significant (P=0.23). 

Phrase: "Again,"

Phrase: "we"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the association between the polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "PD"

Phrase: "was"

Phrase: "stronger in men (OR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0442821:Strong [Qualitative Concept]

Phrase: "=1.84,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: "=1.152.94"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]

Phrase: "; P=0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "than"

Phrase: "in women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "(OR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "=1.21,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: "=0.722.04"

Phrase: "; P=0.47"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "the interaction between sex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "nNOS 29"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0521390:Neuronal [Immunologic Factor]
   827   C1518425:{NOS} [Qualitative Concept]
   755 E C0027882:Neuron [Cell]

Phrase: "was"

Phrase: "not statistically significant"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   913   C1273937:Not significant [Finding]
   901   C0237881:statistically significant [Quantitative Concept]
           significant
   829 E C1709380:Statistical Significance [Quantitative Concept]
   827   C0038215:Statistically [Occupation or Discipline]
   827   C0750502:Significant [Idea or Concept]
   827   C1546944:Significant [Qualitative Concept]

Phrase: "(P=0.23"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0795725:P-23 [Organic Chemical,Pharmacologic Substance]
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0450348:23 [Quantitative Concept]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.61: Similar results were obtained for cases and matched controls without family history of PD (OR for T carriers=1.56, 95% CI=1.082.26; P=0.02), or with both parents born in France (OR for T carriers=1.58, 95% CI=1.102.26; P=0.01), and when cases with young-onset PD were excluded from the analyses (OR for T carriers=1.52, 95% CI=1.072.15; P=0.02). 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained for cases"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0868928:Cases [Functional Concept]
   790   C1301820:Obtained [Functional Concept]
   790   C1533148:Cases [Quantitative Concept]
   756 E C1706255:CASE [Medical Device]
   756 E C1706256:Case [Conceptual Entity]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "and"

Phrase: "matched controls without family history of PD (OR"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0150103:matched [Research Activity]
   742   C1708943:Matched [Qualitative Concept]
   708   C0243148:control [Qualitative Concept]
   708   C1550141:Control [Substance]
   708   C1882979:Control [Conceptual Entity]
   708   C2587213:Control [Functional Concept]
   708   C3274648:Control [Qualitative Concept]

Phrase: "for T carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0007294:carriers [Finding]
   827 E C0560175:Carrier [Finding]
   827 E C1706209:Carrier [Medical Device]
   827 E C3273162:Carrier [Intellectual Product]

Phrase: "=1.56,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: "=1.082.26"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]

Phrase: "; P=0.02"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "or with both parents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0030551:Parents [Family Group]
   737 E C2699423:Parent [Conceptual Entity]

Phrase: "born in France"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1277359:Born in France [Finding]
   790   C0016674:France [Geographic Area]
   756   C0004897:Bear [Mammal]

Phrase: "(OR for T carriers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0028873:Odds Ratio [Quantitative Concept]
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: "=1.58,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: "=1.102.26"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]

Phrase: "; P=0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "when"

Phrase: "cases with young-onset PD"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0868928:Cases [Functional Concept]
   760   C1533148:Cases [Quantitative Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]

Phrase: "were"

Phrase: "excluded from the analyses"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C1554077:Excluded [Idea or Concept]
   770   C2828389:Excluded [Activity]
   737   C0002778:Analysis [Laboratory Procedure]
   737 E C0332196:Exclude [Functional Concept]
   737   C0936012:Analysis [Research Activity]
   737   C1524024:analysis [Functional Concept]

Phrase: "(OR for T carriers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0028873:Odds Ratio [Quantitative Concept]
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: "=1.52,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: "=1.072.15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]

Phrase: "; P=0.02"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.62: This association was not modified by age at onset of PD (data not shown). 

Phrase: "This association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "modified by age at onset of PD (data"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   789   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   770   C0205349:Modified By [Qualitative Concept]
   744   C0001779:Age [Organism Attribute]
   744   C0332162:Onset [Qualitative Concept]
   744   C0392747:Modified [Functional Concept]
   744   C1511726:Data [Idea or Concept]
   744   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.63: Haplotypes were constructed for the two nNOS polymorphisms (Table 3). 

Phrase: "Haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "were"

Phrase: "constructed for the two nNOS polymorphisms"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0032529:polymorphisms [Genetic Function]
   748   C0205448:Two [Quantitative Concept]
   748   C0521390:Neuronal [Immunologic Factor]
   748   C1518425:{NOS} [Qualitative Concept]
   714 E C1882417:Polymorphism [Qualitative Concept]
   714   C2827421:Construct [Classification]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.64: Among patients, there was an excess of haplotypes including the T allele for nNOS 29; 

Phrase: "Among patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "there"

Phrase: "was"

Phrase: "an excess of haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1979886:Excess [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the T allele for nNOS 29"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0002085:Allele [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.65: this excess appeared to be independent of the nNOS 18 allele (casecontrol comparison of nNOS 18nNOS 29 haplotypes C-T and T-T versus all others: OR=1.39, 95% CI=1.071.79, P=0.009). 

Phrase: "this excess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979886:Excess [Qualitative Concept]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be independent of the nNOS 18 allele"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0332291:Independent of [Functional Concept]
   744   C0002085:Allele [Gene or Genome]
   744   C0085862:Independent [Idea or Concept]
   744   C0521390:Neuronal [Immunologic Factor]
   744   C1299583:Independent [Finding]
   744   C1518425:{NOS} [Qualitative Concept]
   744   C2987476:Be [Conceptual Entity]

Phrase: "(casecontrol comparison of nNOS 18nNOS 29 haplotypes C-T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "T-T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "versus"

Phrase: "all others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: ":"

Phrase: "OR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "=1.39,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: "=1.071.79,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]

Phrase: "P=0.009"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.66: View this table: [in this window] [in a new window]  Table 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.67: Estimated frequencies of nNOS haplotypes in Parkinson's disease patients and controls  We explored the hypothesis of an interaction between the nNOS 29 and iNOS 22 polymorphisms (Table 4). 

Phrase: "Estimated frequencies of nNOS haplotypes"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   753   C0439603:Frequencies [Temporal Concept]
   719 E C0376249:frequency [Quantitative Concept]
   719 E C0871396:Frequency [Quantitative Concept]
   719 E C1561548:Frequency [Qualitative Concept]
   719 E C1705502:Frequency [Quantitative Concept]

Phrase: "in Parkinson's disease patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0030705:Patients [Patient or Disabled Group]
   734   C0030567:Parkinson Disease [Disease or Syndrome]
   734   C1521736:Parkinson's Disease [Functional Concept]
   734   C2681933:PARKINSON DISEASE [Gene or Genome]

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "We"

Phrase: "explored"

Phrase: "the hypothesis of an interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1512571:Hypothesis [Idea or Concept]

Phrase: "between the nNOS 29"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0521390:Neuronal [Immunologic Factor]
   827   C1518425:{NOS} [Qualitative Concept]
   755 E C0027882:Neuron [Cell]

Phrase: "and"

Phrase: "iNOS 22 polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0032529:polymorphisms [Genetic Function]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "(Table 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.68: Our data suggest that the protective effect of iNOS 22 was weaker for nNOS 29 TT or CT carriers than for CC homozygotes, or, in other words, that the effect of nNOS 29 was stronger among AA iNOS 22 carriers than among GA or GG carriers (observed OR for joint effects=0.97 versus an expected OR of 0.29 x 1.41=0.41). 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the protective effect of iNOS 22"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "weaker for nNOS 29 TT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0004093:Weak [Sign or Symptom]
   719   C1762617:Weak [Qualitative Concept]

Phrase: "or"

Phrase: "CT carriers than"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0007294:carriers [Finding]
   756 E C0560175:Carrier [Finding]
   756 E C1706209:Carrier [Medical Device]
   756 E C3273162:Carrier [Intellectual Product]

Phrase: "for CC homozygotes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]

Phrase: "or"

Phrase: ","

Phrase: "in other words,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   966   C1705313:Word [Idea or Concept]
   928 E C0439824:Verbal [Qualitative Concept]
   900 E C0871946:verb [Intellectual Product]

Phrase: "that"

Phrase: "the effect of nNOS 29"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "stronger among AA iNOS 22 carriers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0442821:Strong [Qualitative Concept]

Phrase: "than"

Phrase: "among GA"

Phrase: "or"

Phrase: "GG carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0007294:carriers [Finding]
   827 E C0560175:Carrier [Finding]
   827 E C1706209:Carrier [Medical Device]
   827 E C3273162:Carrier [Intellectual Product]

Phrase: "(observed OR for joint effects"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0028873:Odds Ratio [Quantitative Concept]
   753   C0456603:Ratio [Quantitative Concept]
   753   C1547037:Ratio [Intellectual Product]

Phrase: "=0.97"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439073:97 [Intellectual Product]
   861   C0439082:>97 [Quantitative Concept]

Phrase: "versus"

Phrase: "an expected OR of 0.29 x 1.41"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0028873:Odds Ratio [Quantitative Concept]
   739   C0456603:Ratio [Quantitative Concept]
   739   C1547037:Ratio [Intellectual Product]

Phrase: "=0.41"

Phrase: ")."
Processing 00000000.tx.69: However, the interaction test was not significant (P=0.16). 

Phrase: "However,"

Phrase: "the interaction test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0022885:Test [Laboratory Procedure]
   861   C0039593:Test [Functional Concept]
   861   C0392366:test [Intellectual Product]

Phrase: "was"

Phrase: "not significant"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1273937:Not significant [Finding]
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]

Phrase: "(P=0.16"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.70: In a multivariate model that included both polymorphisms as main effects but no interactions, the association between PD and both nNOS 29 (OR for T carriers=1.53, 95% CI=1.082.17; P=0.02) and iNOS 22 (OR for AA carriers=0.48, 95% CI=0.280.83; P=0.01) remained significant. 

Phrase: "In a multivariate model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "that included"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]

Phrase: "both polymorphisms as main effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0032529:polymorphisms [Genetic Function]
   726 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "but"

Phrase: "no interactions,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]

Phrase: "the association between PD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "both nNOS 29"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0521390:Neuronal [Immunologic Factor]
   827   C1518425:{NOS} [Qualitative Concept]
   755 E C0027882:Neuron [Cell]

Phrase: "(OR for T carriers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0028873:Odds Ratio [Quantitative Concept]
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: "=1.53,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: "=1.082.17"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]

Phrase: "; P=0.02"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "iNOS 22"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205263:Inducible [Functional Concept]
   827   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1518425:{NOS} [Qualitative Concept]

Phrase: "(OR for AA carriers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0028873:Odds Ratio [Quantitative Concept]
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: "=0.48,"

Phrase: "95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: "=0.280.83"

Phrase: "; P=0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "remained"

Phrase: "significant."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237881:significant [Quantitative Concept]
  1000   C0750502:Significant [Idea or Concept]
  1000   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.71: View this table: [in this window] [in a new window]  Table 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 4."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.72: Individual and joint effects of the nNOS 29 and iNOS 22 polymorphisms on the risk of Parkinson's disease  Since smoking was inversely associated with PD in this population (Table 1), we tested the interaction between the two polymorphisms in the nNOS gene and cigarette smoking. 

Phrase: "Individual"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027361:Individual [Population Group]
  1000   C0237401:Individual [Human]

Phrase: "and"

Phrase: "joint effects of the nNOS 29"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0022417:Joint [Body Space or Junction]
   748   C0392905:Joint, NOS [Body System]
   748   C1269611:Joint [Body Space or Junction]
   748   C1280500:effects [Qualitative Concept]
   748   C1706309:Joint [Medical Device]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "iNOS 22 polymorphisms on the risk of Parkinson's disease"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C0032529:polymorphisms [Genetic Function]
   706 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "Since"

Phrase: "smoking"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037369:Smoking [Individual Behavior]
  1000   C0453996:Smoking [Individual Behavior]
  1000   C1881674:SMOKING [Phenomenon or Process]

Phrase: "was"

Phrase: "inversely"

Phrase: "associated with PD"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in this population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the interaction between the two polymorphisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704675:Interaction [Functional Concept]

Phrase: "in the nNOS gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "cigarette smoking."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0239059:cigarette smoking [Hazardous or Poisonous Substance]
  1000   C0700219:Cigarette Smoking [Individual Behavior]
   861   C0037369:Smoking [Individual Behavior]
   861   C0453996:Smoking [Individual Behavior]
   861   C1881674:SMOKING [Phenomenon or Process]
Processing 00000000.tx.73: An interaction was observed, as shown in Figure 1. 

Phrase: "An interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "as"

Phrase: "shown in Figure 1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.74: For both nNOS polymorphisms, the inverse association between PD and smoking was lost among carriers of the polymorphic T allele, while it was present among homozygotes for the C allele (with a stronger effect of current smoking than ex-smoking). 

Phrase: "For both nNOS polymorphisms,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0032529:polymorphisms [Genetic Function]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "the inverse association between PD"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1708567:Inverse Association [Conceptual Entity]
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "smoking"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037369:Smoking [Individual Behavior]
  1000   C0453996:Smoking [Individual Behavior]
  1000   C1881674:SMOKING [Phenomenon or Process]

Phrase: "was"

Phrase: "lost among carriers of the polymorphic T allele,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   744   C0002085:Allele [Gene or Genome]
   744   C0007294:carriers [Finding]
   744   C0745777:Lost [Functional Concept]
   744   C1882417:Polymorphic [Qualitative Concept]
   711 E C0560175:Carrier [Finding]
   711 E C1706209:Carrier [Medical Device]
   711 E C3273162:Carrier [Intellectual Product]

Phrase: "while"

Phrase: "it"

Phrase: "was"

Phrase: "present among homozygotes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]

Phrase: "for the C allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "("

Phrase: "with a stronger effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "of current smoking"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037369:Smoking [Individual Behavior]
   861   C0453996:Smoking [Individual Behavior]
   861   C1881674:SMOKING [Phenomenon or Process]

Phrase: "than ex-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704625:EX [Idea or Concept]

Phrase: "smoking"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0037369:Smoking [Individual Behavior]
  1000   C0453996:Smoking [Individual Behavior]
  1000   C1881674:SMOKING [Phenomenon or Process]
   966 E C0037366:Smoke [Environmental Effect of Humans,Hazardous or Poisonous Substance]
   966 E C0439994:Smoke [Hazardous or Poisonous Substance]

Phrase: ")."
Processing 00000000.tx.75: The interaction between the polymorphisms and current smoking was statistically significant (nNOS 18, P=0.04; nNOS 29, P=0.04), while the interaction between the polymorphisms and ex-smoking was not statistically significant (nNOS 18, P=0.22; nNOS 29, P=0.17). 

Phrase: "The interaction between the polymorphisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "current smoking"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037369:Smoking [Individual Behavior]
   861   C0453996:Smoking [Individual Behavior]
   861   C1881674:SMOKING [Phenomenon or Process]

Phrase: "was"

Phrase: "statistically significant"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:statistically significant [Quantitative Concept]
           significant
   928 E C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistically [Occupation or Discipline]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]

Phrase: "(nNOS 18,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0521390:Neuronal [Immunologic Factor]
   827   C1518425:{NOS} [Qualitative Concept]
   755 E C0027882:Neuron [Cell]

Phrase: "P=0.04"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; nNOS 29,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0521390:Neuronal [Immunologic Factor]
   827   C1518425:{NOS} [Qualitative Concept]
   755 E C0027882:Neuron [Cell]

Phrase: "P=0.04"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "while"

Phrase: "the interaction between the polymorphisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "ex-smoking"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037369:Smoking [Individual Behavior]
   861   C0453996:Smoking [Individual Behavior]
   861   C1881674:SMOKING [Phenomenon or Process]

Phrase: "was"

Phrase: "not statistically significant"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   913   C1273937:Not significant [Finding]
   901   C0237881:statistically significant [Quantitative Concept]
           significant
   829 E C1709380:Statistical Significance [Quantitative Concept]
   827   C0038215:Statistically [Occupation or Discipline]
   827   C0750502:Significant [Idea or Concept]
   827   C1546944:Significant [Qualitative Concept]

Phrase: "(nNOS 18,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0521390:Neuronal [Immunologic Factor]
   827   C1518425:{NOS} [Qualitative Concept]
   755 E C0027882:Neuron [Cell]

Phrase: "P=0.22"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; nNOS 29,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0521390:Neuronal [Immunologic Factor]
   827   C1518425:{NOS} [Qualitative Concept]
   755 E C0027882:Neuron [Cell]

Phrase: "P=0.17"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.76: If ex- and current smoking were grouped together (ever smoking), the interaction between ever smoking and the nNOS 18 (P=0.05) and nNOS 29 (P=0.04) polymorphisms remained significant. 

Phrase: "If"

Phrase: "ex-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704625:EX [Idea or Concept]

Phrase: "and"

Phrase: "current smoking"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037369:Smoking [Individual Behavior]
   861   C0453996:Smoking [Individual Behavior]
   861   C1881674:SMOKING [Phenomenon or Process]

Phrase: "were"

Phrase: "grouped"
Meta Candidates (Total=7; Excluded=6; Pruned=0; Remaining=1)
  1000   C0439745:Grouped [Spatial Concept]
   966 E C0441833:Group [Idea or Concept]
   966 E C0687744:group [Population Group]
   966 E C1257890:Group [Population Group]
   966 E C1552516:Group [Health Care Related Organization]
   966 E C1705428:Group [Conceptual Entity]
   966 E C1705429:Group [Population Group]

Phrase: "together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "(ever"

Phrase: "smoking"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0037369:Smoking [Individual Behavior]
  1000   C0453996:Smoking [Individual Behavior]
  1000   C1881674:SMOKING [Phenomenon or Process]
   966 E C0037366:Smoke [Environmental Effect of Humans,Hazardous or Poisonous Substance]
   966 E C0439994:Smoke [Hazardous or Poisonous Substance]

Phrase: ")"

Phrase: ","

Phrase: "the interaction between ever smoking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "the nNOS 18"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0521390:Neuronal [Immunologic Factor]
   827   C1518425:{NOS} [Qualitative Concept]
   755 E C0027882:Neuron [Cell]

Phrase: "(P=0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "nNOS 29"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0521390:Neuronal [Immunologic Factor]
   827   C1518425:{NOS} [Qualitative Concept]
   755 E C0027882:Neuron [Cell]

Phrase: "(P=0.04"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032529:polymorphisms [Genetic Function]
   966 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "remained"

Phrase: "significant."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237881:significant [Quantitative Concept]
  1000   C0750502:Significant [Idea or Concept]
  1000   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.77: View larger version (16K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.78: Interaction between the nNOS 29 (A) and nNOS 18 (B) polymorphisms in the nNOS gene and cigarette smoking. 

Phrase: "Interaction between the nNOS 29"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704675:Interaction [Functional Concept]

Phrase: "(A)"

Phrase: "and"

Phrase: "nNOS 18"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0521390:Neuronal [Immunologic Factor]
   827   C1518425:{NOS} [Qualitative Concept]
   755 E C0027882:Neuron [Cell]

Phrase: "(B) polymorphisms in the nNOS gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   774   C0678951:gene polymorphisms [Genetic Function]
   748   C0032529:polymorphisms [Genetic Function]
   714 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "cigarette smoking."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0239059:cigarette smoking [Hazardous or Poisonous Substance]
  1000   C0700219:Cigarette Smoking [Individual Behavior]
   861   C0037369:Smoking [Individual Behavior]
   861   C0453996:Smoking [Individual Behavior]
   861   C1881674:SMOKING [Phenomenon or Process]
Processing 00000000.tx.79: The tables show the frequency of each exposure category, and the figures display odds ratios (95% confidence intervals) for the individual and joint effects of cigarette smoking and the nNOS 29 (A) and nNOS 18 (B) polymorphisms in the nNOS gene. 

Phrase: "The tables"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0039224:tables [Manufactured Object]
  1000   C1706074:Tables [Intellectual Product]
   966 E C1706073:Table [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the frequency of each exposure category,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0376249:frequency [Quantitative Concept]
   753   C0439603:Frequency [Temporal Concept]
   753   C0871396:Frequency [Quantitative Concept]
   753   C1561548:Frequency [Qualitative Concept]
   753   C1705502:Frequency [Quantitative Concept]

Phrase: "and"

Phrase: "the figures"

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "odds ratios"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratios [Quantitative Concept]
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: "(95% confidence intervals"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   901   C0009667:Confidence Intervals [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:intervals [Temporal Concept]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   793 E C1552654:Interval [Idea or Concept]
   793 E C1552713:Interval [Intellectual Product]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: ")"

Phrase: "for the individual"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027361:Individual [Population Group]
  1000   C0237401:Individual [Human]

Phrase: "and"

Phrase: "joint effects of cigarette smoking"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0022417:Joint [Body Space or Junction]
   760   C0392905:Joint, NOS [Body System]
   760   C1269611:Joint [Body Space or Junction]
   760   C1280500:effects [Qualitative Concept]
   760   C1706309:Joint [Medical Device]
   726 E C2348382:Effect [Qualitative Concept]
   704 E C0521339:Articular [Functional Concept]

Phrase: "and"

Phrase: "the nNOS 29"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0521390:Neuronal [Immunologic Factor]
   827   C1518425:{NOS} [Qualitative Concept]
   755 E C0027882:Neuron [Cell]

Phrase: "(A)"

Phrase: "and"

Phrase: "nNOS 18"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0521390:Neuronal [Immunologic Factor]
   827   C1518425:{NOS} [Qualitative Concept]
   755 E C0027882:Neuron [Cell]

Phrase: "(B) polymorphisms in the nNOS gene."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   774   C0678951:gene polymorphisms [Genetic Function]
   748   C0032529:polymorphisms [Genetic Function]
   714 E C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.80: The solid line corresponds to CC carriers, and the dotted line corresponds to CT and TT carriers. 

Phrase: "The solid line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "corresponds to CC carriers,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007294:carriers [Finding]
   770   C3538933:CC [Cell Component]
   737 E C0560175:Carrier [Finding]
   737 E C1706209:Carrier [Medical Device]
   737 E C3273162:Carrier [Intellectual Product]

Phrase: "and"

Phrase: "the dotted line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "corresponds to CT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3540513:CT [Gene or Genome]

Phrase: "and"

Phrase: "TT carriers."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0007294:carriers [Finding]
   827 E C0560175:Carrier [Finding]
   827 E C1706209:Carrier [Medical Device]
   827 E C3273162:Carrier [Intellectual Product]
Processing 00000000.tx.81: (A) P-value for the interaction between nNOS 29 and current smoking, 0.04; 

Phrase: "(A) P-value for the interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1709380:P-Value [Quantitative Concept]
   753   C1522609:Value [Quantitative Concept]

Phrase: "between nNOS 29"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0521390:Neuronal [Immunologic Factor]
   827   C1518425:{NOS} [Qualitative Concept]
   755 E C0027882:Neuron [Cell]

Phrase: "and"

Phrase: "current smoking,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037369:Smoking [Individual Behavior]
   861   C0453996:Smoking [Individual Behavior]
   861   C1881674:SMOKING [Phenomenon or Process]

Phrase: "0.04"

Phrase: ";"
Processing 00000000.tx.82: ex-smoking, 0.17. 

Phrase: "ex-smoking,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037369:Smoking [Individual Behavior]
   861   C0453996:Smoking [Individual Behavior]
   861   C1881674:SMOKING [Phenomenon or Process]

Phrase: "0.17."
Processing 00000000.tx.83: (B) P-value for the interaction between nNOS 18 and current smoking, 0.04; 

Phrase: "(B) P-value for the interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1709380:P-Value [Quantitative Concept]
   753   C1522609:Value [Quantitative Concept]

Phrase: "between nNOS 18"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0521390:Neuronal [Immunologic Factor]
   827   C1518425:{NOS} [Qualitative Concept]
   755 E C0027882:Neuron [Cell]

Phrase: "and"

Phrase: "current smoking,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037369:Smoking [Individual Behavior]
   861   C0453996:Smoking [Individual Behavior]
   861   C1881674:SMOKING [Phenomenon or Process]

Phrase: "0.04"

Phrase: ";"
Processing 00000000.tx.84: ex-smoking, 0.22.  

Phrase: "ex-smoking,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037369:Smoking [Individual Behavior]
   861   C0453996:Smoking [Individual Behavior]
   861   C1881674:SMOKING [Phenomenon or Process]

Phrase: "0.22."
Processing 00000000.tx.85: Finally, because exposure to pesticides is positively associated with PD, we investigated the joint effect of exposure to pesticides and the polymorphisms, and found no significant interactions between exposure to pesticides and none of the polymorphisms (data not shown).  

Phrase: "Finally,"

Phrase: "because"

Phrase: "exposure to pesticides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332157:Exposure to [Clinical Attribute]
           Exposure
   790   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "is"

Phrase: "positively"

Phrase: "associated with PD,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the joint effect of exposure"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0022417:Joint [Body Space or Junction]
   760   C0392905:Joint, NOS [Body System]
   760   C1269611:Joint [Body Space or Junction]
   760   C1280500:Effect [Qualitative Concept]
   760   C1706309:Joint [Medical Device]
   760   C2348382:Effect [Qualitative Concept]
   704 E C0521339:Articular [Functional Concept]

Phrase: "to pesticides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031253:Pesticides [Hazardous or Poisonous Substance]

Phrase: "and"

Phrase: "the polymorphisms,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032529:polymorphisms [Genetic Function]
   966 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no significant interactions between exposure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1704675:Interaction [Functional Concept]

Phrase: "to pesticides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031253:Pesticides [Hazardous or Poisonous Substance]

Phrase: "and"

Phrase: "none of the polymorphisms"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0032529:polymorphisms [Genetic Function]
   770   C0456148:None [Quantitative Concept]
   770   C0549184:None [Quantitative Concept]
   737 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.86: DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  We have genotyped three polymorphisms in two NOS genes (nNOS and iNOS) in a large community-based casecontrol study of PD, composed essentially of sporadic patients. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "We"

Phrase: "have"

Phrase: "genotyped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0017431:Genotype [Organism Attribute]

Phrase: "three polymorphisms in two NOS genes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   750   C0678951:gene polymorphisms [Genetic Function]
   744   C0032529:polymorphisms [Genetic Function]
   711 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "(nNOS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0521390:Neuronal [Immunologic Factor]
   861   C1518425:{NOS} [Qualitative Concept]
   789 E C0027882:Neuron [Cell]

Phrase: "and"

Phrase: "iNOS) in a large community-based casecontrol study of PD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1518425:{NOS} [Qualitative Concept]

Phrase: "composed"

Phrase: "essentially of sporadic patients."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0205422:Sporadic [Temporal Concept]
Processing 00000000.tx.87: We found a significant over-representation of carriers of at least one nNOS 29 T allele and an under-representation of AA iNOS 22 homozygotes in PD cases compared with controls, this last polymorphism being newly reported. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "a significant over-representation of carriers of"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1514861:Representation [Conceptual Entity]
   748   C1882932:Representation [Activity]

Phrase: "at least one nNOS 29 T allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0002085:Allele [Gene or Genome]

Phrase: "and"

Phrase: "an under-representation of AA iNOS 22 homozygotes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1514861:Representation [Conceptual Entity]
   742   C1882932:Representation [Activity]

Phrase: "in PD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "compared with controls,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "this last polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032529:Polymorphism [Genetic Function]
   861   C1882417:Polymorphism [Qualitative Concept]

Phrase: "being"

Phrase: "newly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750546:newly [Idea or Concept]

Phrase: "reported."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.88: No association was observed between PD and the nNOS 18 polymorphism. 

Phrase: "No association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "was"

Phrase: "observed between PD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "the nNOS 18 polymorphism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0032529:Polymorphism [Genetic Function]
   812   C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.89: Moreover, nNOS 18 and nNOS 29 may modulate the relation between cigarette smoking and PD. 

Phrase: "Moreover,"

Phrase: "nNOS 18"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0521390:Neuronal [Immunologic Factor]
   827   C1518425:{NOS} [Qualitative Concept]
   755 E C0027882:Neuron [Cell]

Phrase: "and"

Phrase: "nNOS 29"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0521390:Neuronal [Immunologic Factor]
   827   C1518425:{NOS} [Qualitative Concept]
   755 E C0027882:Neuron [Cell]

Phrase: "may"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the relation between cigarette smoking"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0080103:Relation [Family Group]
   760   C0869014:relation [Social Behavior]

Phrase: "and"

Phrase: "PD."
Processing 00000000.tx.90: These results suggest that nNOS and iNOS may play a role in the susceptibility to sporadic PD. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that nNOS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0521390:Neuronal [Immunologic Factor]
   861   C1518425:{NOS} [Qualitative Concept]
   789 E C0027882:Neuron [Cell]

Phrase: "and"

Phrase: "iNOS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518425:{NOS} [Qualitative Concept]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in the susceptibility"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "to sporadic PD."
Processing 00000000.tx.91: This is in agreement with several studies in animals or humans. 

Phrase: "This"

Phrase: "is in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0680240:Agreement [Social Behavior]

Phrase: "with several studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "in animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "or"

Phrase: "humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]
Processing 00000000.tx.92: In animals, nNOS inhibitors are protective against MPTP, and mutant mice that lack the nNOS gene are more resistant to MPTP than wild-type mice (1417,23). 

Phrase: "In animals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "nNOS inhibitors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   884   C1373060:NOS Inhibitor [Pharmacologic Substance]
   884   C1744692:NOS inhibitor [Molecular Function]
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   793 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "are"

Phrase: "protective against MPTP"

Phrase: "MPTP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "MPTP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "MPTP,"

Phrase: "and"

Phrase: "mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "that"

Phrase: "lack"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "the nNOS gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Gene [Gene or Genome]

Phrase: "are"

Phrase: "more resistant to MPTP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0332325:Resistant to [Functional Concept]
           Resistant
   748   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "MPTP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "MPTP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "MPTP than wild-type mice"

Phrase: "(1417,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.93: Similar experiments with iNOS show that this enzyme also plays a role in the sensitivity of dopaminergic neurons (18,19,24). 

Phrase: "Similar experiments with iNOS"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0681814:Experiments [Research Activity]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "this enzyme also"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a role in the sensitivity of dopaminergic neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "(18,"

Phrase: "19,"

Phrase: "24"

Phrase: ")."
Processing 00000000.tx.94: There is also evidence of NO overproduction as well as of an implication of nNOS and iNOS in PD patients. 

Phrase: "There"

Phrase: "is"

Phrase: "also evidence of NO overproduction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "as well as of an implication of nNOS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0205170:Well [Qualitative Concept]
   742   C0521390:Neuronal [Immunologic Factor]
   742   C1518425:{NOS} [Qualitative Concept]
   742   C3146287:Well [Manufactured Object]

Phrase: "and"

Phrase: "iNOS in PD patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1518425:{NOS} [Qualitative Concept]
Processing 00000000.tx.95: Increased nitrite concentrations have been found in the CSF of treated and untreated PD patients compared with controls (25), and nNOS was overexpressed in neutrophils of PD patients compared with controls (26). 

Phrase: "Increased nitrite concentrations"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   884   C0427757:Nitrite concentration [Laboratory Procedure]
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "have"

Phrase: "been"

Phrase: "found in the CSF of treated"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0150312:Found [Quantitative Concept]
   753   C0332293:treated [Therapeutic or Preventive Procedure]
   753   C1522326:Treated [Functional Concept]
   753   C3540512:CSF [Therapeutic or Preventive Procedure]
   719 E C0243095:Find [Finding]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "untreated PD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "compared with controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "(25"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "nNOS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0521390:Neuronal [Immunologic Factor]
   861   C1518425:{NOS} [Qualitative Concept]
   789 E C0027882:Neuron [Cell]

Phrase: "was"

Phrase: "overexpressed in neutrophils of PD patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0027950:Neutrophils [Cell]
   753   C0030705:Patients [Patient or Disabled Group]
   719   C1514559:overexpress [Genetic Function]

Phrase: "compared with controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.96: An increased NO signal was found using spectroscopy in the substantia nigra of PD patients compared with controls (27), and considerable amounts of iNOS were expressed in the substantia nigra of post-mortem PD samples, but not in age-matched control samples (28). 

Phrase: "An increased NO signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "spectroscopy in the substantia nigra of PD patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0037812:spectroscopy [Laboratory Procedure]
   744   C2713504:Spectroscopy [Occupation or Discipline]
   744   C2984732:SPECTROSCOPY [Functional Concept]

Phrase: "compared with controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "(27"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "considerable amounts of iNOS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "expressed in the substantia nigra of post-mortem PD samples,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0004398:postmortem [Diagnostic Procedure]
   760   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
   760   C0580205:Postmortem [Temporal Concept]
   760   C0848632:post mortem [Finding]
   760   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]
   739   C0687676:Post [Temporal Concept]
   739   C1704687:Post [Manufactured Object]
   706   C0370003:Sample [Substance]
   706   C2347026:Sample [Conceptual Entity]

Phrase: "but"

Phrase: "not in age-matched control samples"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   753   C0001779:Age [Organism Attribute]
   753   C0150103:matched [Research Activity]
   753   C0243148:control [Qualitative Concept]
   753   C1518422:Not [Functional Concept]
   753   C1550141:Control [Substance]
   753   C1708943:Matched [Qualitative Concept]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   719   C0370003:Sample [Substance]
   719   C2347026:Sample [Conceptual Entity]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.97: Markers of NO formation (e.g. nitrotyrosine immunoreactivity) have been observed in Lewy bodies in PD (29) and MPTP-induced parkinsonism patients. 

Phrase: "Markers of NO formation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0005516:Marker [Clinical Attribute]

Phrase: "("

Phrase: "e.g. nitrotyrosine immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: ")"

Phrase: "have"

Phrase: "been"

Phrase: "observed in Lewy bodies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0085200:Lewy Bodies [Cell Component]
   770   C0242821:bodies [Human]
   770   C1441672:Observed [Functional Concept]
   770   C1995017:Bodies [Cell Component]
   737 E C0460148:Body [Anatomical Structure]
   737 E C1268086:Body [Anatomical Structure]

Phrase: "in PD (29"

Phrase: ")"

Phrase: "and"

Phrase: "MPTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2945751:phenyl [Chemical Viewed Structurally]

Phrase: "MPTP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "MPTP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "MPTP-induced parkinsonism patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.98: Finally, bromocriptine, which is used as a treatment of PD, is a strong inhibitor of rat nNOS and, to a lesser extent, of murine iNOS (30). 

Phrase: "Finally,"

Phrase: "bromocriptine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006230:Bromocriptin [Organic Chemical,Pharmacologic Substance]

Phrase: "which"

Phrase: "is"

Phrase: "used as a treatment of PD,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   767   C1524063:Use of [Functional Concept]
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1273517:used [Finding]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "is"

Phrase: "a strong inhibitor of rat nNOS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1373060:NOS Inhibitor [Pharmacologic Substance]
   774   C1744692:NOS inhibitor [Molecular Function]
   748   C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: ","

Phrase: "to a lesser extent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439792:Extent [Spatial Concept]

Phrase: "of murine iNOS (30"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0026809:Murine [Mammal]
   812   C0205263:Inducible [Functional Concept]
   812   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   812   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1518425:{NOS} [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.99: We did not find a statistically significant interaction between the nNOS 29 and iNOS 22 polymorphisms. 

Phrase: "We"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "a statistically significant interaction between the nNOS 29"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "iNOS 22 polymorphisms."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0032529:polymorphisms [Genetic Function]
   779 E C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.100: However, the protective effect of iNOS 22 was weaker for nNOS 29 TT or CT carriers than for CC homozygotes, and our study may have had insufficient power to detect an interaction of small size. 

Phrase: "However,"

Phrase: "the protective effect of iNOS 22"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "weaker for nNOS 29 TT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0004093:Weak [Sign or Symptom]
   719   C1762617:Weak [Qualitative Concept]

Phrase: "or"

Phrase: "CT carriers than"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0007294:carriers [Finding]
   756 E C0560175:Carrier [Finding]
   756 E C1706209:Carrier [Medical Device]
   756 E C3273162:Carrier [Intellectual Product]

Phrase: "for CC homozygotes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]

Phrase: "and"

Phrase: "our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "may"

Phrase: "have"

Phrase: "had"

Phrase: "insufficient power to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "an interaction of small size."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.101: When the effect of one of the polymorphisms was adjusted for the effect of the other, each of them remained associated with PD. 

Phrase: "When"

Phrase: "the effect of one of the polymorphisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "adjusted for the effect of the"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0456081:Adjusted [Functional Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "other,"

Phrase: "each of them"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1457900:Each [Quantitative Concept]

Phrase: "remained"

Phrase: "associated with PD."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.102: These findings suggest that the two polymorphisms have independent effects. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the two polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032529:polymorphisms [Genetic Function]
   827 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "have"

Phrase: "independent effects."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0085862:Independent [Idea or Concept]
   861   C1280500:effects [Qualitative Concept]
   861   C1299583:Independent [Finding]
   827 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.103: The two polymorphisms in the nNOS gene appeared to modulate the protective effect of cigarette smoking. 

Phrase: "The two polymorphisms in the nNOS gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C0678951:gene polymorphisms [Genetic Function]
   744   C0032529:polymorphisms [Genetic Function]
   711 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the protective effect of cigarette smoking."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.104: It has been reported, in post-partum placentas, that cigarette smoking was associated with decreased eNOS expression only among carriers of the rare allele of an eNOS polymorphism (31). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: ","

Phrase: "in post-partum placentas,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0032043:Placentas [Embryonic Structure]
   793 E C1278988:Placenta [Embryonic Structure]
   793 E C1550656:Placenta [Body Substance]
   743 E C0230956:Placental [Mammal]
   734   C0086839:Postpartum [Temporal Concept]

Phrase: "that cigarette smoking"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0239059:cigarette smoking [Hazardous or Poisonous Substance]
  1000   C0700219:Cigarette Smoking [Individual Behavior]
   861   C0037369:Smoking [Individual Behavior]
   861   C0453996:Smoking [Individual Behavior]
   861   C1881674:SMOKING [Phenomenon or Process]

Phrase: "was"

Phrase: "associated with decreased eNOS expression only"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0014257:Endothelial [Tissue]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0205171:Only [Quantitative Concept]
   748   C0205216:Decreased [Quantitative Concept]
   748   C0392756:Decreased [Qualitative Concept]
   748   C0442797:decreased [Qualitative Concept]
   748   C1518425:{NOS} [Qualitative Concept]
   748   C1720467:Only [Intellectual Product]
   714 E C0547047:Decrease [Quantitative Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "among carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0007294:carriers [Finding]
   966 E C0560175:Carrier [Finding]
   966 E C1706209:Carrier [Medical Device]
   966 E C3273162:Carrier [Intellectual Product]

Phrase: "of the rare allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "of an eNOS polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.105: Nicotine injection or exposure to cigarette smoke leads to an increase in NO and/or NO metabolites in the brains of rats and rabbits, which may be mediated through the action of the NOS (32,33). 

Phrase: "Nicotine injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1828121:Injection [Functional Concept]

Phrase: "or"

Phrase: "exposure to cigarette smoke"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332157:Exposure to [Clinical Attribute]
           Exposure
   770   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "leads to an increase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0181586:leads [Medical Device]
   770   C0442805:Increase [Functional Concept]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in NO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "and/or"

Phrase: "NO metabolites in the brains of rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0870883:Metabolites [Biologically Active Substance]
   744   C2698672:METABOLITES [Regulation or Law]

Phrase: "and"

Phrase: "rabbits,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034493:Rabbit [Mammal]

Phrase: "which"

Phrase: "may"

Phrase: "be"

Phrase: "mediated through the action of the NOS"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   764   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   742   C0030015:oxide [Inorganic Chemical]
   742   C0086597:mediated [Social Behavior]
   742   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   742   C0441472:Action [Functional Concept]
   742   C2986642:oxide [Chemical Viewed Functionally]
   742   C3266814:Action [Activity]

Phrase: "(32,"

Phrase: "33"

Phrase: ")."
Processing 00000000.tx.106: In this study, we observed, both for nNOS 29 and nNOS 18, that the inverse relation between smoking and PD was lost among carriers of the polymorphic T allele. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "both for nNOS 29"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0238767:Both [Spatial Concept]
   760   C0521390:Neuronal [Immunologic Factor]
   760   C1518425:{NOS} [Qualitative Concept]
   760   C1706086:Both [Qualitative Concept]

Phrase: "and"

Phrase: "nNOS 18,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0521390:Neuronal [Immunologic Factor]
   827   C1518425:{NOS} [Qualitative Concept]
   755 E C0027882:Neuron [Cell]

Phrase: "that"

Phrase: "the inverse relation between smoking"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0080103:Relation [Family Group]
   760   C0869014:relation [Social Behavior]

Phrase: "and"

Phrase: "PD"

Phrase: "was"

Phrase: "lost among carriers of the polymorphic T allele."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   744   C0002085:Allele [Gene or Genome]
   744   C0007294:carriers [Finding]
   744   C0745777:Lost [Functional Concept]
   744   C1882417:Polymorphic [Qualitative Concept]
   711 E C0560175:Carrier [Finding]
   711 E C1706209:Carrier [Medical Device]
   711 E C3273162:Carrier [Intellectual Product]
Processing 00000000.tx.107: This observation is in agreement with the hypothesis that an effect of smoking on NO production by nNOS is modulated by nNOS polymorphisms, but this hypothesis needs to be confirmed. 

Phrase: "This observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "is in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0680240:Agreement [Social Behavior]

Phrase: "with the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that"

Phrase: "an effect of smoking"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on NO production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033268:production [Occupational Activity]
   734   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]

Phrase: "by nNOS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0521390:Neuronal [Immunologic Factor]
   861   C1518425:{NOS} [Qualitative Concept]
   789 E C0027882:Neuron [Cell]

Phrase: "is"

Phrase: "modulated by nNOS polymorphisms,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0032529:polymorphisms [Genetic Function]
   760   C0443264:Modulated [Spatial Concept]
   760   C0521390:Neuronal [Immunologic Factor]
   760   C1518425:{NOS} [Qualitative Concept]
   726 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "but"

Phrase: "this hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "needs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "confirmed."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.108: MPTP has been shown to increase nNOS and iNOS expression (18,19,21). 

Phrase: "MPTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2945751:phenyl [Chemical Viewed Structurally]

Phrase: "MPTP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "MPTP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "MPTP"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "nNOS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0521390:Neuronal [Immunologic Factor]
   861   C1518425:{NOS} [Qualitative Concept]
   789 E C0027882:Neuron [Cell]

Phrase: "and"

Phrase: "iNOS expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(18,"

Phrase: "19,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.109: However, we did not find evidence in favour of an interaction between exposure to pesticides and the polymorphisms that were tested in the present study. 

Phrase: "However,"

Phrase: "we"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "evidence in favour of an interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "between exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0274281:Exposure, NOS [Injury or Poisoning]
  1000   C0332157:Exposure [Clinical Attribute]

Phrase: "to pesticides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031253:Pesticides [Hazardous or Poisonous Substance]

Phrase: "and"

Phrase: "the polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032529:polymorphisms [Genetic Function]
   966 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "that"

Phrase: "were"

Phrase: "tested in the present study."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0150312:Present [Quantitative Concept]
   760   C0392366:tested [Intellectual Product]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]
Processing 00000000.tx.110: Therefore, if the effect of pesticides was mediated by an increase in NO production (as observed for MPTP), the increase is likely to be independent of these polymorphisms. 

Phrase: "Therefore,"

Phrase: "if"

Phrase: "the effect of pesticides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "mediated by an increase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   770   C0442805:Increase [Functional Concept]

Phrase: "in NO production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033268:production [Occupational Activity]
   734   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]

Phrase: "("

Phrase: "as"

Phrase: "observed for MPTP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1441672:Observed [Functional Concept]
   753   C2945751:phenyl [Chemical Viewed Structurally]

Phrase: "MPTP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "MPTP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "MPTP"

Phrase: ")"

Phrase: ","

Phrase: "the increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be independent of these polymorphisms."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0332291:Independent of [Functional Concept]
   760   C0032529:polymorphisms [Genetic Function]
   760   C0085862:Independent [Idea or Concept]
   760   C1299583:Independent [Finding]
   760   C2987476:Be [Conceptual Entity]
   726 E C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.111: Since the functionality of these polymorphisms is unknown, it remains to determine whether the associations of the iNOS 22 and nNOS 29 polymorphisms with PD are the initiating event responsible for susceptibility to PD. 

Phrase: "Since"

Phrase: "the functionality of these polymorphisms"

Phrase: "is"

Phrase: "unknown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]

Phrase: "it"

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the associations of the iNOS 22"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0004083:Associations [Mental Process]
   714 E C0439849:Association [Qualitative Concept]
   714 E C0596306:Association [Phenomenon or Process]
   714 E C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "nNOS 29 polymorphisms with PD"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0032529:polymorphisms [Genetic Function]
   719 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "are"

Phrase: "the initiating event"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441471:Event [Event]

Phrase: "responsible for susceptibility"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1273518:Responsible [Finding]

Phrase: "to PD."
Processing 00000000.tx.112: Another possibility is that they are in linkage disequilibrium with another functional polymorphism or another gene nearby. 

Phrase: "Another possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "that"

Phrase: "they"

Phrase: "are in linkage disequilibrium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0023746:Linkage Disequilibrium [Quantitative Concept]
   770   C0023745:linkage [Molecular Function]
   770   C0281825:Disequilibrium [Finding]
   770   C0394006:Disequilibrium [Disease or Syndrome]
   770   C1551058:Are [Quantitative Concept]

Phrase: "with another functional polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032529:Polymorphism [Genetic Function]
   861   C1882417:Polymorphism [Qualitative Concept]

Phrase: "or"

Phrase: "another gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "nearby."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706276:Nearby [Qualitative Concept]
Processing 00000000.tx.113: iNOS 22 is an exonic polymorphism, but does not change the amino acids sequence. 

Phrase: "iNOS 22"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205263:Inducible [Functional Concept]
   827   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1518425:{NOS} [Qualitative Concept]

Phrase: "is"

Phrase: "an exonic polymorphism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032529:Polymorphism [Genetic Function]
   861   C1882417:Polymorphism [Qualitative Concept]

Phrase: "but"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "the amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "sequence."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.114: Another repeat polymorphism located in the promoter of the iNOS gene has been associated with dementia with Lewy bodies (34), a disease also characterized by the presence of Lewy bodies in the brain. 

Phrase: "Another repeat polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032529:Polymorphism [Genetic Function]
   861   C1882417:Polymorphism [Qualitative Concept]

Phrase: "located in the promoter of the iNOS gene"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C0314621:Promoter gene [Gene or Genome]
   742   C0017337:Gene [Gene or Genome]
   742   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0205263:Inducible [Functional Concept]
   742   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]
   742   C1518425:{NOS} [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "associated with dementia"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0011265:dementia [Mental or Behavioral Dysfunction]
   790   C0497327:Dementia [Mental or Behavioral Dysfunction]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "with Lewy bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "(34"

Phrase: ")"

Phrase: ","

Phrase: "a disease also"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "characterized by the presence of Lewy bodies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   778   C0085200:Lewy Bodies [Cell Component]
   748   C0242821:bodies [Human]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C1880022:Characterized [Activity]
   748   C1995017:Bodies [Cell Component]
   714 E C0460148:Body [Anatomical Structure]
   714 E C1268086:Body [Anatomical Structure]

Phrase: "in the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.115: The fact that both nNOS and iNOS genes are implicated in NO metabolism and were found to be associated with PD in this study argues against the implication of another gene. 

Phrase: "The fact"

Phrase: "that"

Phrase: "both nNOS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0521390:Neuronal [Immunologic Factor]
   861   C1518425:{NOS} [Qualitative Concept]
   789 E C0027882:Neuron [Cell]

Phrase: "and"

Phrase: "iNOS genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "are"

Phrase: "implicated in NO metabolism"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C1158468:nitric oxide metabolism [Molecular Function]
   806   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   760   C0025519:Metabolism [Organism Function]
   760   C0025520:metabolism [Functional Concept]
   760   C0030015:oxide [Inorganic Chemical]
   760   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "and"

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated with PD"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "argues against the implication of another gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.116: However, the Tau gene, for which a positive association with PD has been observed, is located at less than 15cM of the iNOS gene on chromosome 17q (3537). 

Phrase: "However,"

Phrase: "the Tau gene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "for which"

Phrase: "a positive association with PD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "has"

Phrase: "been"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "is"

Phrase: "located at less"

Phrase: "than 15cM"

Phrase: "of the iNOS gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Gene [Gene or Genome]

Phrase: "on chromosome 17q"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1327938:chromosome 17q [Gene or Genome]
   861   C1520755:17q [Nucleotide Sequence]

Phrase: "(3537"

Phrase: ")."
Processing 00000000.tx.117: The strongest evidence of linkage from a genomic screen performed in late-onset PD was located at 7cM from iNOS gene (38). 

Phrase: "The strongest evidence of linkage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "from a genomic screen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220908:screen [Health Care Activity]
   861   C1305399:screen [Functional Concept]
   861   C1705053:Screen [Medical Device]

Phrase: "performed in late-onset PD"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0205087:Late [Temporal Concept]
   760   C0332162:Onset [Qualitative Concept]
   760   C0884358:Performed [Functional Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "was"

Phrase: "located at 7cM"

Phrase: "from iNOS gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Gene [Gene or Genome]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.118: We therefore investigated the linkage disequilibrium between Tau and iNOS 22 and adjusted our analyses of the relation between PD and iNOS 22 for the Tau genotype. 

Phrase: "We therefore"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the linkage disequilibrium between Tau"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0023746:Linkage Disequilibrium [Quantitative Concept]
   760   C0023745:linkage [Molecular Function]
   760   C0281825:Disequilibrium [Finding]
   760   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "and"

Phrase: "iNOS 22"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205263:Inducible [Functional Concept]
   827   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1518425:{NOS} [Qualitative Concept]

Phrase: "and"

Phrase: "adjusted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456081:Adjusted [Functional Concept]

Phrase: "our analyses of the relation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0002778:Analysis [Laboratory Procedure]
   726   C0936012:Analysis [Research Activity]
   726   C1524024:analysis [Functional Concept]

Phrase: "between PD"

Phrase: "and"

Phrase: "iNOS 22 for the Tau genotype."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0017431:Genotype [Organism Attribute]
   748   C0205263:Inducible [Functional Concept]
   748   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1518425:{NOS} [Qualitative Concept]
   748   C1720655:Tau [Intellectual Product]
   748   C1947974:Tau [Research Activity]
Processing 00000000.tx.119: Tau and iNOS 22 were not in linkage disequilibrium in cases (D'=0.05) and controls (D'=0.006), and the OR remained unchanged after adjustment (data not shown). 

Phrase: "Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "iNOS 22"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205263:Inducible [Functional Concept]
   827   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1518425:{NOS} [Qualitative Concept]

Phrase: "were"

Phrase: "not in linkage disequilibrium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0023746:Linkage Disequilibrium [Quantitative Concept]
   770   C0023745:linkage [Molecular Function]
   770   C0281825:Disequilibrium [Finding]
   770   C0394006:Disequilibrium [Disease or Syndrome]
   770   C1518422:Not [Functional Concept]

Phrase: "in cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "("

Phrase: "D'="

Phrase: "0.05"

Phrase: ")"

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "("

Phrase: "D'="

Phrase: "0.006"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the OR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "remained"

Phrase: "unchanged after adjustment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442739:Unchanged [Finding]
   790   C2346711:Unchanged [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.120: The association between PD and iNOS is thus independent from the Tau gene. 

Phrase: "The association between PD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "iNOS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518425:{NOS} [Qualitative Concept]

Phrase: "is"

Phrase: "thus independent from the Tau gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0085862:Independent [Idea or Concept]
   753   C1299583:Independent [Finding]
Processing 00000000.tx.121: nNOS 29 is located in an exon of the 5' untranslated region (UTR). 

Phrase: "nNOS 29"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0521390:Neuronal [Immunologic Factor]
   827   C1518425:{NOS} [Qualitative Concept]
   755 E C0027882:Neuron [Cell]

Phrase: "is"

Phrase: "located in an exon of the 5' untranslated region (UTR)."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0600680:Untranslated Region [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0017446:Region [Geographic Area]
   742   C0205147:Region [Spatial Concept]
Processing 00000000.tx.122: This region is often associated with the regulation of transcripts and mRNA stability. 

Phrase: "This region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "is"

Phrase: "often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Often [Temporal Concept]

Phrase: "associated with the regulation of transcripts"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]
   753   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "mRNA stability."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1257757:mRNA Stability [Qualitative Concept]
   861   C0205360:Stability [Qualitative Concept]
   861   C2347098:Stability [Qualitative Concept]
   789 E C1547311:Stable [Intellectual Product]
Processing 00000000.tx.123: This polymorphism or another one located in the regulatory regions of gene expression may mediate this effect. 

Phrase: "This polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032529:Polymorphism [Genetic Function]
  1000   C1882417:Polymorphism [Qualitative Concept]

Phrase: "or"

Phrase: "another one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "located in the regulatory regions of gene expression"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0017262:Gene Expression [Genetic Function]
   770   C0034987:Regulatory Regions [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   767   C0017362:Regulatory Gene [Gene or Genome]
   744   C0017337:Gene [Gene or Genome]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0220905:regulatory [Regulation or Law]
   744   C1704735:Regulatory [Conceptual Entity]
   711   C0017446:Region [Geographic Area]
   711   C0205147:Region [Spatial Concept]

Phrase: "may"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "this effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.124: This issue is difficult to solve, since the regulation of nNOS expression is very complex, with more than 12 transcripts (obtained by alternative splicing or promoter usage) and possible suppression of expression by an antisens RNA transcript. 

Phrase: "This issue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033213:Issue [Finding]
  1000   C1706387:Issue [Intellectual Product]

Phrase: "is"

Phrase: "difficult to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: "solve"

Phrase: ","

Phrase: "since"

Phrase: "the regulation of nNOS expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "is"

Phrase: "very complex,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "with more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "than 12 transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "("

Phrase: "obtained by alternative splicing"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0002345:Alternative Splicing [Genetic Function]
   770   C0035687:Splicing [Genetic Function]
   770   C1301820:Obtained [Functional Concept]
   770   C1523987:Alternative [Conceptual Entity]
   770   C2610186:splicing [Genetic Function]
   737 E C1706701:Obtain [Activity]

Phrase: "or"

Phrase: "promoter usage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0457083:Usage [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "possible suppression of expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0221103:Suppression [Pathologic Function]
   770   C0301625:Suppression [Organism Function]
   770   C0439181:% suppression [Quantitative Concept]
   770   C0728721:suppression [Mental Process]

Phrase: "by an antisens RNA transcript."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.125: An association between PD and another repeat polymorphism in the nNOS gene promoter has been recently reported. 

Phrase: "An association between PD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "another repeat polymorphism in the nNOS gene promoter"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0678951:gene polymorphism [Genetic Function]
   742   C0032529:Polymorphism [Genetic Function]
   742   C1882417:Polymorphism [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "reported."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.126: Allele size distribution was significantly different between 64 Chinese patients and controls (39). 

Phrase: "Allele size distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0520511:distribution [Idea or Concept]
   827   C1704711:Distribution [Functional Concept]

Phrase: "was"

Phrase: "significantly different between 64 Chinese patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.127: Association studies are at risk of population stratification bias if there are differences in ethnic background between patients and controls, and variations of allelic frequencies according to ethnic background. 

Phrase: "Association studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "are at risk of population stratification"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   820   C0242444:Population at Risk [Population Group]
           population risk
   783   C2987720:Population risk [Quantitative Concept]
   753   C0032659:Population [Quantitative Concept]
   753   C0035647:Risk [Qualitative Concept]
   753   C1257890:Population [Population Group]
   753   C1514983:Stratification [Research Activity]
   753   C1551058:Are [Quantitative Concept]

Phrase: "bias"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242568:Bias [Idea or Concept]
  1000   C1504315:Bias [Bird]

Phrase: "if"

Phrase: "there"

Phrase: "are"

Phrase: "differences in ethnic background"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0682076:ethnic differences [Finding]
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "between patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "controls,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "variations of allelic frequencies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205419:variations [Qualitative Concept]

Phrase: "according to ethnic background."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0015031:Ethnic background [Population Group]
           ETHNIC
   861   C0680174:ethnic [Finding]
   861   C1706907:Background [Conceptual Entity]
Processing 00000000.tx.128: In this study, only subjects whose two parents were born in Europe were included. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "whose two parents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0030551:Parents [Family Group]
   827 E C2699423:Parent [Conceptual Entity]

Phrase: "were"

Phrase: "born in Europe"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0015176:Europe [Geographic Area]
   756   C0004897:Bear [Mammal]

Phrase: "were"

Phrase: "included."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]
Processing 00000000.tx.129: The majority of the participants had both parents born in France, and analyses restricted to this subgroup yielded results similar to the overall findings. 

Phrase: "The majority of the participants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680220:majority [Social Behavior]

Phrase: "had"

Phrase: "both parents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0030551:Parents [Family Group]
   966 E C2699423:Parent [Conceptual Entity]

Phrase: "born in France,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1277359:Born in France [Finding]
   790   C0016674:France [Geographic Area]
   756   C0004897:Bear [Mammal]

Phrase: "and"

Phrase: "analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "restricted to this subgroup"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0443288:Restricted [Functional Concept]
   770   C1079230:subgroup [Virus]
   770   C1515021:Subgroup [Classification]

Phrase: "yielded"

Phrase: "results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "similar to the overall findings."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.130: In addition, for the nNOS 29 and nNOS 18 polymorphisms we found frequencies similar to those reported in a Caucasian population from the USA (40). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "for the nNOS 29"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0521390:Neuronal [Immunologic Factor]
   827   C1518425:{NOS} [Qualitative Concept]
   755 E C0027882:Neuron [Cell]

Phrase: "and"

Phrase: "nNOS 18 polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0032529:polymorphisms [Genetic Function]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "frequencies"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0439603:Frequencies [Temporal Concept]
   966 E C0376249:frequency [Quantitative Concept]
   966 E C0871396:Frequency [Quantitative Concept]
   966 E C1561548:Frequency [Qualitative Concept]
   966 E C1705502:Frequency [Quantitative Concept]
   916 E C0332183:Frequent [Temporal Concept]

Phrase: "similar to those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "reported in a Caucasian population"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0007457:Caucasian [Population Group]
   760   C0032659:Population [Quantitative Concept]
   760   C0043157:Caucasian [Population Group]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C1257890:Population [Population Group]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]

Phrase: "from the USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.131: Therefore, population stratification is unlikely to have biased our findings. 

Phrase: "Therefore,"

Phrase: "population stratification"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514983:Stratification [Research Activity]

Phrase: "is"

Phrase: "unlikely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0750558:Unlikely [Conceptual Entity]
   861   C1710571:Unlikely [Qualitative Concept]

Phrase: "have"

Phrase: "biased"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0242568:Biased [Idea or Concept]
   966 E C1504315:Bias [Bird]

Phrase: "our findings."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]
Processing 00000000.tx.132: In conclusion, our findings suggest that nNOS and iNOS genes are susceptibility genes in PD, and that nNOS polymorphisms modify the relation between cigarette smoking and PD. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that nNOS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0521390:Neuronal [Immunologic Factor]
   861   C1518425:{NOS} [Qualitative Concept]
   789 E C0027882:Neuron [Cell]

Phrase: "and"

Phrase: "iNOS genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "are"

Phrase: "susceptibility genes in PD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   816   C0919453:Susceptibility Gene [Gene or Genome]
   770   C0017337:Genes [Gene or Genome]

Phrase: "and"

Phrase: "that nNOS polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0032529:polymorphisms [Genetic Function]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "the relation between cigarette smoking"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0080103:Relation [Family Group]
   760   C0869014:relation [Social Behavior]

Phrase: "and"

Phrase: "PD."
Processing 00000000.tx.133: Further studies should be undertaken in order to confirm this association in other populations, and to decipher the functionality of the polymorphisms that were studied.  

Phrase: "Further studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "should"

Phrase: "be"

Phrase: "undertaken in order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1705175:Order [Intellectual Product]
   770   C1705176:Order [Qualitative Concept]
   770   C1705177:Order [Classification]
   770   C1705178:Order [Activity]
   770   C1882348:Order [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "this association in other populations,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "decipher"

Phrase: "the functionality of the polymorphisms"

Phrase: "that"

Phrase: "were"

Phrase: "studied."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]
Processing 00000000.tx.134: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Participants This study was conducted among subjects enrolled in a French social security organization, the MSA, which is responsible for the reimbursement of health-related expenses to workers connected to agriculture (i.e. farmers and farm workers, but also workers in silos, agricultural cooperatives and seed shops, as well as tertiary sector professionals). 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Participants"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0679646:participants [Population Group]
   966 E C2698741:Participant [Classification]

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "conducted among subjects"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C0004927:Conduct [Individual Behavior]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "enrolled in a French social security organization,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0037435:Social Security [Governmental or Regulatory Activity]
   774   C0597480:social organization [Organization]
   748   C0029237:Organisation [Physiologic Function]
   748   C0029246:Organization [Organization]
   748   C0220885:organization [Qualitative Concept]
   748   C0728831:Social [Functional Concept]
   748   C1300196:Organization [Functional Concept]
   748   C1519222:Security [Conceptual Entity]
   748   C1522486:Organization [Professional or Occupational Group]
   748   C1556084:French [Population Group]

Phrase: "the MSA,"

Phrase: "which"

Phrase: "is"

Phrase: "responsible for the reimbursement of health-related expenses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1273518:Responsible [Finding]

Phrase: "to workers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024752:workers [Functional Concept]
  1000   C1306056:workers [Occupation or Discipline]
  1000   C1527116:Workers [Population Group]

Phrase: "connected to agriculture"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0001829:Agriculture [Occupation or Discipline]
   756   C2986575:Connect [Activity]

Phrase: "(i.e. farmers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0221460:FARMERS [Professional or Occupational Group]
   734   C0683454:I-E [Diagnostic Procedure,Intellectual Product]

Phrase: "and"

Phrase: "farm workers,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0024752:workers [Functional Concept]
   861   C0557759:Farm [Geographic Area]
   861   C1306056:workers [Occupation or Discipline]
   861   C1527116:Workers [Population Group]

Phrase: "but"

Phrase: "also workers in silos,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0024752:workers [Functional Concept]
   770   C1306056:workers [Occupation or Discipline]
   770   C1527116:Workers [Population Group]

Phrase: "agricultural cooperatives"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0679729:cooperatives [Organization]

Phrase: "and"

Phrase: "seed shops,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0700383:shops [Geographic Area]
   827 E C0150768:Shop [Daily or Recreational Activity]

Phrase: "as well as"

Phrase: "tertiary sector professionals"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0679924:professionals [Professional or Occupational Group]
   793 E C2698884:Professional [Occupation or Discipline]
   734   C0039567:Tertiary Sector [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.135: The study protocol has been described in detail elsewhere (41). 

Phrase: "The study protocol"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1507394:Study Protocol [Intellectual Product]
           Protocol
  1000   C2348563:Study Protocol [Intellectual Product]
           Protocol
   861   C0442711:Protocol [Intellectual Product]
   861   C0557651:Study [Manufactured Object]
   861   C1522729:Protocol [Intellectual Product]
   861   C2603343:Study [Research Activity]

Phrase: "has"

Phrase: "been"

Phrase: "described in detail elsewhere"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1522508:Detail [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C1561567:detail [Functional Concept]

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.136: Briefly, individuals aged 1875 years old who submitted an application for benefit from complete health care coverage for PD during an 18 months period were invited to participate. 

Phrase: "Briefly,"

Phrase: "individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "aged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001779:Aged [Organism Attribute]
  1000   C0001792:Aged [Population Group]
  1000   C1999167:aged [Population Group]

Phrase: "1875 years old"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0580836:Old [Temporal Concept]

Phrase: "who"

Phrase: "submitted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515023:Submitted [Functional Concept]

Phrase: "an application for benefit"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   909   C0587173:Application for benefit [Finding]
   770   C0185125:Application [Health Care Activity]
   770   C1947919:Application [Intellectual Product]
   770   C2347934:Application [Intellectual Product]
   770   C3539080:APPLICATION [Quantitative Concept]

Phrase: "from complete health care coverage"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0086388:Health Care [Health Care Activity]
   812   C0018684:Health [Idea or Concept]
   812   C1551362:coverage [Idea or Concept]
   812   C1947933:Care [Activity]
   812   C1999244:Coverage [Functional Concept]
   712 E C0031206:healthiness [Finding]

Phrase: "for PD"

Phrase: "during an 18 months period"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   755 E C0332182:Periodic [Temporal Concept]
   755 E C1706381:PERIODIC [Intellectual Product]
   727 E C0031084:Periodicities [Temporal Concept]

Phrase: "were"

Phrase: "invited"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "participate."
Processing 00000000.tx.137: As part of the study protocol, they were examined by a neurologist with experience in movement disorders. 

Phrase: "As part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "of the study protocol,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1507394:Study Protocol [Intellectual Product]
           Protocol
  1000   C2348563:Study Protocol [Intellectual Product]
           Protocol
   861   C0442711:Protocol [Intellectual Product]
   861   C0557651:Study [Manufactured Object]
   861   C1522729:Protocol [Intellectual Product]
   861   C2603343:Study [Research Activity]

Phrase: "they"

Phrase: "were"

Phrase: "examined by a neurologist"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237426:Neurologist [Professional or Occupational Group]
   770   C0332128:Examined [Finding]

Phrase: "with experience"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237607:experience [Mental Process]
  1000   C0596545:Experience [Mental Process]

Phrase: "in movement disorders."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0026650:Movement Disorders [Disease or Syndrome]
   861   C0012634:Disorders [Disease or Syndrome]
   861   C0026649:Movement [Organism Function]
Processing 00000000.tx.138: Whenever it was impossible to directly examine the patient, the patient's treating neurologist was contacted and asked to fill a clinical questionnaire. 

Phrase: "Whenever"

Phrase: "it"

Phrase: "was"

Phrase: "impossible to directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1947931:Directly [Qualitative Concept]

Phrase: "examine"

Phrase: "the patient,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "the patient's"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "treating"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treating [Therapeutic or Preventive Procedure]
  1000   C1522326:Treating [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "neurologist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237426:Neurologist [Professional or Occupational Group]

Phrase: "was"

Phrase: "contacted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0332158:contact [Functional Concept]
   966   C0337611:Contact [Population Group]
   966   C1705415:Contact [Idea or Concept]

Phrase: "and"

Phrase: "asked"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "fill"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708059:Fill [Activity]

Phrase: "a clinical questionnaire."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034394:Questionnaire [Intellectual Product]
Processing 00000000.tx.139: Parkinsonism was defined as the presence of two or more of the four cardinal signs: rest tremor, bradykinesia, rigidity, and impaired postural reflexes (42,43). 

Phrase: "Parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "was"

Phrase: "defined as the presence of two"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205448:Two [Quantitative Concept]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C1704788:Defined [Conceptual Entity]
   753   C3539106:Defined [Intellectual Product]

Phrase: "or"

Phrase: "more of the four cardinal signs"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0205172:More [Functional Concept]
   753   C0205450:Four [Quantitative Concept]
   753   C0220912:signs [Functional Concept]
   753   C0220913:signs [Manufactured Object]
   753   C0311392:SIGNS [Finding]
   753   C0326926:Cardinal [Bird]
   753   C2700598:cardinal [Fungus]
   719 E C1547188:Sign [Idea or Concept]

Phrase: ":"

Phrase: "rest tremor,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0234379:Rest Tremor [Sign or Symptom]
   861   C0035253:Rest [Daily or Recreational Activity]
   861   C0040822:Tremor [Sign or Symptom]
   861   C1622890:ResT [Molecular Function]
   861   C1963252:Tremor [Finding]

Phrase: "bradykinesia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0233565:Bradykinesia [Sign or Symptom]

Phrase: "rigidity,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0026837:Rigidity, NOS [Sign or Symptom]
  1000   C0700109:rigidity [Natural Phenomenon or Process]
   928 E C0231517:Rigid [Individual Behavior]
   928 E C1882952:RIGID [Phenomenon or Process]

Phrase: "and"

Phrase: "impaired postural reflexes"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   867   C0234154:Postural reflex [Organ or Tissue Function]
   827   C0034929:reflexes [Organ or Tissue Function]
   827   C0205278:Postural [Functional Concept]
   827   C0596002:Reflexes [Finding]
   793 E C0439840:reflex [Organ or Tissue Function]
   755 E C1262869:Posture [Organism Attribute]

Phrase: "(42,"

Phrase: "43"

Phrase: ")."
Processing 00000000.tx.140: PD was defined as the presence of parkinsonism after exclusion of the following criteria: prominent or early signs of more extensive nervous system involvement not explained otherwise; 

Phrase: "PD"

Phrase: "was"

Phrase: "defined as the presence of parkinsonism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0242422:Parkinsonism [Disease or Syndrome]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C1704788:Defined [Conceptual Entity]
   753   C3539106:Defined [Intellectual Product]

Phrase: "after exclusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0680251:EXCLUSION [Functional Concept]
  1000   C2828389:Exclusion [Activity]

Phrase: "of the following criteria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0243161:criteria [Intellectual Product]

Phrase: ":"

Phrase: "prominent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205402:Prominent [Qualitative Concept]

Phrase: "or"

Phrase: "early signs of more extensive nervous system involvement"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   765   C0751378:Neurologic Signs [Sign or Symptom]
   744   C0220912:signs [Functional Concept]
   744   C0220913:signs [Manufactured Object]
   744   C0311392:SIGNS [Finding]
   711 E C1547188:Sign [Idea or Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "explained"

Phrase: "otherwise"

Phrase: ";"
Processing 00000000.tx.141: supranuclear gaze palsy; 

Phrase: "supranuclear gaze palsy"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1720037:Supranuclear gaze palsy [Finding]
   913   C0270920:Supranuclear palsy [Disease or Syndrome]
   901   C1112261:Gaze palsy [Disease or Syndrome]
   827   C0522224:Palsy [Finding]

Phrase: ";"
Processing 00000000.tx.142: repeated strokes with step-wise progression of parkinsonism; 

Phrase: "repeated strokes with step-wise progression of parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0038454:Strokes [Disease or Syndrome]

Phrase: ";"
Processing 00000000.tx.143: neuroleptic treatment before onset of the disease; 

Phrase: "neuroleptic treatment before onset of the disease"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: ";"
Processing 00000000.tx.144: unresponsiveness to levodopa (42,43). 

Phrase: "unresponsiveness to levodopa"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0241526:Unresponsiveness [Finding]
   718 E C0205269:Unresponsive [Functional Concept]
   718 E C0237284:Unresponsive [Finding]

Phrase: "(42,"

Phrase: "43"

Phrase: ")."
Processing 00000000.tx.145: Patients who already benefitted from or requested free health coverage for dementia or who were bedridden were not included. 

Phrase: "Patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "who already"

Phrase: "benefitted from"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0814225:Benefit [Quantitative Concept]

Phrase: "or"

Phrase: "requested free health coverage for dementia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1551362:coverage [Idea or Concept]
   753   C1999244:Coverage [Functional Concept]

Phrase: "or"

Phrase: "who"

Phrase: "were"

Phrase: "bedridden"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0425251:Bed-ridden [Finding]
  1000   C0741453:Bedridden [Finding]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "included."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]
Processing 00000000.tx.146: Controls were recruited among all MSA affiliates who made requests to be reimbursed for health expenses (e.g. rehabilitation, glasses, dental care, podiatric care, hydrotherapy, nursing care, respiratory function testing, holter monitoring). 

Phrase: "Controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "recruited among all MSA affiliates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1510825:Affiliate [Qualitative Concept]
   714   C1696107:affiliate [Idea or Concept]

Phrase: "who"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "requests"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0686900:request [Functional Concept]
  1000   C1272683:Request [Functional Concept]
  1000   C1522634:Request [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "reimbursed for health expenses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   816   C3242647:health expense [Idea or Concept]
   770   C0018684:Health [Idea or Concept]
   770   C0680864:expenses [Quantitative Concept]

Phrase: "("

Phrase: "e.g. rehabilitation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034991:Rehabilitation [Therapeutic or Preventive Procedure]
  1000   C0034992:rehabilitation [Functional Concept]
  1000   C1306847:Rehabilitation [Biomedical Occupation or Discipline]

Phrase: "glasses,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0015421:Glasses [Medical Device]
   966 E C0017596:Glass [Manufactured Object]
   966 E C1947936:Glass [Medical Device]
   916 E C0074759:Glassy [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   916 E C0522500:Glassy [Qualitative Concept]

Phrase: "dental care,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011331:Dental Care [Health Care Activity]
   861   C0226984:Dental [Qualitative Concept]
   861   C1947933:Care [Activity]

Phrase: "podiatric care,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1947933:Care [Activity]

Phrase: "hydrotherapy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020311:Hydrotherapy [Therapeutic or Preventive Procedure]

Phrase: "nursing care,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0028678:nursing care [Therapeutic or Preventive Procedure]
           nursing
  1000   C0028682:Nursing Care [Health Care Activity]
  1000   C1552413:Nursing Care [Health Care Related Organization]
   861   C0006147:Nursing [Organism Function]
   861   C0028677:Nursing [Biomedical Occupation or Discipline]
   861   C1947933:Care [Activity]
   827 E C0028661:Nurse [Professional or Occupational Group]

Phrase: "respiratory function testing,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0039593:Testing [Functional Concept]
   827   C0392366:testing [Intellectual Product]
   734   C0035203:Respiratory function [Physiologic Function]
   734   C0035245:respiratory function [Organ or Tissue Function]

Phrase: "holter monitoring"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
  1000   C0013801:Monitoring, Holter [Diagnostic Procedure]
   983 E C0182920:Holter monitor [Medical Device]
   861   C0150369:Monitoring [Health Care Activity]
   861   C1516647:monitoring [Research Activity]
   827 E C0030695:monitor [Health Care Activity]
   827 E C0181904:Monitor [Medical Device]
   827 E C0596972:Monitor [Medical Device]
   827 E C1521743:Monitor [Professional or Occupational Group]
   827 E C1704646:Monitor [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.147: A maximum number of three controls were matched by age (2 years), sex and region of residency at the time of the study to each case. 

Phrase: "A maximum number of three controls"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "were"

Phrase: "matched by age (2 years"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   797   C1510829:Age-Years [Temporal Concept]
   760   C0001779:Age [Organism Attribute]
   760   C0150103:matched [Research Activity]
   760   C0439234:years [Temporal Concept]
   760   C1708943:Matched [Qualitative Concept]
   726 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "sex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0009253:Sex [Organism Function]
  1000   C0036864:Sex [Behavior]
  1000   C0079399:sex [Organism Attribute]
  1000   C1314687:Sex [Finding]
  1000   C1522384:sex [Organism Attribute]

Phrase: "and"

Phrase: "region of residency"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0017446:Region [Geographic Area]
   790   C0205147:Region [Spatial Concept]
   718 E C0205276:Regional [Spatial Concept]
   718 E C1947913:Regional [Spatial Concept]

Phrase: "at the time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "of the study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "to each case."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]
Processing 00000000.tx.148: Participants were not included as controls if they already benefitted from free health coverage for PD or dementia, were treated for PD, were found to fulfil the criteria for parkinsonism, or were bedridden. 

Phrase: "Participants"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0679646:participants [Population Group]
   966 E C2698741:Participant [Classification]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "included as controls"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0332257:included [Functional Concept]
   790   C3538986:INCLUDED [Gene or Genome]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756 E C1552866:include [Idea or Concept]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756 E C2700399:Include [Activity]
   756   C3274648:Control [Qualitative Concept]

Phrase: "if"

Phrase: "they already"

Phrase: "benefitted from free health coverage"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   781   C0086387:Health Benefit [Quantitative Concept]
   760   C0018684:Health [Idea or Concept]
   760   C0332296:free [Functional Concept]
   760   C1551362:coverage [Idea or Concept]
   760   C1880497:Free [Qualitative Concept]
   760   C1996904:Free [Qualitative Concept]
   760   C1999244:Coverage [Functional Concept]
   726   C0814225:Benefit [Quantitative Concept]

Phrase: "for PD"

Phrase: "or"

Phrase: "dementia,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "were"

Phrase: "treated for PD,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332293:treated [Therapeutic or Preventive Procedure]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "fulfil"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550543:Fulfill [Idea or Concept]

Phrase: "the criteria for parkinsonism,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0243161:criteria [Intellectual Product]

Phrase: "or"

Phrase: "were"

Phrase: "bedridden."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0425251:Bed-ridden [Finding]
  1000   C0741453:Bedridden [Finding]
Processing 00000000.tx.149: Information about demographic data, comorbidities, family history of PD, and the country of birth of the two parents were obtained. 

Phrase: "Information about demographic data,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1533716:Information [Idea or Concept]

Phrase: "comorbidities,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009488:Comorbidities [Idea or Concept]

Phrase: "family history of PD,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0241889:Family history [Finding]
   833   C1705495:Family History [Idea or Concept]
   770   C0015576:Family [Family Group]
   770   C0019664:History [Occupation or Discipline]
   770   C0019665:history [Intellectual Product]
   770   C0262512:History, NOS [Organism Attribute]
   770   C0262926:History [Finding]
   770   C1704727:Family [Conceptual Entity]
   770   C1705255:History [Conceptual Entity]
   770   C2004062:History [Finding]

Phrase: "and"

Phrase: "the country of birth of the two parents"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   800   C1300001:Country of birth [Finding]
           Origin - country
   772 E C1549631:Country Of Origin [Idea or Concept]
   772 E C3262211:Country of origin [Clinical Attribute]
   744   C0454664:Country [Geographic Area]

Phrase: "were"

Phrase: "obtained."
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]
Processing 00000000.tx.150: A face-to-face administered questionnaire elicited detailed information on cigarette smoking, including the average number of cigarettes smoked per day, as well as the starting and stopping age. 

Phrase: "A face-to-face administered questionnaire"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0034394:Questionnaire [Intellectual Product]
   717   C1553514:face-to-face [Idea or Concept]

Phrase: "elicited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicited [Qualitative Concept]

Phrase: "detailed information on cigarette smoking,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1533716:Information [Idea or Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the average number of cigarettes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "smoked per day,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0332173:/day [Temporal Concept]
   790   C0439228:day [Temporal Concept]
   790   C0439505:/day [Temporal Concept]
   756   C0037366:Smoke [Environmental Effect of Humans,Hazardous or Poisonous Substance]
   756   C0439994:Smoke [Hazardous or Poisonous Substance]
   756   C1881674:SMOKE [Phenomenon or Process]

Phrase: "as well as"

Phrase: "the starting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439659:Start [Temporal Concept]

Phrase: "and"

Phrase: "stopping age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]
Processing 00000000.tx.151: In addition, if the number of cigarettes smoked per day varied during their lifetime, the participants were asked to divide their smoking history into a maximum of three time periods. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "if"

Phrase: "the number of cigarettes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "smoked per day"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0332173:/day [Temporal Concept]
   790   C0439228:day [Temporal Concept]
   790   C0439505:/day [Temporal Concept]
   756   C0037366:Smoke [Environmental Effect of Humans,Hazardous or Poisonous Substance]
   756   C0439994:Smoke [Hazardous or Poisonous Substance]
   756   C1881674:SMOKE [Phenomenon or Process]

Phrase: "varied during their lifetime,"

Phrase: "the participants"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0679646:participants [Population Group]
   966 E C2698741:Participant [Classification]

Phrase: "were"

Phrase: "asked"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "divide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332849:Divide [Functional Concept]

Phrase: "their smoking history into a maximum of three time periods."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C1519384:Smoking History [Finding]
   739   C0019664:History [Occupation or Discipline]
   739   C0019665:history [Intellectual Product]
   739   C0262512:History, NOS [Organism Attribute]
   739   C0262926:History [Finding]
   739   C1705255:History [Conceptual Entity]
   739   C2004062:History [Finding]
   722   C0681698:historical periods [Temporal Concept]
Processing 00000000.tx.152: Based on this information, participants were classified as current, ex- or never cigarette smokers, according to their smoking status at onset of PD (in patients), or index age (in controls; defined as the age at onset of PD in the matched case). 

Phrase: "Based on this information,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C1527178:Based [Functional Concept]
   770   C1533716:Information [Idea or Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "participants"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0679646:participants [Population Group]
   966 E C2698741:Participant [Classification]

Phrase: "were"

Phrase: "classified as current,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0008902:Classified [Classification]
   790   C0521116:Current [Temporal Concept]
   790   C1705970:Current [Natural Phenomenon or Process]

Phrase: "ex-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704625:EX [Idea or Concept]

Phrase: "or"

Phrase: "never cigarette smokers,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0337667:cigarette smokers [Finding]
   896   C0425293:Never Smoker [Finding]
   827   C0337664:smokers [Finding]

Phrase: "according to their smoking status"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1519386:Smoking Status [Clinical Attribute]
   861   C0449438:Status [Qualitative Concept]

Phrase: "at onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "of PD ("

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "index age (in controls"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0001779:Age [Organism Attribute]

Phrase: ";"

Phrase: "defined as the age at onset of PD"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   789   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   744   C0001779:Age [Organism Attribute]
   744   C0332162:Onset [Qualitative Concept]
   744   C1704788:Defined [Conceptual Entity]
   744   C3539106:Defined [Intellectual Product]

Phrase: "in the matched case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0868928:Case [Functional Concept]
   861   C1706255:CASE [Medical Device]
   861   C1706256:Case [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.153: The cumulative number of pack-years smoked until PD onset (in patients) or index age (in controls) was computed as the number of packs smoked per day (cigarettes smoked per day divided by 20) times the number of years smoked; 

Phrase: "The cumulative number of pack-years"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "smoked until PD onset"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0332162:Onset [Qualitative Concept]
   737   C0037366:Smoke [Environmental Effect of Humans,Hazardous or Poisonous Substance]
   737   C0439994:Smoke [Hazardous or Poisonous Substance]
   737   C1881674:SMOKE [Phenomenon or Process]

Phrase: "("

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: ")"

Phrase: "or"

Phrase: "index age (in controls"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0001779:Age [Organism Attribute]

Phrase: ")"

Phrase: "was"

Phrase: "computed as the number of packs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]
   753   C1441526:Computed [Laboratory Procedure]
   753   C1880157:Computed [Activity]
   753   C1968515:packs [Medical Device]
   753   C2825051:Packs [Drug Delivery Device]
   719 E C2828395:Pack [Activity]

Phrase: "smoked per day"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0332173:/day [Temporal Concept]
   790   C0439228:day [Temporal Concept]
   790   C0439505:/day [Temporal Concept]
   756   C0037366:Smoke [Environmental Effect of Humans,Hazardous or Poisonous Substance]
   756   C0439994:Smoke [Hazardous or Poisonous Substance]
   756   C1881674:SMOKE [Phenomenon or Process]

Phrase: "(cigarettes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0677453:Cigarettes [Manufactured Object]
   966 E C1704760:Cigarette [Biomedical or Dental Material]

Phrase: "smoked per day"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0332173:/day [Temporal Concept]
   790   C0439228:day [Temporal Concept]
   790   C0439505:/day [Temporal Concept]
   756   C0037366:Smoke [Environmental Effect of Humans,Hazardous or Poisonous Substance]
   756   C0439994:Smoke [Hazardous or Poisonous Substance]
   756   C1881674:SMOKE [Phenomenon or Process]

Phrase: "divided by 20"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332849:Divided [Functional Concept]

Phrase: ")"

Phrase: "times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:times [Temporal Concept]
  1000   C1632851:Times [Quantitative Concept]
   966 E C3541383:Time [Temporal Concept]
   928 E C0442043:Temporal [Spatial Concept]
   928 E C2362314:Temporal [Temporal Concept]

Phrase: "the number of years"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "smoked"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0037366:Smoke [Environmental Effect of Humans,Hazardous or Poisonous Substance]
   966   C0439994:Smoke [Hazardous or Poisonous Substance]
   966   C1881674:SMOKE [Phenomenon or Process]

Phrase: ";"
Processing 00000000.tx.154: our computation took into account variations in the number of cigarettes smoked per day according to the time periods defined above. 

Phrase: "our computation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1880157:Computation [Activity]
   928 E C1516769:Computational [Research Activity]

Phrase: "took into account variations"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205419:variations [Qualitative Concept]
   770   C1551359:account [Idea or Concept]
   770   C2741673:Account # [Clinical Attribute]
   770   C2981730:Account [Classification]
   737   C1515187:Take [Health Care Activity]

Phrase: "in the number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "of cigarettes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0677453:Cigarettes [Manufactured Object]
   966 E C1704760:Cigarette [Biomedical or Dental Material]

Phrase: "smoked per day"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0332173:/day [Temporal Concept]
   790   C0439228:day [Temporal Concept]
   790   C0439505:/day [Temporal Concept]
   756   C0037366:Smoke [Environmental Effect of Humans,Hazardous or Poisonous Substance]
   756   C0439994:Smoke [Hazardous or Poisonous Substance]
   756   C1881674:SMOKE [Phenomenon or Process]

Phrase: "according to the time periods"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
  1000   C0439582:Time periods [Temporal Concept]
   972 E C0585019:Temporal periods [Temporal Concept]
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C0332182:Periodic [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]
   777 E C1706381:PERIODIC [Intellectual Product]
   755 E C0031084:Periodicities [Temporal Concept]

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: "above."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]
Processing 00000000.tx.155: Exposure to pesticides was assessed using a two-phase case-by-case exposure assessment procedure that involved screening for professional exposure using a self-administered questionnaire and, for individuals professionally exposed according to this screening, a detailed interview at home with an occupational health physician from the MSA (41,44,45). 

Phrase: "Exposure to pesticides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332157:Exposure to [Clinical Attribute]
           Exposure
   790   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "was"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a two-phase case-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0868928:Case [Functional Concept]
   827   C1706255:CASE [Medical Device]
   827   C1706256:Case [Conceptual Entity]

Phrase: "by-case exposure assessment procedure"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C1261322:Assessment procedure [Health Care Activity]
   812   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   812   C1948041:Procedure [Therapeutic or Preventive Procedure]
   812   C2700391:Procedure [Activity]
   812   C3274430:PROCEDURE [Health Care Activity]
   812   C3538935:Procedure [Idea or Concept]
   812   C3539779:Procedure [Intellectual Product]

Phrase: "that involved screening for professional exposure"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0220908:Screening [Health Care Activity]
   753   C0220909:screening [Functional Concept]
   753   C1698960:screening [Intellectual Product]
   753   C1710031:Screening [Diagnostic Procedure]
   753   C1710477:SCREENING [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a self-administered questionnaire"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C1519231:Self-Administered [Functional Concept]
   827   C0034394:Questionnaire [Intellectual Product]
   827   C0036588:Self [Idea or Concept]
   827   C1521801:Administered [Functional Concept]
   827   C1551994:self [Intellectual Product]
   827   C3244295:Self [Intellectual Product]
   793 E C1621583:Administer [Functional Concept]

Phrase: "and"

Phrase: ","

Phrase: "for individuals professionally"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "exposed according to this screening,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   797   C0332157:Exposed to [Clinical Attribute]
           Exposed
   760   C0220908:Screening [Health Care Activity]
   760   C0220909:screening [Functional Concept]
   760   C0680240:according [Social Behavior]
   760   C1698960:screening [Intellectual Product]
   760   C1710031:Screening [Diagnostic Procedure]
   760   C1710477:SCREENING [Research Activity]

Phrase: "a detailed interview at home"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021822:Interview [Activity]
   760   C0935630:Interview [Intellectual Product]

Phrase: "with an occupational health physician"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1955959:Physician, Occupational Health [Professional or Occupational Group]
   913   C0401976:Occupational physician [Professional or Occupational Group]
   827   C0031831:Physician [Professional or Occupational Group]
   827   C0804815:Physician [Clinical Attribute]
   734   C0079920:Occupational Health [Occupation or Discipline]

Phrase: "from the MSA"

Phrase: "(41,"

Phrase: "44,"

Phrase: "45"

Phrase: ")."
Processing 00000000.tx.156: Using a specific questionnaire, the physician completed the occupational history, and confirmed whether or not that the participant had personally sprayed or prepared pesticides in a professional setting; 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a specific questionnaire,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034394:Questionnaire [Intellectual Product]

Phrase: "the physician"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031831:Physician [Professional or Occupational Group]
  1000   C0804815:Physician [Clinical Attribute]

Phrase: "completed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:COMPLETED [Qualitative Concept]

Phrase: "the occupational history,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0019664:History [Occupation or Discipline]
   861   C0019665:history [Intellectual Product]
   861   C0262512:History, NOS [Organism Attribute]
   861   C0262926:History [Finding]
   861   C0521127:Occupational [Functional Concept]
   861   C1705255:History [Conceptual Entity]
   861   C2004062:History [Finding]
   789 E C1552658:Historical [Idea or Concept]
   789 E C1552723:Historical [Idea or Concept]

Phrase: "and"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "whether"

Phrase: "or"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "that"

Phrase: "the participant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0679646:Participant [Population Group]
  1000   C2698741:Participant [Classification]

Phrase: "had"

Phrase: "personally"

Phrase: "sprayed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0233601:sprayed [Mental or Behavioral Dysfunction]
   966 E C1704413:{Spray} [Quantitative Concept]
   966 E C2003858:Spray [Functional Concept]

Phrase: "or"

Phrase: "prepared pesticides in a professional setting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0031253:Pesticides [Hazardous or Poisonous Substance]

Phrase: ";"
Processing 00000000.tx.157: 20% of those who had declared to be professional users of pesticides in the self-administered questionnaire were not professional users according to the interview with the physician (11% were users for gardening exclusively, and 9% were never users). 

Phrase: "20% of those"

Phrase: "who"

Phrase: "had"

Phrase: "declared"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "professional users of pesticides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1706077:Users [Human]
   737 E C1548600:User [Idea or Concept]

Phrase: "in the self-administered questionnaire"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C1519231:Self-Administered [Functional Concept]
   827   C0034394:Questionnaire [Intellectual Product]
   827   C0036588:Self [Idea or Concept]
   827   C1521801:Administered [Functional Concept]
   827   C1551994:self [Intellectual Product]
   827   C3244295:Self [Intellectual Product]
   793 E C1621583:Administer [Functional Concept]

Phrase: "were"

Phrase: "not professional users according to the interview"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1706077:Users [Human]
   714 E C1548600:User [Idea or Concept]

Phrase: "with the physician"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031831:Physician [Professional or Occupational Group]
  1000   C0804815:Physician [Clinical Attribute]

Phrase: "(11%"

Phrase: "were"

Phrase: "users for gardening exclusively,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1706077:Users [Human]
   737 E C1548600:User [Idea or Concept]

Phrase: "and"

Phrase: "9%"

Phrase: "were"

Phrase: "never users"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1706077:Users [Human]
   827 E C1548600:User [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.158: Finally, the questionnaires were reviewed by a panel of experts blinded to the case or control status, and we were able to classify the participants in three groups with respect to pesticides exposure: never users, users for gardening exclusively and professional users. 

Phrase: "Finally,"

Phrase: "the questionnaires"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034394:Questionnaires [Intellectual Product]
  1000   C1706422:Questionnaires [Idea or Concept]

Phrase: "were"

Phrase: "reviewed by a panel of experts"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0282443:reviewed [Intellectual Product]
   753   C0441833:Panel [Idea or Concept]
   753   C1709940:Reviewed [Qualitative Concept]
   753   C1999270:Panel [Intellectual Product]
   753   C3537156:Panel [Manufactured Object]
   719 E C1552617:Review [Idea or Concept]

Phrase: "blinded to the case"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0150108:Blinded [Research Activity]
   770   C0868928:Case [Functional Concept]
   770   C1706255:CASE [Medical Device]
   770   C1706256:Case [Conceptual Entity]
   737 E C0456909:Blind [Disease or Syndrome]
   737 E C0525065:blind [Patient or Disabled Group]

Phrase: "or"

Phrase: "control status,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449438:Status [Qualitative Concept]

Phrase: "and"

Phrase: "we"

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "classify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008902:classify [Classification]

Phrase: "the participants in three groups"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0679646:participants [Population Group]
   726 E C2698741:Participant [Classification]

Phrase: "with respect to pesticides exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0274281:Exposure, NOS [Injury or Poisoning]
   861   C0332157:Exposure [Clinical Attribute]

Phrase: ":"

Phrase: "never users,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1706077:Users [Human]
   827 E C1548600:User [Idea or Concept]

Phrase: "users for gardening exclusively"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1706077:Users [Human]
   737 E C1548600:User [Idea or Concept]

Phrase: "and"

Phrase: "professional users."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1706077:Users [Human]
   827 E C1548600:User [Idea or Concept]
Processing 00000000.tx.159: We carried out a small validation study by interviewing over the phone subjects randomly chosen among those who had been classified as never users (n=15) or users for gardening exclusively (n=15); 

Phrase: "We"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "a small validation study by interviewing"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0681836:validation study [Intellectual Product,Research Activity]
   753   C0557651:Study [Manufactured Object]
   753   C1519941:Validation [Research Activity]
   753   C2603343:Study [Research Activity]

Phrase: "over the phone"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C1515258:Phone [Conceptual Entity]
  1000   C1705541:Phone [Manufactured Object]
   907 E C0042939:Voice [Organism Function]
   907 E C3244282:voice [Qualitative Concept]
   893 E C0205382:Vocal [Functional Concept]
   893 E C0871074:phonic [Intellectual Product]

Phrase: "subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "randomly"

Phrase: "chosen among those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707391:Chosen [Activity]

Phrase: "who"

Phrase: "had"

Phrase: "been"

Phrase: "classified as never users"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0008902:Classified [Classification]
   770   C1706077:Users [Human]
   770   C2003901:Never [Temporal Concept]
   737 E C1548600:User [Idea or Concept]

Phrase: "(n=15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "or"

Phrase: "users for gardening exclusively"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1706077:Users [Human]
   737 E C1548600:User [Idea or Concept]

Phrase: "(n=15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.160: the self-administered questionnaire and the phone interview were always consistent and none of these 30 subjects had ever used pesticides in a professional setting. 

Phrase: "the self-administered questionnaire"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C1519231:Self-Administered [Functional Concept]
   827   C0034394:Questionnaire [Intellectual Product]
   827   C0036588:Self [Idea or Concept]
   827   C1521801:Administered [Functional Concept]
   827   C1551994:self [Intellectual Product]
   827   C3244295:Self [Intellectual Product]
   793 E C1621583:Administer [Functional Concept]

Phrase: "and"

Phrase: "the phone interview"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021822:Interview [Activity]
   861   C0935630:Interview [Intellectual Product]

Phrase: "were"

Phrase: "always consistent"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0332290:Consistent [Idea or Concept]
   789 E C0332529:Consistencies [Qualitative Concept]
   789 E C1547017:Consistency [Quantitative Concept]

Phrase: "and"

Phrase: "none of these 30 subjects"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0456148:None [Quantitative Concept]
   760   C0549184:None [Quantitative Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "had"

Phrase: "ever used pesticides in a professional setting."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0031253:Pesticides [Hazardous or Poisonous Substance]
Processing 00000000.tx.161: The ethics committee of Hpital du Kremlin-Bictre (Paris) approved the research protocol, and all subjects signed an informed consent. 

Phrase: "The ethics committee of Hpital du Kremlin-Bictre"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0085546:Ethics Committee [Professional or Occupational Group]
   744   C2699414:Committee [Group]

Phrase: "(Paris"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030561:Paris [Geographic Area]
  1000   C0331677:Paris [Plant]
  1000   C1824032:PARIS [Gene or Genome]
   966 E C1824369:PARI [Gene or Genome]

Phrase: ")"

Phrase: "approved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205540:Approved [Qualitative Concept]

Phrase: "the research protocol,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]

Phrase: "and"

Phrase: "all"

Phrase: "subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "signed"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1519316:Signed [Intellectual Product]
  1000   C1561610:signed [Idea or Concept]
   966 E C0311392:Sign [Finding]
   966 E C1547188:Sign [Idea or Concept]

Phrase: "an informed consent."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0021430:Informed Consent [Regulation or Law]
   861   C1511481:Consent [Functional Concept]
   861   C1522154:Informed [Qualitative Concept]
   861   C1554192:consent [Idea or Concept]
   827 E C0537670:Inform [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827 E C0700287:inform [Health Care Activity]
   827 E C1552002:inform [Idea or Concept]
Processing 00000000.tx.162: Genotyping Participants were blood sampled and genomic DNA was extracted from peripheral blood leukocytes using a standard technique. 

Phrase: "Genotyping Participants"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679646:participants [Population Group]
   827 E C2698741:Participant [Classification]

Phrase: "were"

Phrase: "blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "sampled"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0441621:sampled [Diagnostic Procedure]
  1000   C0870078:sampled [Idea or Concept]
   966 E C0370003:Sample [Substance]
   966 E C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "genomic DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017428:Genomic [Gene or Genome]
   861   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "was"

Phrase: "extracted from peripheral blood leukocytes"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   806   C0023516:blood leukocytes [Cell]
           Leukocytes
   806   C0229664:peripheral blood [Body Substance]
           Blood
   765 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   760   C0005767:Blood [Tissue]
   760   C0005768:blood [Body Substance]
   760   C0185115:Extracted [Therapeutic or Preventive Procedure]
   760   C0205100:Peripheral [Spatial Concept]
   760   C3541890:EXTRACTED [Finding]
   726 E C2828366:Extract [Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a standard technique."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449851:Technique [Functional Concept]
   777 E C0025664:techniques [Intellectual Product]
Processing 00000000.tx.163: For the iNOS gene (NOS2A), we studied a G/A substitution at position 37498, in exon 22 (iNOS 22) that does not lead to an amino acid change (PubMed, accession NT_024889), but creates a BtgI restriction enzyme site. 

Phrase: "For the iNOS gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Gene [Gene or Genome]

Phrase: "(NOS2A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0669372:NOS2A [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417760:NOS2A [Gene or Genome]
  1000   C3539722:NOS2A [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "a G/A substitution at position 37498,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1555721:Substitution [Idea or Concept]
   748   C1706204:Substitution [Activity]

Phrase: "in exon 22"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(iNOS 22"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205263:Inducible [Functional Concept]
   827   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1518425:{NOS} [Qualitative Concept]

Phrase: ")"

Phrase: "that"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "lead to an amino acid change"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C1953353:Amino acid change [Finding]
   790   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acid [Chemical]
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0392747:Change [Functional Concept]
   753   C0443172:change [Quantitative Concept]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1522538:Lead [Functional Concept]
   753   C1705241:Change [Quantitative Concept]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(PubMed,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138432:PubMed [Intellectual Product]

Phrase: "accession NT_024889"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0332126:NT [Qualitative Concept]
   827   C1449832:NT [Diagnostic Procedure]
   827   C1510755:Accession [Intellectual Product]
   827   C1706078:Accession [Activity]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "creates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "a BtgI restriction enzyme site."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1882940:Restriction Enzyme Site [Nucleotide Sequence]
           Restriction Site
   812   C0205145:Site [Spatial Concept]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]
Processing 00000000.tx.164: Primers were 5'-CTGCTGGCTTCCTGCTTTCC-3' and 5'-CTCGGGTGTGGTAGGTGACC-3'. 

Phrase: "Primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "5'-CTGCTGGCTTCCTGCTTTCC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "5'-CTCGGGTGTGGTAGGTGACC-3'."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.165: DNA was initially denatured for 10min at 95C, then a touch-down program: 12 cycles at 95C for 1 min, 7266C for 30s, 72C for 30s and 23 cycles at 95C for 1min, 66C for 30s, 72C for 30s and, finally, 10min at 72C. 

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "denatured for 10min"

Phrase: "at 95C,"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "a touch-down program"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1709697:Program [Conceptual Entity]
   827   C2728259:Program [Pharmacologic Substance]
   827   C3484370:Program [Functional Concept]
   734   C0912256:Touchdown [Amino Acid, Peptide, or Protein,Organophosphorus Compound,Pharmacologic Substance]

Phrase: ":"

Phrase: "12 cycles at 95C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1511572:Cycle [Temporal Concept]

Phrase: "for 1 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "7266C for 30s,"

Phrase: "72C for 30s"

Phrase: "and"

Phrase: "23 cycles at 95C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1511572:Cycle [Temporal Concept]

Phrase: "for 1min,"

Phrase: "66C for 30s,"

Phrase: "72C for 30s"

Phrase: "and"

Phrase: ","

Phrase: "finally,"

Phrase: "10min at 72C."
Processing 00000000.tx.166: The restriction fragments were visualized after electrophoresis on a 3% agarose gel: three fragments of 79, 24 and 23bp defined the presence of the G allele, and two fragments of 103 and 23bp the presence of the A allele. 

Phrase: "The restriction fragments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0332255:fragments [Functional Concept]
   861   C0443288:Restriction [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "visualized after electrophoresis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0013855:Electrophoresis [Laboratory Procedure]
   790   C0234621:Visualized [Functional Concept]

Phrase: "on a 3% agarose gel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1706746:Agarose Gel [Research Device]
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C1382104:Gel [Substance]

Phrase: ":"

Phrase: "three fragments of 79,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0332255:fragments [Functional Concept]
   770   C0486805:Fragments [Body Substance]
   737 E C1708096:Fragment [Qualitative Concept]

Phrase: "24"

Phrase: "and"

Phrase: "23bp"

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: "the presence of the G allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "two fragments of 103"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0332255:fragments [Functional Concept]
   770   C0486805:Fragments [Body Substance]
   737 E C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "23bp"

Phrase: "the presence of the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "A allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.167: We also genotyped two T/C polymorphisms of the nNOS gene, identified by Grasemann et al. in exon 18 (nNOS 18) and in exon 29 (nNOS 29) (40). 

Phrase: "We also"

Phrase: "genotyped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0017431:Genotype [Organism Attribute]

Phrase: "two T/C polymorphisms of the nNOS gene,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   762   C0678951:gene polymorphisms [Genetic Function]
   742   C0032529:polymorphisms [Genetic Function]
   708 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "identified by Grasemann et al."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205396:Identified [Qualitative Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]

Phrase: "in exon 18"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(nNOS 18"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0521390:Neuronal [Immunologic Factor]
   827   C1518425:{NOS} [Qualitative Concept]
   755 E C0027882:Neuron [Cell]

Phrase: ")"

Phrase: "and in exon 29"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1515981:And [Idea or Concept]

Phrase: "(nNOS 29"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0521390:Neuronal [Immunologic Factor]
   827   C1518425:{NOS} [Qualitative Concept]
   755 E C0027882:Neuron [Cell]

Phrase: ")"

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.168: Primers and PCR condition used for exon 18 have been previously described. 

Phrase: "Primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "PCR condition"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0012634:condition [Disease or Syndrome]
   861   C0348080:Condition [Qualitative Concept]
   861   C1705253:Condition [Conceptual Entity]
   789 E C0009647:Conditioned [Mental Process]
   789 E C1701901:Conditional [Qualitative Concept]
   789 E C1963686:Conditional [Functional Concept]
   761 E C1519605:Conditionality [Conceptual Entity]

Phrase: "used for exon 18"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "previously"

Phrase: "described."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]
Processing 00000000.tx.169: The polymorphism in exon 18 abolished a DraIII restriction site. 

Phrase: "The polymorphism in exon 18"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0032529:Polymorphism [Genetic Function]
   760   C1882417:Polymorphism [Qualitative Concept]

Phrase: "abolished"

Phrase: "a DraIII restriction site."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882940:Restriction Site [Nucleotide Sequence]
   827   C0205145:Site [Spatial Concept]
   827   C0443288:Restriction [Functional Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
Processing 00000000.tx.170: The C allele was defined by the presence of two fragments of 124 and 55bp, and the T allele by the presence of a fragment of 179bp. 

Phrase: "The C allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "was"

Phrase: "defined by the presence of two fragments of 124"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   742   C0205448:Two [Quantitative Concept]
   742   C0332255:fragments [Functional Concept]
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
   742   C0486805:Fragments [Body Substance]
   742   C1704788:Defined [Conceptual Entity]
   742   C3539106:Defined [Intellectual Product]
   708 E C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "55bp,"

Phrase: "and"

Phrase: "the T allele by the presence of a fragment of 179bp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.171: We designed the following set of primers for the polymorphism in exon 29: 5'-TTGAGTTTTCCTGCTGCGATGT-3' and 5'-GCTTGTGCCTAGTTCCTGCA-3'. 

Phrase: "We"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "the following set of primers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0036849:Set [Mental Process]
   760   C1442518:Set [Functional Concept]
   760   C1705195:Set [Conceptual Entity]

Phrase: "for the polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032529:Polymorphism [Genetic Function]
  1000   C1882417:Polymorphism [Qualitative Concept]

Phrase: "in exon 29"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ":"

Phrase: "5'-TTGAGTTTTCCTGCTGCGATGT-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "5'-GCTTGTGCCTAGTTCCTGCA-3'."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.172: PCR conditions were identical to those used for nNOS 18. 

Phrase: "PCR conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "were"

Phrase: "identical to those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205280:Identical [Qualitative Concept]

Phrase: "used for nNOS 18."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0521390:Neuronal [Immunologic Factor]
   760   C1273517:used [Finding]
   760   C1518425:{NOS} [Qualitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.173: The mutation created an NlaIII restriction site. 

Phrase: "The mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "created"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1706214:Created [Activity]
   966 E C3244320:create [Functional Concept]

Phrase: "an NlaIII restriction site."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882940:Restriction Site [Nucleotide Sequence]
   827   C0205145:Site [Spatial Concept]
   827   C0443288:Restriction [Functional Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
Processing 00000000.tx.174: The C allele was defined by three fragments of 102, 69 and 16bp, and the T allele by the presence of four fragments of 94, 69, 16 and 8bp. 

Phrase: "The C allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "was"

Phrase: "defined by three fragments of 102,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0205449:Three [Quantitative Concept]
   753   C0332255:fragments [Functional Concept]
   753   C0486805:Fragments [Body Substance]
   753   C1704788:Defined [Conceptual Entity]
   753   C3539106:Defined [Intellectual Product]
   719 E C1708096:Fragment [Qualitative Concept]

Phrase: "69"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: "and"

Phrase: "16bp,"

Phrase: "and"

Phrase: "the T allele by the presence of four fragments of 94,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0002085:Allele [Gene or Genome]

Phrase: "69,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: "16"

Phrase: "and"

Phrase: "8bp."
Processing 00000000.tx.175: Statistical methods To minimize the risk of population stratification bias, only cases and controls with both parents born in Europe were included. 

Phrase: "Statistical methods To"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   884   C1710191:Statistical Method [Research Activity]
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   793 E C0871511:METHOD [Intellectual Product]

Phrase: "minimize"

Phrase: "the risk of population stratification bias,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0242444:population risk [Population Group]
   783   C2987720:Population risk [Quantitative Concept]
   753   C0035647:Risk [Qualitative Concept]

Phrase: "only cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "controls with both parents"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   777   C0814584:parental control [Social Behavior]
   770   C0030551:Parents [Family Group]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C2699423:Parent [Conceptual Entity]

Phrase: "born in Europe"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0015176:Europe [Geographic Area]
   756   C0004897:Bear [Mammal]

Phrase: "were"

Phrase: "included."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]
Processing 00000000.tx.176: Consistent with the matched design, matched analyses were performed, and the odds ratio (OR) was used to estimate the relative risk. 

Phrase: "Consistent with the matched design,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "matched analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: ","

Phrase: "and"

Phrase: "the odds ratio (OR)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "estimate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimate [Quantitative Concept]

Phrase: "the relative risk."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242492:Relative Risk [Quantitative Concept]
   861   C0035647:Risk [Qualitative Concept]
   861   C0080103:Relative [Family Group]
   861   C0205345:Relative [Qualitative Concept]
   861   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.177: For each studied variable, we calculated an OR, a 95% confidence interval (CI), and a P-value, using conditional logistic regression for matched sets with a variable number of controls. 

Phrase: "For each studied variable,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439828:Variable [Qualitative Concept]

Phrase: "we"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "an OR,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "a 95% confidence interval (CI),"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: "and"

Phrase: "a P-value,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1709380:P-Value [Quantitative Concept]
   827   C1522609:Value [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "conditional logistic regression for matched sets"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0206031:Logistic Regression [Research Activity]
   753   C0242415:logistic [Occupational Activity]
   753   C0684320:Regression [Pathologic Function]
   753   C0684321:Regression [Mental Process]

Phrase: "with a variable number"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0237753:*Number [Quantitative Concept]
   861   C0439828:Variable [Qualitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "of controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.178: Conditional logistic regression models were also used to investigate the independent effect of the variables of interest, to adjust for potential confounding variables, and to test for multiplicative interactions. 

Phrase: "Conditional logistic regression models"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C0023965:Logistic Models [Intellectual Product,Quantitative Concept]
   861   C0206031:Logistic Regression [Research Activity]
   812   C0242415:logistic [Occupational Activity]
   812   C0684320:Regression [Pathologic Function]
   812   C0684321:Regression [Mental Process]
   812   C3161035:Models [Intellectual Product]

Phrase: "were"

Phrase: "also"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the independent effect of the variables of interest,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0332291:Independent of [Functional Concept]
   744   C0085862:Independent [Idea or Concept]
   744   C1280500:Effect [Qualitative Concept]
   744   C1299583:Independent [Finding]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "adjust for potential confounding variables,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0009673:Confounding Variables [Functional Concept]
   760   C0439828:variables [Qualitative Concept]
   760   C3245505:Potential [Qualitative Concept]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test for multiplicative interactions."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0022885:Test [Laboratory Procedure]
   770   C0039593:Test [Functional Concept]
   770   C0392366:test [Intellectual Product]
   737   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.179: To compare genotypic distributions in cases and controls, ORs were calculated separately for heterozygotes and homozygotes for the polymorphic allele, and a general test of association was performed by including dummy variables in the models and considering homozygotes for the wild allele as the reference group. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "genotypic distributions in cases"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0037775:Distributions [Spatial Concept]
   737 E C0520511:distribution [Idea or Concept]
   737 E C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "controls,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "ORs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0069590:ORS [Inorganic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "separately for heterozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0019425:Heterozygotes [Organism Attribute]

Phrase: "and"

Phrase: "homozygotes for the polymorphic allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0019904:Homozygotes [Organism Attribute]

Phrase: "and"

Phrase: "a general test of association"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0022885:Test [Laboratory Procedure]
   760   C0039593:Test [Functional Concept]
   760   C0392366:test [Intellectual Product]

Phrase: "was"

Phrase: "performed by"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1550369:Performed By [Qualitative Concept]
   833   C0884358:Performed [Functional Concept]
   799 E C2947996:Perform [Pharmacologic Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "dummy variables in the models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439828:variables [Qualitative Concept]

Phrase: "and"

Phrase: "considering homozygotes for the wild allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0019904:Homozygotes [Organism Attribute]

Phrase: "as the reference group."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0680399:reference group [Population Group]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1514811:Reference [Idea or Concept]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C1706462:Reference [Conceptual Entity]
Processing 00000000.tx.180: In addition, we computed a P-value for trend by including an ordinal variable corresponding to the number of polymorphic alleles (codominant model). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "computed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1441526:Computed [Laboratory Procedure]
  1000   C1880157:Computed [Activity]

Phrase: "a P-value for trend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1709380:P-Value [Quantitative Concept]
   760   C1522609:Value [Quantitative Concept]

Phrase: "by"

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "an ordinal variable"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439828:Variable [Qualitative Concept]

Phrase: "corresponding to the number of polymorphic alleles"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0002085:Alleles [Gene or Genome]
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]
   748   C1882417:Polymorphic [Qualitative Concept]

Phrase: "(codominant model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.181: Analyses assuming a dominant model (nNOS 29 and nNOS 18) or a recessive model (iNOS 22) were also carried out. 

Phrase: "Analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "assuming"

Phrase: "a dominant model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "(nNOS 29"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0521390:Neuronal [Immunologic Factor]
   827   C1518425:{NOS} [Qualitative Concept]
   755 E C0027882:Neuron [Cell]

Phrase: "and"

Phrase: "nNOS 18"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0521390:Neuronal [Immunologic Factor]
   827   C1518425:{NOS} [Qualitative Concept]
   755 E C0027882:Neuron [Cell]

Phrase: ")"

Phrase: "or"

Phrase: "a recessive model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "(iNOS 22"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205263:Inducible [Functional Concept]
   827   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1518425:{NOS} [Qualitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "also"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]
Processing 00000000.tx.182: To compare the dominant and the codominant models for the nNOS 29 polymorphism, we used the Akaike Information Criterion, because the two models are not nested. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the dominant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1527180:Dominant [Functional Concept]

Phrase: "and"

Phrase: "the codominant models for the nNOS 29 polymorphism,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C3161035:Models [Intellectual Product]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Akaike Information Criterion,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0243161:Criterion [Intellectual Product]
   827   C1533716:Information [Idea or Concept]
   755 E C3242430:informational [Idea or Concept]

Phrase: "because"

Phrase: "the two models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Models [Intellectual Product]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "nested."
Processing 00000000.tx.183: Haplotype frequencies for the two nNOS polymorphisms were estimated from genotype data using the E-M algorithm under the assumption of HardyWeinberg equilibrium. 

Phrase: "Haplotype frequencies for the two nNOS polymorphisms"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   744   C0439603:Frequencies [Temporal Concept]
   711 E C0376249:frequency [Quantitative Concept]
   711 E C0871396:Frequency [Quantitative Concept]
   711 E C1561548:Frequency [Qualitative Concept]
   711 E C1705502:Frequency [Quantitative Concept]

Phrase: "were"

Phrase: "estimated from genotype data"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0017431:Genotype [Organism Attribute]
   770   C0750572:Estimated [Quantitative Concept]
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the E-M algorithm under the assumption of HardyWeinberg equilibrium."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0002045:algorithm [Intellectual Product]
   739   C1553907:algorithm [Laboratory Procedure]
Processing 00000000.tx.184: An overall likelihood ratio statistic was computed to compare the overall distribution of nNOS haplotypes between cases and controls, and tests for differences in individual haplotypes frequencies were performed using permutations (n=10,000) (46). 

Phrase: "An overall likelihood ratio statistic"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C2348149:Statistic [Quantitative Concept]
   812   C2828391:Statistic [Quantitative Concept]
   741 E C0038215:Statistical [Occupation or Discipline]

Phrase: "was"

Phrase: "computed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1441526:Computed [Laboratory Procedure]
  1000   C1880157:Computed [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the overall distribution of nNOS haplotypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0520511:distribution [Idea or Concept]
   748   C1704711:Distribution [Functional Concept]

Phrase: "between cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "controls,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "tests for differences"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0022885:Test [Laboratory Procedure]
   790   C0039593:Test [Functional Concept]
   790   C0392366:Tests [Intellectual Product]
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "in individual haplotypes frequencies"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0439603:Frequencies [Temporal Concept]
   793 E C0376249:frequency [Quantitative Concept]
   793 E C0871396:Frequency [Quantitative Concept]
   793 E C1561548:Frequency [Qualitative Concept]
   793 E C1705502:Frequency [Quantitative Concept]
   743 E C0332183:Frequent [Temporal Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "permutations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882348:Permutation [Qualitative Concept]

Phrase: "(n=10,000"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441922:N+ [Intellectual Product]
   827   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.185: Linkage disequilibrium coefficients (D') between the two nNOS polymorphisms were computed using standard formulas (47). 

Phrase: "Linkage disequilibrium coefficients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1707429:*Coefficient [Quantitative Concept]
   734   C0023746:Linkage Disequilibrium [Quantitative Concept]

Phrase: "("

Phrase: "D') between the two nNOS polymorphisms"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0032529:polymorphisms [Genetic Function]
   748   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0205448:Two [Quantitative Concept]
   748   C0521390:Neuronal [Immunologic Factor]
   748   C1518425:{NOS} [Qualitative Concept]
   714 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "were"

Phrase: "computed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1441526:Computed [Laboratory Procedure]
  1000   C1880157:Computed [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "standard formulas"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1442989:Standard [Qualitative Concept]
   861   C2828392:Standard [Intellectual Product]
   827   C0489829:Formula [Intellectual Product]
   827   C1705501:Formula [Intellectual Product]

Phrase: "(47"

Phrase: ")."
Processing 00000000.tx.186: The SAS software release 6.11 was used for statistical analysis (SAS institute, Cary, NC, USA).  

Phrase: "The SAS software release 6.11"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   875   C1822613:SAS-6 [Gene or Genome]
   804   C0030685:Release [Health Care Activity]
   804   C0037585:Software [Intellectual Product,Manufactured Object]
   804   C0391871:Release [Functional Concept]
   804   C0439180:% release [Quantitative Concept]
   804   C0605290:SAS [Organic Chemical]
   804   C0680255:release [Health Care Activity]
   804   C1283071:Release [Functional Concept]
   804   C1426104:SAS [Gene or Genome]
   804   C1823519:SAS [Gene or Genome]
   804   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "used for statistical analysis"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0871424:statistical analysis [Research Activity]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0038215:Statistical [Occupation or Discipline]
   770   C0936012:Analysis [Research Activity]
   770   C1273517:used [Finding]
   770   C1524024:analysis [Functional Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "(SAS institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "Cary,"

Phrase: "NC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027964:NC [Geographic Area]
  1000   C0028407:NC [Geographic Area]
  1000   C0067895:NC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")."
Processing 00000000.tx.187: ACKNOWLEDGEMENTS  We thank all the MSA (Mutualit Sociale Agricole) physicians who interviewed the participants and the MSA employees who helped with the coordination of the study. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "all the MSA"

Phrase: "(Mutualit Sociale Agricole"

Phrase: ")"

Phrase: "physicians"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0031831:Physicians [Professional or Occupational Group]
   966 E C0804815:Physician [Clinical Attribute]

Phrase: "who"

Phrase: "interviewed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0021822:Interview [Activity]
   966   C0935630:Interview [Intellectual Product]

Phrase: "the participants"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0679646:participants [Population Group]
   966 E C2698741:Participant [Classification]

Phrase: "and"

Phrase: "the MSA employees"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0024752:employees [Functional Concept]
   779 E C0599987:Employee [Professional or Occupational Group]

Phrase: "who"

Phrase: "helped with the coordination of the study."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0242414:Coordination [Physiologic Function]
   748   C0557651:Study [Manufactured Object]
   748   C0700114:Coordination [Functional Concept]
   748   C2603343:Study [Research Activity]
   714   C0018896:Help [Social Behavior]
   714   C1552861:help [Idea or Concept]
Processing 00000000.tx.188: Drs David Gervais and Lamia Benslamia participated in the examination of PD patients. 

Phrase: "Drs David Gervais"

Phrase: "and"

Phrase: "Lamia Benslamia"

Phrase: "participated in the examination of PD patients."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0031809:Examination of patient [Health Care Activity]
           patient examination
   748   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.189: Mrs Chantal Cordelier and Drs Carline Amiel, Frdrique Brunner and Jean-Philippe Galanaud helped with the assessment of exposure to pesticides. 

Phrase: "Mrs Chantal Cordelier"

Phrase: "and"

Phrase: "Drs Carline Amiel,"

Phrase: "Frdrique Brunner"

Phrase: "and"

Phrase: "Jean-Philippe Galanaud"

Phrase: "helped with the assessment of exposure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0274281:Exposure, NOS [Injury or Poisoning]
   753   C0332157:Exposure [Clinical Attribute]
   753   C1261322:Assessment [Health Care Activity]
   753   C1516048:Assessment [Activity]
   719   C0018896:Help [Social Behavior]
   719   C1552861:help [Idea or Concept]

Phrase: "to pesticides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031253:Pesticides [Hazardous or Poisonous Substance]
Processing 00000000.tx.190: Dr Safia Zenagui participated in the coordination of the study. 

Phrase: "Dr Safia Zenagui"

Phrase: "participated in the coordination of the study."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0242414:Coordination [Physiologic Function]
   748   C0557651:Study [Manufactured Object]
   748   C0700114:Coordination [Functional Concept]
   748   C2603343:Study [Research Activity]
Processing 00000000.tx.191: We thank Xavier Hermant and Vincent Mouroux for their technical assistance. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Xavier Hermant"

Phrase: "and"

Phrase: "Vincent Mouroux for their technical assistance."
Processing 00000000.tx.192: This study was supported by the INSERM (Institut National de la Sant et de la Recherche Mdicale), the Institut Pasteur de Lille, the MSA, and by the French Ministry of the Environment. 

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "supported by the INSERM"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1521721:Supported [Conceptual Entity]
   737 E C0183683:Support [Medical Device]

Phrase: "(Institut National de la Sant et de la Recherche Mdicale"

Phrase: ")"

Phrase: ","

Phrase: "the Institut Pasteur de Lille,"

Phrase: "the MSA,"

Phrase: "and by the French Ministry of the Environment."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0014406:Environment [Spatial Concept]
   744   C1515981:And [Idea or Concept]
   744   C1556084:French [Population Group]
Processing 00000000.tx.193: CL is a recipient of the Ministre de la Recherche et de la Technologie.  

Phrase: "CL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "is"

Phrase: "a recipient of the Ministre de la Recherche et de la Technologie."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C1709854:Recipient [Human]
Processing 00000000.tx.194: FOOTNOTES  * To whom correspondence should be addressed at: INSERM Unit 508 Institut Pasteur de Lille, 1 rue du Pr Calmette, BP 245, 59019 Lille, France. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed at"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0376649:Address [Intellectual Product]
   799   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "INSERM Unit 508 Institut Pasteur de Lille,"

Phrase: "1 rue du Pr Calmette,"

Phrase: "BP 245,"

Phrase: "59019 Lille,"

Phrase: "France."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]
Processing 00000000.tx.195: Tel: +33 320877228; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+33 320877228"

Phrase: ";"
Processing 00000000.tx.196: Fax: +33 320877894; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+33 320877894"

Phrase: ";"
Processing 00000000.tx.197: Email: marie-christine.chartier{at}pasteur-lille.fr The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors  REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R. et al. 

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "marie-christine.chartier{at}pasteur-lille.fr"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C2348513:Fr. [Conceptual Entity]
   795   C3538902:FR [Gene or Genome]

Phrase: "The authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "wish"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1423524:WISH [Gene or Genome]
  1000   C3273411:WISH [Gene or Genome]
  1000   C3273412:WISH [Amino Acid, Peptide, or Protein]

Phrase: "it to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "that,"

Phrase: "in their opinion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871010:opinion [Mental Process]

Phrase: "the first two authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0221193:Authors [Professional or Occupational Group]

Phrase: "should"

Phrase: "be"

Phrase: "regarded as joint First Authors"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0022417:Joint [Body Space or Junction]
   760   C0205435:First [Quantitative Concept]
   760   C0221193:Authors [Professional or Occupational Group]
   760   C0392905:Joint, NOS [Body System]
   760   C1269611:Joint [Body Space or Junction]
   760   C1279901:First [Qualitative Concept]
   760   C1706309:Joint [Medical Device]
   704 E C0521339:Articular [Functional Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Polymeropoulos,"

Phrase: "M."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lavedan,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Leroy,"

Phrase: "E.,"

Phrase: "Ide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "S."

Phrase: "E.,"

Phrase: "Dehejia,"

Phrase: "A.,"

Phrase: "Dutra,"

Phrase: "A.,"

Phrase: "Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Root,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040452:Root [Body Part, Organ, or Organ Component]
  1000   C0242726:Root [Plant]
  1000   C1318154:Root [Body Part, Organ, or Organ Component]
  1000   C1705917:Root [Idea or Concept]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rubenstein,"

Phrase: "J.,"

Phrase: "Boyer,"

Phrase: "R. et al."
Processing 00000000.tx.198: (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Mutation in the alpha-synuclein gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0596611:Gene Mutation [Genetic Function]
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "identified in families"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0015576:Families [Family Group]
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]
   790   C1704727:Family [Conceptual Entity]
   706 E C0241888:Familial [Functional Concept]

Phrase: "with Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.199: Science, 276, 20452047.[Abstract/Free FullText] Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M.J., Jonnalagada, S., Chernova, T. et al. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "276,"

Phrase: "20452047."

Phrase: "[Abstract/Free FullText"

Phrase: "] Leroy,"

Phrase: "E.,"

Phrase: "Boyer,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Auburger,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Leube,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Ulm,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Mezey,"

Phrase: "E.,"

Phrase: "Harta,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Brownstein,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Jonnalagada,"

Phrase: "S."

Phrase: ","

Phrase: "Chernova,"

Phrase: "T. et al."
Processing 00000000.tx.200: (1998) The ubiquitin pathway in Parkinson's disease Nature, 395, 451452.[CrossRef][ISI][Medline] Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y. and Shimizu, N. 

Phrase: "(1998"

Phrase: ")"

Phrase: "The ubiquitin pathway in Parkinson's disease Nature,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1521736:Parkinson's Disease Pathway [Functional Concept]
   774   C1511986:Disease Pathway [Conceptual Entity]
   748   C1704259:Pathway [Molecular Function]
   748   C1705987:Pathway [Conceptual Entity]

Phrase: "395,"

Phrase: "451452."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kitada,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Asakawa,"

Phrase: "S."

Phrase: ","

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Matsumine,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yamamura,"

Phrase: "Y.,"

Phrase: "Minoshima,"

Phrase: "S."

Phrase: ","

Phrase: "Yokochi,"

Phrase: "M."

Phrase: ","

Phrase: "Mizuno,"

Phrase: "Y."

Phrase: "and"

Phrase: "Shimizu,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.201: (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Mutations in the parkin gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0596611:gene mutations [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "autosomal recessive juvenile parkinsonism."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1868675:Parkinsonism, Juvenile, Autosomal Recessive [Disease or Syndrome]
   923   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   861   C0752105:Parkinsonism, Juvenile [Disease or Syndrome]
   812   C0242422:Parkinsonism [Disease or Syndrome]
Processing 00000000.tx.202: Nature, 392, 605608.[CrossRef][ISI][Medline] Gasser, T., Muller-Myhsok, B., Wszolek, Z.K., Oehlmann, R., Calne, D.B., Bonifati, V., Bereznai, B., Fabrizio, E., Vieregge, P. and Horstmann, R.D. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "392,"

Phrase: "605608."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gasser,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Muller-Myhsok,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Wszolek,"

Phrase: "Z.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Oehlmann,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Calne,"

Phrase: "D."

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Bonifati,"

Phrase: "V.,"

Phrase: "Bereznai,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Fabrizio,"

Phrase: "E.,"

Phrase: "Vieregge,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Horstmann,"

Phrase: "R.D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.203: (1998) A susceptibility locus for Parkinson's disease maps to chromosome 2p13. 

Phrase: "(1998"

Phrase: ")"

Phrase: "A susceptibility locus for Parkinson's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1708726:Locus [Gene or Genome]

Phrase: "maps to chromosome 2p13."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0814036:chromosome map [Intellectual Product]
   770   C0008633:Chromosome [Cell Component]
   770   C0024779:Map [Manufactured Object]
   770   C0026045:MAPs [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1521172:2p13 [Cell Component]
   770   C1706473:Map [Conceptual Entity]
Processing 00000000.tx.204: Nat. 

Phrase: "Nat."
Processing 00000000.tx.205: Genet., 18, 262265.[ISI][Medline] Farrer, M., Gwinn-Hardy, K., Muenter, M., DeVrieze, F.W., Crook, R., Perez-Tur, J., Lincoln, S., Maraganore, D., Adler, C., Newman, S. et al. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "18,"

Phrase: "262265."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Farrer,"

Phrase: "M."

Phrase: ","

Phrase: "Gwinn-Hardy,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Muenter,"

Phrase: "M."

Phrase: ","

Phrase: "DeVrieze,"

Phrase: "F.W., Crook,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Perez-Tur,"

Phrase: "J.,"

Phrase: "Lincoln,"

Phrase: "S."

Phrase: ","

Phrase: "Maraganore,"

Phrase: "D."

Phrase: ","

Phrase: "Adler,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Newman,"

Phrase: "S. et al."
Processing 00000000.tx.206: (1999) A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor. 

Phrase: "(1999"

Phrase: ")"

Phrase: "A chromosome 4p haplotype segregating with Parkinson's disease"

Phrase: "and"

Phrase: "postural tremor."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0234378:Postural tremor [Sign or Symptom]
   861   C0040822:Tremor [Sign or Symptom]
   861   C0205278:Postural [Functional Concept]
   861   C1963252:Tremor [Finding]
   789 E C1262869:Posture [Organism Attribute]
Processing 00000000.tx.207: Hum. 

Phrase: "Hum."
Processing 00000000.tx.208: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.209: Genet., 8, 8185.[Abstract/Free FullText] Valente, E.M., Bentivoglio, A.R., Dixon, P.H., Ferraris, A., Ialongo, T., Frontali, M., Albanese, A. and Wood, N.W. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "8,"

Phrase: "8185."

Phrase: "[Abstract/Free FullText"

Phrase: "] Valente,"

Phrase: "E.M.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bentivoglio,"

Phrase: "A.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Dixon,"

Phrase: "P.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Ferraris,"

Phrase: "A.,"

Phrase: "Ialongo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Frontali,"

Phrase: "M."

Phrase: ","

Phrase: "Albanese,"

Phrase: "A."

Phrase: "and"

Phrase: "Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0043217:Wood [Substance]
   944 E C0144237:Sylvan [Organic Chemical]
   916 E C0442548:Woods [Geographic Area]

Phrase: "N.W."
Processing 00000000.tx.210: (2001) Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35p36. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Localization of a novel locus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "for autosomal recessive early-onset parkinsonism,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   911   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   884   C1838631:Parkinsonism, early-onset [Finding]
   804   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "PARK6,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1853833:PARK6 [Disease or Syndrome]

Phrase: "on human chromosome 1p35p36."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0008643:Human Chromosome [Cell Component]
Processing 00000000.tx.211: Am. 

Phrase: "Am."
Processing 00000000.tx.212: J. 

Phrase: "J."
Processing 00000000.tx.213: Hum. 

Phrase: "Hum."
Processing 00000000.tx.214: Genet., 68, 895900.[CrossRef][ISI][Medline] van Duijn, C.M., Dekker, M.C., Bonifati, V., Galjaard, R.J., Houwing-Duistermaat, J.J., Snijders, P.J., Testers, L., Breedveld, G.J., Horstink, M., Sandkuijl, L.A. et al. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "68,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: "895900."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] van Duijn,"

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "Dekker,"

Phrase: "M.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bonifati,"

Phrase: "V.,"

Phrase: "Galjaard,"

Phrase: "R.J.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Houwing-Duistermaat,"

Phrase: "J.J.,"

Phrase: "Snijders,"

Phrase: "P.J.,"

Phrase: "Testers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0183885:testers [Medical Device]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Breedveld,"

Phrase: "G.J.,"

Phrase: "Horstink,"

Phrase: "M."

Phrase: ","

Phrase: "Sandkuijl,"

Phrase: "L.A. et al."
Processing 00000000.tx.215: (2001) Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Park7,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:PARK7 [Gene or Genome]
  1000   C1853445:PARK7 [Disease or Syndrome]
  1000   C3538910:PARK7 [Amino Acid, Peptide, or Protein]

Phrase: "a novel locus for autosomal recessive early-onset parkinsonism,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1708726:Locus [Gene or Genome]

Phrase: "on chromosome 1p36."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520972:1p36 [Cell Component]
Processing 00000000.tx.216: Am. 

Phrase: "Am."
Processing 00000000.tx.217: J. 

Phrase: "J."
Processing 00000000.tx.218: Hum. 

Phrase: "Hum."
Processing 00000000.tx.219: Genet., 69, 629634.[CrossRef][Medline] Funayama, M., Hasegawa, K., Kowa, H., Saito, M., Tsuji, S. and Obata, F. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "69,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: "629634."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Funayama,"

Phrase: "M."

Phrase: ","

Phrase: "Hasegawa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kowa,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Saito,"

Phrase: "M."

Phrase: ","

Phrase: "Tsuji,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Obata,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.220: (2002) A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1. 

Phrase: "(2002"

Phrase: ")"

Phrase: "A new locus for Parkinson's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1708726:Locus [Gene or Genome]

Phrase: "(PARK8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1846862:PARK8 [Disease or Syndrome]
  1000   C2697861:PARK8 [Gene or Genome]

Phrase: ")"

Phrase: "maps to chromosome 12p11.2-q13.1."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C1520469:12p11.2 [Cell Component]
   774   C0008651:Chromosome 1 [Cell Component]
   774   C0008662:Chromosome 2 [Cell Component]
   774   C0814036:chromosome map [Intellectual Product]
   774   C1424473:MAP-1 [Gene or Genome]
   774   C1520468:12p11.1 [Cell Component]
   748   C0008633:Chromosome [Cell Component]
   748   C0024779:Map [Manufactured Object]
   748   C0026045:MAPs [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1549864:Q13 [Intellectual Product]
   748   C1706473:Map [Conceptual Entity]
Processing 00000000.tx.221: Ann. 

Phrase: "Ann."
Processing 00000000.tx.222: Neurol., 51, 296301.[CrossRef][ISI][Medline] Li, Y.J., Scott, W.K., Hedges, D.J., Zhang, F., Gaskell, P.C., Nance, M.A., Watts, R.L., Hubble, J.P., Koller, W.C., Pahwa, R. et al. 

Phrase: "Neurol.,"

Phrase: "51,"

Phrase: "296301."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "Y.J.,"

Phrase: "Scott,"

Phrase: "W.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Hedges,"

Phrase: "D.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Zhang,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Gaskell,"

Phrase: "P.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Nance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330910:nance [Plant]

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Watts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439261:Watt [Quantitative Concept]

Phrase: "R.L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Hubble,"

Phrase: "J.P.,"

Phrase: "Koller,"

Phrase: "W.C., Pahwa,"

Phrase: "R. et al."
Processing 00000000.tx.223: (2002) Age at onset in two common neurodegenerative diseases is genetically controlled. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Age at onset in two common neurodegenerative diseases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0206132:Onset Age [Quantitative Concept]
   767   C0277793:diseases onset [Temporal Concept]
   744   C0001779:Age [Organism Attribute]
   744   C0332162:Onset [Qualitative Concept]

Phrase: "is"

Phrase: "genetically"

Phrase: "controlled."
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C2587213:Controlled [Functional Concept]
   966 E C0243148:control [Qualitative Concept]
   966 E C1550141:Control [Substance]
   966 E C1882979:Control [Conceptual Entity]
   966 E C3274648:Control [Qualitative Concept]
Processing 00000000.tx.224: Am. 

Phrase: "Am."
Processing 00000000.tx.225: J. 

Phrase: "J."
Processing 00000000.tx.226: Hum. 

Phrase: "Hum."
Processing 00000000.tx.227: Genet., 70, 985993.[CrossRef][ISI][Medline] Tan, E.K., Khajavi, M., Thornby, J.I., Nagamitsu, S., Jankovic, J. and Ashizawa, T. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "70,"

Phrase: "985993."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tan,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302595:tan [Individual Behavior]
  1000   C1537110:Tan [Clinical Attribute]
  1000   C3275241:Tan [Qualitative Concept]

Phrase: "E.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Khajavi,"

Phrase: "M."

Phrase: ","

Phrase: "Thornby,"

Phrase: "J.I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Nagamitsu,"

Phrase: "S."

Phrase: ","

Phrase: "Jankovic,"

Phrase: "J."

Phrase: "and"

Phrase: "Ashizawa,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.228: (2000) Variability and validity of polymorphism association studies in Parkinson's disease. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Variability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2827666:Variability [Conceptual Entity]
   928 E C0439828:Variable [Qualitative Concept]

Phrase: "and"

Phrase: "validity of polymorphism association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2349101:Validity [Quantitative Concept]

Phrase: "studies in Parkinson's disease."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   833   C0030567:Parkinson Disease [Disease or Syndrome]
   833   C1521736:Parkinson's Disease [Functional Concept]
   833   C2681933:PARKINSON DISEASE [Gene or Genome]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0557651:Study [Manufactured Object]
   770   C0947630:studies [Laboratory Procedure]
   770   C2603343:Study [Research Activity]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.229: Neurology, 55, 533538.[Abstract/Free FullText] Law, A., Gauthier, S. and Quirion, R. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "533538."

Phrase: "[Abstract/Free FullText"

Phrase: "] Law,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0023150:Law [Regulation or Law]
  1000   C0220866:Law [Regulation or Law]
  1000   C0728724:law [Regulation or Law]
  1000   C1947938:Law [Intellectual Product]
  1000   C1947939:Law [Occupation or Discipline]

Phrase: "A.,"

Phrase: "Gauthier,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Quirion,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.230: (2001) Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Say NO to Alzheimer's disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   753   C0030015:oxide [Inorganic Chemical]
   753   C2986642:oxide [Chemical Viewed Functionally]

Phrase: ":"

Phrase: "the putative links between nitric oxide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1517892:Link [Intellectual Product]
   719   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "dementia of the Alzheimer's type."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0002395:DEMENTIA OF THE ALZHEIMER TYPE [Disease or Syndrome]
           Dementia, Alzheimer Type
           Alzheimer's Dementia
   760   C0011265:dementia [Mental or Behavioral Dysfunction]
   760   C0497327:Dementia [Mental or Behavioral Dysfunction]
Processing 00000000.tx.231: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.232: Rev., 35, 7396.[ISI][Medline] Togashi, H., Sasaki, M., Frohman, E., Taira, E., Ratan, R.R., Dawson, T.M. and Dawson, V.L. 

Phrase: "Rev.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]

Phrase: "35,"

Phrase: "7396."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Togashi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sasaki,"

Phrase: "M."

Phrase: ","

Phrase: "Frohman,"

Phrase: "E.,"

Phrase: "Taira,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2998461:Taira [Eukaryote]

Phrase: "E.,"

Phrase: "Ratan,"

Phrase: "R.R.,"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "T.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "V.L."
Processing 00000000.tx.233: (1997) Neuronal (type I) nitric oxide synthase regulates nuclear factor kappaB activity and immunologic (type II) nitric oxide synthase expression. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Neuronal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521390:Neuronal [Immunologic Factor]
   928 E C0027882:Neuron [Cell]

Phrase: "(type I) nitric oxide synthase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0669368:Nitric Oxide Synthase, Type I [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   840   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   804   C0030015:oxide [Inorganic Chemical]
   804   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "regulates"

Phrase: "nuclear factor kappaB activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   756   C0079904:Nuclear Factor kappa B [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "immunologic"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0152036:Immunologic [Biomedical Occupation or Discipline]
  1000   C0205470:immunologic [Functional Concept]
   928 E C1522005:immunology [Qualitative Concept]

Phrase: "(type II"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441730:Type II [Classification]

Phrase: ")"

Phrase: "nitric oxide synthase expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   756   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.234: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.235: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.236: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.237: USA, 94, 26762680.[Abstract/Free FullText] Alderton, W.K., Cooper, C.E. and Knowles, R.G. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "94,"

Phrase: "26762680."

Phrase: "[Abstract/Free FullText"

Phrase: "] Alderton,"

Phrase: "W.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Cooper,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335912:Cooper [Professional or Occupational Group]

Phrase: "C.E."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Knowles,"

Phrase: "R.G."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205090:R- [Spatial Concept]
   861   C0439267:g% [Quantitative Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.238: (2001) Nitric oxide synthases: structure, function and inhibition. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Nitric oxide synthases"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0132555:nitric oxide synthases [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   901   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0030015:oxide [Inorganic Chemical]
   827   C2986642:oxide [Chemical Viewed Functionally]

Phrase: ":"

Phrase: "structure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "inhibition."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]
Processing 00000000.tx.239: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.240: J., 357, 593615.[CrossRef][ISI][Medline] Klivenyi, P., Andreassen, O.A., Ferrante, R.J., Lancelot, E., Reif, D. and Beal, M.F. 

Phrase: "J.,"

Phrase: "357,"

Phrase: "593615."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Klivenyi,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Andreassen,"

Phrase: "O.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0029408:o a [Disease or Syndrome]
   861   C0439114:O NOS [Intellectual Product]

Phrase: "Ferrante,"

Phrase: "R.J.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Lancelot,"

Phrase: "E.,"

Phrase: "Reif,"

Phrase: "D."

Phrase: "and"

Phrase: "Beal,"

Phrase: "M."

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.241: (2000) Inhibition of neuronal nitric oxide synthase protects against MPTP toxicity. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Inhibition of neuronal nitric oxide synthase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C0234074:Neuronal inhibition [Organ or Tissue Function]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]
   716   C0669368:Neuronal Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   716   C0907533:Neuronal Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "protects against MPTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2945751:phenyl [Chemical Viewed Structurally]

Phrase: "MPTP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "MPTP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "MPTP toxicity."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   827   C0040539:toxicity [Qualitative Concept]
   827   C0600688:Toxicity [Injury or Poisoning]
   755 E C1407029:Toxic [Qualitative Concept]
   734 E C0032346:Poison [Hazardous or Poisonous Substance]
   734 E C1548769:Poison [Intellectual Product]
   734 E C1550590:poison [Idea or Concept]
Processing 00000000.tx.242: Neuroreport, 11, 12651268.[ISI][Medline] Hantraye, P., Brouillet, E., Ferrante, R., Palfi, S., Dolan, R., Matthews, R.T. and Beal, M.F. 

Phrase: "Neuroreport,"

Phrase: "11,"

Phrase: "12651268."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hantraye,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Brouillet,"

Phrase: "E.,"

Phrase: "Ferrante,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Palfi,"

Phrase: "S."

Phrase: ","

Phrase: "Dolan,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Matthews,"

Phrase: "R.T."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0232024:R T [Clinical Attribute]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Beal,"

Phrase: "M."

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.243: (1996) Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Inhibition of neuronal nitric oxide synthase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C0234074:Neuronal inhibition [Organ or Tissue Function]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]
   716   C0669368:Neuronal Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   716   C0907533:Neuronal Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "MPTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2945751:phenyl [Chemical Viewed Structurally]

Phrase: "MPTP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "MPTP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "MPTP-induced parkinsonism in baboons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0242422:Parkinsonism [Disease or Syndrome]
Processing 00000000.tx.244: Nat. 

Phrase: "Nat."
Processing 00000000.tx.245: Med., 2, 10171021.[ISI][Medline] Przedborski, S., Jackson-Lewis, V., Yokoyama, R., Shibata, T., Dawson, V.L. and Dawson, T.M. 

Phrase: "Med.,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "10171021."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Przedborski,"

Phrase: "S."

Phrase: ","

Phrase: "Jackson-Lewis,"

Phrase: "V.,"

Phrase: "Yokoyama,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Shibata,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "V.L."

Phrase: "and"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "T.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.246: (1996) Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Role of neuronal nitric oxide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in 1-methyl-4-phenyl-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C2827734:1+ [Quantitative Concept]
   804   C2945751:phenyl [Chemical Viewed Structurally]
   804   C2981698:1+ [Classification]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0235032:Neurotoxicity [Injury or Poisoning]
Processing 00000000.tx.247: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.248: Natl. 

Phrase: "Natl."
Processing 00000000.tx.249: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.250: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.251: USA, 93, 45654571.[Abstract/Free FullText] Schulz, J.B., Matthews, R.T., Muqit, M.M., Browne, S.E. and Beal, M.F. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "93,"

Phrase: "45654571."

Phrase: "[Abstract/Free FullText"

Phrase: "] Schulz,"

Phrase: "J.B.,"

Phrase: "Matthews,"

Phrase: "R.T.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0232024:R T [Clinical Attribute]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Muqit,"

Phrase: "M."

Phrase: "M."

Phrase: ","

Phrase: "Browne,"

Phrase: "S."

Phrase: "E."

Phrase: "and"

Phrase: "Beal,"

Phrase: "M."

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.252: (1995) Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Inhibition of neuronal nitric oxide synthase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C0234074:Neuronal inhibition [Organ or Tissue Function]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]
   716   C0669368:Neuronal Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   716   C0907533:Neuronal Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "by 7-nitroindazole"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0214185:7-nitroindazole [Organic Chemical,Pharmacologic Substance]

Phrase: "protects against MPTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2945751:phenyl [Chemical Viewed Structurally]

Phrase: "MPTP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "MPTP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "MPTP-induced neurotoxicity in mice."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0235032:Neurotoxicity [Injury or Poisoning]
Processing 00000000.tx.253: J. 

Phrase: "J."
Processing 00000000.tx.254: Neurochem., 64, 936939.[ISI][Medline] Liberatore, G.T., Jackson-Lewis, V., Vukosavic, S., Mandir, A.S., Vila, M., McAuliffe, W.G., Dawson, V.L., Dawson, T.M. and Przedborski, S. 

Phrase: "Neurochem.,"

Phrase: "64,"

Phrase: "936939."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Liberatore,"

Phrase: "G.T.,"

Phrase: "Jackson-Lewis,"

Phrase: "V.,"

Phrase: "Vukosavic,"

Phrase: "S."

Phrase: ","

Phrase: "Mandir,"

Phrase: "A.S.,"

Phrase: "Vila,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1061396:Vila [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "McAuliffe,"

Phrase: "W.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "V.L.,"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "T.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Przedborski,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.255: (1999) Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Inducible nitric oxide synthase"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0669372:Nitric Oxide Synthase, Inducible [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417760:NITRIC OXIDE SYNTHASE, INDUCIBLE [Gene or Genome]
  1000   C1533698:Inducible Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "stimulates"

Phrase: "dopaminergic neurodegeneration in the MPTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "MPTP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "MPTP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "MPTP model of Parkinson disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0683033:disease model [Intellectual Product]
   783   C0684309:Disease model [Experimental Model of Disease]
   753   C3161035:Model [Intellectual Product]
Processing 00000000.tx.256: Nat. 

Phrase: "Nat."
Processing 00000000.tx.257: Med., 5, 14031409.[CrossRef][ISI][Medline] Dehmer, T., Lindenau, J., Haid, S., Dichgans, J. and Schulz, J.B. 

Phrase: "Med.,"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "14031409."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Dehmer,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Lindenau,"

Phrase: "J.,"

Phrase: "Haid,"

Phrase: "S."

Phrase: ","

Phrase: "Dichgans,"

Phrase: "J."

Phrase: "and"

Phrase: "Schulz,"

Phrase: "J.B."
Processing 00000000.tx.258: (2000) Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Deficiency of inducible nitric oxide synthase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0011155:Deficiency [Functional Concept]
   753   C0162429:Deficiency [Disease or Syndrome]
   753   C1623416:deficiency [Qualitative Concept]
   716   C0669372:Nitric Oxide Synthase, Inducible [Amino Acid, Peptide, or Protein,Enzyme]
   716   C1417760:NITRIC OXIDE SYNTHASE, INDUCIBLE [Gene or Genome]
   716   C1533698:Inducible Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "protects against MPTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2945751:phenyl [Chemical Viewed Structurally]

Phrase: "MPTP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "MPTP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "MPTP toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   827   C0040539:toxicity [Qualitative Concept]
   827   C0600688:Toxicity [Injury or Poisoning]
   755 E C1407029:Toxic [Qualitative Concept]
   734 E C0032346:Poison [Hazardous or Poisonous Substance]
   734 E C1548769:Poison [Intellectual Product]
   734 E C1550590:poison [Idea or Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.259: J. 

Phrase: "J."
Processing 00000000.tx.260: Neurochem., 74, 22132216.[CrossRef][ISI][Medline] Checkoway, H. and Nelson, L.M. 

Phrase: "Neurochem.,"

Phrase: "74,"

Phrase: "22132216."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Checkoway,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Nelson,"

Phrase: "L.M."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.261: (1999) Epidemiologic approaches to the study of Parkinson's disease etiology. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Epidemiologic approaches to the study of Parkinson's disease etiology."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0449445:Approaches [Spatial Concept]
   742   C1292724:Approaches [Functional Concept]
Processing 00000000.tx.262: Epidemiology, 10, 327336.[ISI][Medline] Grunewald, T. and Beal, M.F. 

Phrase: "Epidemiology,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014507:Epidemiology [Biomedical Occupation or Discipline]
  1000   C0014508:epidemiology [Functional Concept]
  1000   C0699910:epidemiology [Health Care Activity]

Phrase: "10,"

Phrase: "327336."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Grunewald,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Beal,"

Phrase: "M."

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.263: (1999) NOS knockouts and neuroprotection. 

Phrase: "(1999"

Phrase: ")"

Phrase: "NOS knockouts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "neuroprotection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598958:Neuroprotection [Cell Function]
Processing 00000000.tx.264: Nat. 

Phrase: "Nat."
Processing 00000000.tx.265: Med., 5, 13541355.[CrossRef][ISI][Medline] Pogun, S., Demirgoren, S., Taskiran, D., Kanit, L., Yilmaz, O., Koylu, E.O., Balkan, B. and London, E.D. 

Phrase: "Med.,"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "13541355."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pogun,"

Phrase: "S."

Phrase: ","

Phrase: "Demirgoren,"

Phrase: "S."

Phrase: ","

Phrase: "Taskiran,"

Phrase: "D."

Phrase: ","

Phrase: "Kanit,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Yilmaz,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Koylu,"

Phrase: "E.O.,"

Phrase: "Balkan,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "London,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023973:London [Geographic Area]

Phrase: "E.D."
Processing 00000000.tx.266: (2000) Nicotine modulates nitric oxide in rat brain. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Nicotine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028040:Nicotine [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "nitric oxide in rat brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   760   C0030015:oxide [Inorganic Chemical]
   760   C2986642:oxide [Chemical Viewed Functionally]
Processing 00000000.tx.267: Eur. 

Phrase: "Eur."
Processing 00000000.tx.268: Neuropsychopharmac., 10, 463472. 

Phrase: "Neuropsychopharmac.,"

Phrase: "10,"

Phrase: "463472."
Processing 00000000.tx.269: Matthews, R.T., Yang, L. and Beal, M.F. 

Phrase: "Matthews,"

Phrase: "R.T.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0232024:R T [Clinical Attribute]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Beal,"

Phrase: "M."

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.270: (1997) S-Methylthiocitrulline, a neuronal nitric oxide synthase inhibitor, protects against malonate and MPTP neurotoxicity. 

Phrase: "(1997"

Phrase: ")"

Phrase: "S-"

Phrase: "Methylthiocitrulline,"

Phrase: "a neuronal nitric oxide synthase inhibitor,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   937   C1373060:Nitric Oxide Synthase Inhibitor [Pharmacologic Substance]
   937   C1744692:nitric-oxide synthase inhibitor [Molecular Function]
   804   C1999216:Inhibitor [Qualitative Concept]
   771   C0669368:Neuronal Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   771   C0907533:Neuronal Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "protects against malonate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0220875:Malonate [Biologically Active Substance,Organic Chemical]

Phrase: "and"

Phrase: "MPTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2945751:phenyl [Chemical Viewed Structurally]

Phrase: "MPTP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "MPTP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "MPTP neurotoxicity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0235032:Neurotoxicity [Injury or Poisoning]
Processing 00000000.tx.271: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.272: Neurol., 143, 282286.[CrossRef][ISI][Medline] Imam, S.Z., Islam, F., Itzhak, Y., Slikker, W. 

Phrase: "Neurol.,"

Phrase: "143,"

Phrase: "282286."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Imam,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521321:Imam [Professional or Occupational Group]

Phrase: "S."

Phrase: "Z.,"

Phrase: "Islam,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022126:Islam [Idea or Concept]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Itzhak,"

Phrase: "Y.,"

Phrase: "Slikker,"

Phrase: "W."
Processing 00000000.tx.273: Jr. and Ali, S.F. 

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "and"

Phrase: "Ali,"

Phrase: "S.F."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.274: (2000) Prevention of dopaminergic neurotoxicity by targeting nitric oxide and peroxynitrite: implications for the prevention of methamphetamine-induced neurotoxic damage. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Prevention of dopaminergic neurotoxicity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0199176:Prevention [Therapeutic or Preventive Procedure]
   770   C1706420:PREVENTION [Research Activity]
   770   C2700409:prevention [Qualitative Concept]

Phrase: "by targeting nitric oxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0030015:oxide [Inorganic Chemical]
   827   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "and"

Phrase: "peroxynitrite"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0136157:Peroxynitrite [Biologically Active Substance,Inorganic Chemical]

Phrase: ":"

Phrase: "implications for the prevention of methamphetamine-induced neurotoxic damage."
Processing 00000000.tx.275: Ann. 

Phrase: "Ann."
Processing 00000000.tx.276: NY Acad. 

Phrase: "NY Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.277: Sci., 914, 157171.[Abstract/Free FullText] Qureshi, G.A., Baig, S., Bednar, I., Sodersten, P., Forsberg, G. and Siden, A. 

Phrase: "Sci.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]

Phrase: "914,"

Phrase: "157171."

Phrase: "[Abstract/Free FullText"

Phrase: "] Qureshi,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "A.,"

Phrase: "Baig,"

Phrase: "S."

Phrase: ","

Phrase: "Bednar,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Sodersten,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Forsberg,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Siden,"

Phrase: "A."
Processing 00000000.tx.278: (1995) Increased cerebrospinal fluid concentration of nitrite in Parkinson's disease. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "cerebrospinal fluid concentration of nitrite"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0427757:Nitrite concentration [Laboratory Procedure]
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "in Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.279: Neuroreport, 6, 16421644.[ISI][Medline] Gatto, E.M., Riobo, N.A., Carreras, M.C., Chernavsky, A., Rubio, A., Satz, M.L. and Poderoso, J.J. 

Phrase: "Neuroreport,"

Phrase: "6,"

Phrase: "16421644."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gatto,"

Phrase: "E.M.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Riobo,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "A.,"

Phrase: "Carreras,"

Phrase: "M.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Chernavsky,"

Phrase: "A.,"

Phrase: "Rubio,"

Phrase: "A.,"

Phrase: "Satz,"

Phrase: "M.L."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Poderoso,"

Phrase: "J.J."
Processing 00000000.tx.280: (2000) Overexpression of neutrophil neuronal nitric oxide synthase in Parkinson's disease. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Overexpression of neutrophil neuronal nitric oxide synthase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1514559:Overexpression [Genetic Function]

Phrase: "in Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.281: Nitric Oxide, 4, 534539.[CrossRef][ISI][Medline] Shergill, J.K., Cammack, R., Cooper, C.E., Cooper, J.M., Mann, V.M. and Schapira, A.H. 

Phrase: "Nitric Oxide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "4,"

Phrase: "534539."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shergill,"

Phrase: "J.K.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346601:J/K [Quantitative Concept]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Cammack,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Cooper,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335912:Cooper [Professional or Occupational Group]

Phrase: "C.E.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Cooper,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335912:Cooper [Professional or Occupational Group]

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Mann,"

Phrase: "V.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2349138:V/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Schapira,"

Phrase: "A.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.282: (1996) Detection of nitrosyl complexes in human substantia nigra, in relation to Parkinson's disease. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Detection of nitrosyl complexes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "in human substantia nigra,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
   901   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "in relation to Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.283: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.284: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.285: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.286: Commun., 228, 298305.[CrossRef][ISI][Medline] Hunot, S., Boissiere, F., Faucheux, B., Brugg, B., Mouatt-Prigent, A., Agid, Y. and Hirsch, E.C. 

Phrase: "Commun.,"

Phrase: "228,"

Phrase: "298305."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hunot,"

Phrase: "S."

Phrase: ","

Phrase: "Boissiere,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Faucheux,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Brugg,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Mouatt-Prigent,"

Phrase: "A.,"

Phrase: "Agid,"

Phrase: "Y."

Phrase: "and"

Phrase: "Hirsch,"

Phrase: "E.C."
Processing 00000000.tx.287: (1996) Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Nitric oxide synthase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   901   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0030015:oxide [Inorganic Chemical]
   827   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "and"

Phrase: "neuronal vulnerability in Parkinson's disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   797   C0012655:disease vulnerability [Clinical Attribute]
Processing 00000000.tx.288: Neuroscience, 72, 355363.[CrossRef][ISI][Medline] Good, P.F., Hsu, A., Werner, P., Perl, D.P. and Olanow, C.W. 

Phrase: "Neuroscience,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027910:Neuroscience [Biomedical Occupation or Discipline]
  1000   C1552241:Neuroscience [Professional or Occupational Group]
  1000   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "72,"

Phrase: "355363."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Good, P.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "Hsu,"

Phrase: "A.,"

Phrase: "Werner,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Perl,"

Phrase: "D.P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1512024:D.P. [Intellectual Product]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Olanow,"

Phrase: "C.W."
Processing 00000000.tx.289: (1998) Protein nitration in Parkinson's disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Protein nitration in Parkinson's disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1328815:nitration [Phenomenon or Process]
Processing 00000000.tx.290: J. 

Phrase: "J."
Processing 00000000.tx.291: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.292: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.293: Neurol., 57, 338342.[ISI][Medline] Renodon, A., Boucher, J.L., Sari, M.A., Delaforge, M., Ouazzani, J. and Mansuy, D. 

Phrase: "Neurol.,"

Phrase: "57,"

Phrase: "338342."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Renodon,"

Phrase: "A.,"

Phrase: "Boucher,"

Phrase: "J.L., Sari,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0443055:Sari [Classification]
   827   C1281896:Sari [Manufactured Object]
   827   C1826412:SARI [Gene or Genome]

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Delaforge,"

Phrase: "M."

Phrase: ","

Phrase: "Ouazzani,"

Phrase: "J."

Phrase: "and"

Phrase: "Mansuy,"

Phrase: "D."
Processing 00000000.tx.294: (1997) Bromocriptine is a strong inhibitor of brain nitric oxide synthase: possible consequences for the origin of its therapeutic effects. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Bromocriptine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006230:Bromocriptin [Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "a strong inhibitor of brain nitric oxide synthase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   822   C1373060:Nitric Oxide Synthase Inhibitor [Pharmacologic Substance]
   822   C1744692:nitric-oxide synthase inhibitor [Molecular Function]
   744   C1999216:Inhibitor [Qualitative Concept]

Phrase: ":"

Phrase: "possible consequences for the origin of its therapeutic effects."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   745   C0686907:Consequence of [Functional Concept]
           consequences
Processing 00000000.tx.295: FEBS Lett., 406, 3336.[CrossRef][ISI][Medline] Wang, X.L., Sim, A.S., Wang, M.X., Murrell, G.A., Trudinger, B. and Wang, J. 

Phrase: "FEBS Lett.,"

Phrase: "406,"

Phrase: "3336."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wang,"

Phrase: "X.L., Sim,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1420068:SIM [Gene or Genome]

Phrase: "A.S.,"

Phrase: "Wang,"

Phrase: "M."

Phrase: "X.,"

Phrase: "Murrell,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "A.,"

Phrase: "Trudinger,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Wang,"

Phrase: "J."
Processing 00000000.tx.296: (2000) Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]

Phrase: "dependent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0851827:Dependent [Qualitative Concept]
  1000   C1701901:Dependent [Qualitative Concept]
  1000   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "cigarette specific effects on endothelial nitric oxide synthase gene expression"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C1280500:effects [Qualitative Concept]
   706 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "enzyme activity."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0243102:enzyme activity [Molecular Function]
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
   777 E C0014445:enzymes [Functional Concept]
Processing 00000000.tx.297: FEBS Lett., 471, 4550.[CrossRef][ISI][Medline] Weruaga, E., Balkan, B., Koylu, E.O., Pogun, S. and Alonso, J.R. 

Phrase: "FEBS Lett.,"

Phrase: "471,"

Phrase: "4550."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Weruaga,"

Phrase: "E.,"

Phrase: "Balkan,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Koylu,"

Phrase: "E.O.,"

Phrase: "Pogun,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Alonso,"

Phrase: "J.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.298: (2002) Effects of chronic nicotine administration on nitric oxide synthase expression and activity in rat brain. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Effects of chronic nicotine administration"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on nitric oxide synthase expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   756   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "activity in rat brain."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C0443158:Brain activity [Physiologic Function]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.299: J. 

Phrase: "J."
Processing 00000000.tx.300: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.301: Res., 67, 689697.[CrossRef][ISI][Medline] Deliconstantinos, G. and Villiotou, V. 

Phrase: "Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]

Phrase: "67,"

Phrase: "689697."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Deliconstantinos,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Villiotou,"

Phrase: "V."
Processing 00000000.tx.302: (2000) Gas phase oxidants of cigarette smoke increase nitric oxide synthase and xanthine oxidase activities of rabbit brain synaptosomes. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Gas phase oxidants of cigarette smoke"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085403:Oxidants [Chemical Viewed Functionally]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "nitric oxide synthase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   901   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0030015:oxide [Inorganic Chemical]
   827   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "and"

Phrase: "xanthine oxidase activities of rabbit brain synaptosomes."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   797   C1151293:xanthine oxidase activity [Molecular Function]
   757   C0443158:Brain activity [Physiologic Function]
   748   C0441655:Activities [Activity]
   714 E C0205177:Activity [Functional Concept]
   714 E C0439167:% activity [Quantitative Concept]
   714 E C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.303: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.304: Res., 25, 769774.[CrossRef][ISI][Medline] Xu, W., Liu, L., Emson, P., Harrington, C.R., McKeith, I.G., Perry, R.H., Morris, C.M. and Charles, I.G. 

Phrase: "Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]

Phrase: "25,"

Phrase: "769774."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Xu,"

Phrase: "W.,"

Phrase: "Liu,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Emson,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Harrington,"

Phrase: "C.R.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0722969:c r [Organic Chemical,Pharmacologic Substance]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "McKeith,"

Phrase: "I.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Perry,"

Phrase: "R.H.,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0205090:R- [Spatial Concept]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Morris,"

Phrase: "C.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Charles,"

Phrase: "I.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.305: (2000) The CCTTT polymorphism in the NOS2A gene is associated with dementia with Lewy bodies. 

Phrase: "(2000"

Phrase: ")"

Phrase: "The CCTTT polymorphism in the NOS2A gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0678951:gene polymorphism [Genetic Function]
   748   C0032529:Polymorphism [Genetic Function]
   748   C1882417:Polymorphism [Qualitative Concept]

Phrase: "is"

Phrase: "associated with dementia"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0011265:dementia [Mental or Behavioral Dysfunction]
   790   C0497327:Dementia [Mental or Behavioral Dysfunction]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "with Lewy bodies."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]
Processing 00000000.tx.306: Neuroreport, 11, 297299.[ISI][Medline] Martin, E.R., Scott, W.K., Nance, M.A., Watts, R.L., Hubble, J.P., Koller, W.C., Lyons, K., Pahwa, R., Stern, M.B., Colcher, A. et al. 

Phrase: "Neuroreport,"

Phrase: "11,"

Phrase: "297299."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Martin,"

Phrase: "E.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Scott,"

Phrase: "W.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Nance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330910:nance [Plant]

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Watts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439261:Watt [Quantitative Concept]

Phrase: "R.L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Hubble,"

Phrase: "J.P.,"

Phrase: "Koller,"

Phrase: "W.C., Lyons,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Pahwa,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Stern,"

Phrase: "M.B.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Colcher,"

Phrase: "A. et al."
Processing 00000000.tx.307: (2001) Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Association of single-nucleotide polymorphisms of the tau gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0004083:Association [Mental Process]
   742   C0439849:Association [Qualitative Concept]
   742   C0596306:Association [Phenomenon or Process]
   742   C0699792:association [Social Behavior]

Phrase: "with late-onset Parkinson disease."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C3160718:PARKINSON DISEASE, LATE-ONSET [Disease or Syndrome]
   861   C0030567:Parkinson Disease [Disease or Syndrome]
   861   C1521736:Parkinson's Disease [Functional Concept]
   861   C2681933:PARKINSON DISEASE [Gene or Genome]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
   712   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.308: JAMA, 286, 22452250.[Abstract/Free FullText] Farrer, M., Skipper, L., Berg, M., Bisceglio, G., Hanson, M., Hardy, J., Adam, A., Gwinn-Hardy, K. and Aasly, J. 

Phrase: "JAMA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422839:JAMA [Gene or Genome]

Phrase: "286,"

Phrase: "22452250."

Phrase: "[Abstract/Free FullText"

Phrase: "] Farrer,"

Phrase: "M."

Phrase: ","

Phrase: "Skipper,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Berg,"

Phrase: "M."

Phrase: ","

Phrase: "Bisceglio,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hanson,"

Phrase: "M."

Phrase: ","

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Adam,"

Phrase: "A.,"

Phrase: "Gwinn-Hardy,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Aasly,"

Phrase: "J."
Processing 00000000.tx.309: (2002) The tau H1 haplotype is associated with Parkinson's disease in the Norwegian population. 

Phrase: "(2002"

Phrase: ")"

Phrase: "The tau H1 haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotype [Organism Attribute]

Phrase: "is"

Phrase: "associated with Parkinson's disease"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   833   C0030567:Parkinson Disease [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1521736:Parkinson's Disease [Functional Concept]
   833   C2681933:PARKINSON DISEASE [Gene or Genome]
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "in the Norwegian population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]
Processing 00000000.tx.310: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.311: Lett., 322, 8386.[CrossRef][ISI][Medline] Maraganore, D.M., Hernandez, D.G., Singleton, A.B., Farrer, M.J., McDonnell, S.K., Hutton, M.L., Hardy, J.A. and Rocca, W.A. 

Phrase: "Lett.,"

Phrase: "322,"

Phrase: "8386."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Maraganore,"

Phrase: "D."

Phrase: "M."

Phrase: ","

Phrase: "Hernandez,"

Phrase: "D."

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Singleton,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0481462:singleton [Finding]
  1000   C1313913:Singleton [Family Group]

Phrase: "A.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1440044:A,B [Immunologic Factor]

Phrase: "Farrer,"

Phrase: "M."

Phrase: "J.,"

Phrase: "McDonnell,"

Phrase: "S."

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hutton,"

Phrase: "M.L.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hardy,"

Phrase: "J."

Phrase: "A."

Phrase: "and"

Phrase: "Rocca,"

Phrase: "W."

Phrase: "A."
Processing 00000000.tx.312: (2001) Casecontrol study of the extended tau gene haplotype in Parkinson's disease. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Casecontrol study of the extended tau gene haplotype"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0007328:Case-Control Study [Research Activity]
   744   C0557651:Study [Manufactured Object]
   744   C2603343:Study [Research Activity]

Phrase: "in Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.313: Ann. 

Phrase: "Ann."
Processing 00000000.tx.314: Neurol., 50, 658661.[CrossRef][ISI][Medline] Scott, W.K., Nance, M.A., Watts, R.L., Hubble, J.P., Koller, W.C., Lyons, K., Pahwa, R., Stern, M.B., Colcher, A., Hiner, B.C. et al. 

Phrase: "Neurol.,"

Phrase: "50,"

Phrase: "658661."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Scott,"

Phrase: "W.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Nance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330910:nance [Plant]

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Watts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439261:Watt [Quantitative Concept]

Phrase: "R.L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Hubble,"

Phrase: "J.P.,"

Phrase: "Koller,"

Phrase: "W.C., Lyons,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Pahwa,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Stern,"

Phrase: "M.B.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Colcher,"

Phrase: "A.,"

Phrase: "Hiner,"

Phrase: "B.C. et al."
Processing 00000000.tx.315: (2001) Complete genomic screen in Parkinson disease: evidence for multiple genes. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Complete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Complete [Qualitative Concept]

Phrase: "genomic screen in Parkinson disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220908:screen [Health Care Activity]
   760   C1305399:screen [Functional Concept]
   760   C1705053:Screen [Medical Device]

Phrase: ":"

Phrase: "evidence for multiple genes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]
Processing 00000000.tx.316: JAMA, 286, 22392244.[Abstract/Free FullText] Lo, H.S., Hogan, E.L. and Soong, B.W. 

Phrase: "JAMA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422839:JAMA [Gene or Genome]

Phrase: "286,"

Phrase: "22392244."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lo,"

Phrase: "H.S.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Hogan,"

Phrase: "E.L."

Phrase: "and"

Phrase: "Soong,"

Phrase: "B.W."
Processing 00000000.tx.317: (2002) 5'-Flanking region polymorphism of the neuronal nitric oxide synthase gene with Parkinson's disease in Taiwan. 

Phrase: "(2002"

Phrase: ")"

Phrase: "5'-Flanking region polymorphism of the neuronal nitric oxide synthase gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C0678951:gene polymorphism [Genetic Function]
   738   C0032529:Polymorphism [Genetic Function]
   738   C1882417:Polymorphism [Qualitative Concept]

Phrase: "with Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "in Taiwan."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039260:Taiwan [Geographic Area]
Processing 00000000.tx.318: J. 

Phrase: "J."
Processing 00000000.tx.319: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.320: Sci., 194, 1113.[CrossRef][ISI][Medline] Grasemann, H., Yandava, C.N. and Drazen, J.M. 

Phrase: "Sci.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]

Phrase: "194,"

Phrase: "1113."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Grasemann,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yandava,"

Phrase: "C.N."

Phrase: "and"

Phrase: "Drazen,"

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.321: (1999) Neuronal NO synthase (NOS1) is a major candidate gene for asthma. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Neuronal NO synthase"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0669368:Neuronal Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0907533:Neuronal Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0030015:oxide [Inorganic Chemical]
   812   C0521390:Neuronal [Immunologic Factor]
   812   C2986642:oxide [Chemical Viewed Functionally]
   741 E C0027882:Neuron [Cell]

Phrase: "(NOS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0907533:NOS1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417759:NOS1 [Gene or Genome]
  1000   C1427871:NOS1 [Gene or Genome]

Phrase: ")"

Phrase: "is"

Phrase: "a major candidate gene for asthma."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1332838:Candidate Gene [Gene or Genome]
   783   C0079429:A Gene [Gene or Genome]
   753   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.322: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.323: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.324: Allergy, 29(Suppl. 

Phrase: "Allergy,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0002111:Allergy [Biomedical Occupation or Discipline]
  1000   C0020517:Allergy [Pathologic Function]
  1000   C0489531:allergy [Finding]
  1000   C1314973:ALLERGY [Clinical Attribute]
  1000   C3539909:Allergy [Disease or Syndrome]
   928 E C0700624:Allergic [Functional Concept]

Phrase: "29"

Phrase: "(Suppl."
Processing 00000000.tx.325: 4), 3941.[ISI][Medline] Elbaz, A., Levecque, C., Clavel, J., Vidal, J.S., Richard, F., Corrze, J.R., Delemotte, B., Amouyel, P., Alprovitch, A., Chartier-Harlin, M.C. and Tzourio, C. 

Phrase: "4"

Phrase: ")"

Phrase: ","

Phrase: "3941."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Elbaz,"

Phrase: "A.,"

Phrase: "Levecque,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Clavel,"

Phrase: "J.,"

Phrase: "Vidal,"

Phrase: "J.S.,"

Phrase: "Richard,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Corrze,"

Phrase: "J.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Delemotte,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Amouyel,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Alprovitch,"

Phrase: "A.,"

Phrase: "Chartier-Harlin,"

Phrase: "M.C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Tzourio,"

Phrase: "C."
Processing 00000000.tx.326: (2002) The S18Y polymorphism in the UCH-L1 gene and Parkinson's disease: evidence for an age-dependent relation. 

Phrase: "(2002"

Phrase: ")"

Phrase: "The S18Y polymorphism in the UCH-L1 gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0678951:gene polymorphism [Genetic Function]
   744   C0032529:Polymorphism [Genetic Function]
   744   C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: ":"

Phrase: "evidence for an age-dependent relation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332120:Evidence [Functional Concept]
Processing 00000000.tx.327: Mov. 

Phrase: "Mov."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825516:MOV [Quantitative Concept]
Processing 00000000.tx.328: Disord., DOI 10.1002/mds.10326. 

Phrase: "Disord.,"

Phrase: "DOI 10.1002/mds.10326."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C2348291:DOI [Classification]
   804   C3539662:MDS [Gene or Genome]
Processing 00000000.tx.329: de Rijk, M.C., Rocca, W.A., Anderson, D.W., Melcon, M.O., Breteler, M.M. and Maraganore, D.M. 

Phrase: "de Rijk,"

Phrase: "M.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Rocca,"

Phrase: "W."

Phrase: "A.,"

Phrase: "Anderson,"

Phrase: "D.W.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Melcon,"

Phrase: "M.O.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Breteler,"

Phrase: "M."

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Maraganore,"

Phrase: "D."

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.330: (1997) A population perspective on diagnostic criteria for Parkinson's disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "A population perspective on diagnostic criteria"

Phrase: "for Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.331: Neurology, 48, 12771281.[Abstract] Bower, J.H., Maraganore, D.M., McDonnell, S.K. and Rocca, W.A. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "48,"

Phrase: "12771281."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Bower,"

Phrase: "J.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Maraganore,"

Phrase: "D."

Phrase: "M."

Phrase: ","

Phrase: "McDonnell,"

Phrase: "S."

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Rocca,"

Phrase: "W."

Phrase: "A."
Processing 00000000.tx.332: (1999) Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 19761990. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Incidence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0021149:Incidence [Quantitative Concept]
  1000   C0220856:incidence [Functional Concept]
   928 E C1551358:incident [Idea or Concept]

Phrase: "and"

Phrase: "distribution of parkinsonism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520511:distribution [Idea or Concept]
   790   C1704711:Distribution [Functional Concept]

Phrase: "in Olmsted County,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0079170:County [Geographic Area]

Phrase: "Minnesota,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026183:Minnesota [Geographic Area]

Phrase: "19761990."
Processing 00000000.tx.333: Neurology, 52, 12141220.[Abstract/Free FullText] Clavel, J., Glass, D.C., Cordier, S. and Hemon, D. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "52,"

Phrase: "12141220."

Phrase: "[Abstract/Free FullText"

Phrase: "] Clavel,"

Phrase: "J.,"

Phrase: "Glass,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017596:Glass [Manufactured Object]
  1000   C1947936:Glass [Medical Device]
   928 E C0074759:Glassy [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   928 E C0522500:Glassy [Qualitative Concept]

Phrase: "D.C.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012358:D & C [Therapeutic or Preventive Procedure]
  1000   C0012764:D.C. [Geographic Area]
  1000   C1444662:D/C [Finding]
  1000   C1512015:D.C. [Intellectual Product]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Cordier,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Hemon,"

Phrase: "D."
Processing 00000000.tx.334: (1993) Standardization in the retrospective evaluation by experts of occupational exposure to organic solvents in a population-based case-control study. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Standardization in the retrospective evaluation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0038136:Standardization [Research Activity]

Phrase: "by experts"

Phrase: "of occupational exposure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028798:Occupational Exposure [Injury or Poisoning]
   861   C0274281:Exposure, NOS [Injury or Poisoning]
   861   C0332157:Exposure [Clinical Attribute]

Phrase: "to organic solvents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0360100:Organic Solvents [Organic Chemical]
   861   C0037638:Solvents [Indicator, Reagent, or Diagnostic Aid]
   861   C1697819:solvents [Intellectual Product]

Phrase: "in a population-based case-control study."
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   911   C1709599:Population Based Study [Research Activity]
   897   C0681876:Population Study [Research Activity]
   888   C0007328:based case study [Research Activity]
           Case-Control Study
   875   C0032662:Population Control [Occupation or Discipline]
   853   C0085973:Case Study [Intellectual Product]
   840   C0872128:case control [Health Care Activity]
   804   C0243148:control [Qualitative Concept]
   804   C0557651:Study [Manufactured Object]
   804   C0868928:Case [Functional Concept]
   804   C1550141:Control [Substance]
   804   C1706255:CASE [Medical Device]
   804   C1706256:Case [Conceptual Entity]
   804   C1882979:Control [Conceptual Entity]
   804   C2587213:Control [Functional Concept]
   804   C2603343:Study [Research Activity]
   804   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.335: Int. 

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.336: J. 

Phrase: "J."
Processing 00000000.tx.337: Epidemiol., 22(Suppl. 

Phrase: "Epidemiol.,"

Phrase: "22"

Phrase: "(Suppl."
Processing 00000000.tx.338: 2), S121126.[ISI][Medline] Stewart, W.F. and Stewart, P.A. 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "S121126."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Stewart,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551641:Stewart [Population Group]

Phrase: "W.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Stewart,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551641:Stewart [Population Group]

Phrase: "P.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.339: (1994) Occupational case-control studies: I. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Occupational case-control studies"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   923   C0007328:Case-Control Studies [Research Activity]
   875   C0085973:Case Studies [Intellectual Product]
   861   C0872128:case control [Health Care Activity]
   812   C0243148:control [Qualitative Concept]
   812   C0868928:Case [Functional Concept]
   812   C0947630:studies [Laboratory Procedure]
   812   C1550141:Control [Substance]
   812   C1706255:CASE [Medical Device]
   812   C1706256:Case [Conceptual Entity]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]
   779 E C0557651:Study [Manufactured Object]
   779 E C2603343:Study [Research Activity]

Phrase: ":"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.340: Collecting information on work histories and work-related exposures. 

Phrase: "Collecting information on work histories"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1533716:Information [Idea or Concept]

Phrase: "and"

Phrase: "work-related exposures."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   983   C3258406:Work related exposure [Finding]
   827   C0274281:exposures [Injury or Poisoning]
   827   C0728853:exposures [Phenomenon or Process]
   793 E C0332157:Exposure [Clinical Attribute]
   734   C1698590:work related [Finding]
Processing 00000000.tx.341: Am. 

Phrase: "Am."
Processing 00000000.tx.342: J. 

Phrase: "J."
Processing 00000000.tx.343: Ind. 

Phrase: "Ind."
Processing 00000000.tx.344: Med., 26, 297312.[ISI][Medline] Schaid, D.J., Rowland, C.M., Tines, D.E., Jacobson, R.M. and Poland, G.A. 

Phrase: "Med.,"

Phrase: "26,"

Phrase: "297312."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Schaid,"

Phrase: "D.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Rowland,"

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "Tines,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456171:Tines [Medical Device]

Phrase: "D."

Phrase: "E.,"

Phrase: "Jacobson,"

Phrase: "R.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0694746:r m [Immunologic Factor,Pharmacologic Substance]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Poland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032356:Poland [Geographic Area]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "A."
Processing 00000000.tx.345: (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Score tests for association"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   816   C0237855:score test [Qualitative Concept]
   816   C0237856:score test [Educational Activity]
   770   C0022885:Tests [Laboratory Procedure]
   770   C0392366:Tests [Intellectual Product]
   737 E C0039593:Test [Functional Concept]

Phrase: "between traits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0599883:traits [Organism Attribute]
  1000   C1427926:TRAITS [Gene or Genome]

Phrase: "and"

Phrase: "haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "when"

Phrase: "linkage phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205390:Phase [Temporal Concept]

Phrase: "is"

Phrase: "ambiguous."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1549102:Ambiguous [Organism Attribute]
  1000   C3539086:Ambiguous [Intellectual Product]
   928 E C2346729:Ambiguity [Qualitative Concept]
Processing 00000000.tx.346: Am. 

Phrase: "Am."
Processing 00000000.tx.347: J. 

Phrase: "J."
Processing 00000000.tx.348: Hum. 

Phrase: "Hum."
Processing 00000000.tx.349: Genet., 70, 425434.[CrossRef][ISI][Medline] Thompson, E.A., Deeb, S., Walker, D. and Motulsky, A.G. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "70,"

Phrase: "425434."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Thompson,"

Phrase: "E.A.,"

Phrase: "Deeb,"

Phrase: "S."

Phrase: ","

Phrase: "Walker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043016:Walker [Medical Device]

Phrase: "D."

Phrase: "and"

Phrase: "Motulsky,"

Phrase: "A.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.350: (1988) The detection of linkage disequilibrium between closely linked markers: RFLPs at the AI-CIII apolipoprotein genes. 

Phrase: "(1988"

Phrase: ")"

Phrase: "The detection of linkage disequilibrium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "between closely linked markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0005516:Marker [Clinical Attribute]

Phrase: ":"

Phrase: "RFLPs at the AI-CIII apolipoprotein genes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0035268:RFLPs [Clinical Attribute]
Processing 00000000.tx.351: Am. 

Phrase: "Am."
Processing 00000000.tx.352: J. 

Phrase: "J."
Processing 00000000.tx.353: Hum. 

Phrase: "Hum."
Processing 00000000.tx.354: Genet., 42, 113124.[ISI][Medline]

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "42,"

Phrase: "113124."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

